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II. ABSTRACT
The main aim of this project was to determine the neurotrophic actions of glial 
cell line-derived neurotrophic factor (GDNF) and neurturin, two novel members of 
the transforming growth factor-beta superfamily of proteins, on neurons from the 
peripheral nervous system and to identify their receptors. It is found that GDNF 
promotes the survival of multiple populations of chicken sensory and autonomic 
neurons in culture throughout development. Whereas sympathetic, parasympathetic 
and propioceptive neurons become less responsive to GDNF with age, 
enteroceptive and sensory cutaneous neurons become more responsive to GDNF. 
GDNF mRNA is expressed in the tissues innervated by these neurons, and 
developmental changes in its expression in several tissues mirror the changing 
responses of the innervating neurons to GDNF. These results have changed the 
previous notion that GDNF is a highly specific neurotrophic factor for motoneurons 
and dopaminergic neurons. It is shown that neurturin, which is structurally related 
to GDNF, also promotes the in vitro survival of embryonic chicken sensory and 
autonomic neurons. Thus, GDNF and neurturin compose a novel subfamily of 
homologous neurotrophic factors with a similar pattern of activity.
The cloning of chicken GDNF receptor-alpha (GDNFR-a) and a novel 
receptor termed neurturin receptor-alpha (NTNR-a) is reported. GDNFR-a and 
NTNR-a are homologous receptors linked to the membrane via a glycosyl- 
phosphatidylinositol linkage. It is shown that ectopic co-expression in neurons of 
GDNFR-a with RET (rearranged during transfection), a transmembrane receptor 
tyrosine kinase, confers a survival response to GDNF, but not neurturin, and that 
co-expression of NTNR-a with RET confers a survival response to neurturin, but 
not GDNF. GDNFR-a and NTNR-a mRNAs are widely expressed in the nervous 
system, including GDNF and neurturin responsive neurons, and in non-neuronal 
tissues. These findings indicate that GDNF and neurturin promote neuronal 
survival by signalling via similar multicomponent receptors that consist of a 
common transducing receptor tyrosine kinase and a member of a newly emerging 
family of glycosyl-phosphatidylinositol-linked receptors that confer ligand- 
specificity.
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VIII. CHAPTER 1
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GENERAL INTRODUCTION
1. GENERALITIES
The nervous system is the most complex organ structure in the human body. 
Despite the relative simplicity of its basic units, neurons and glial cells, the 
complexity of the nervous system is due to (1) the large number of neurons, there 
are about IQii neurons in the adult human brain, (2) the large number of different
kinds of nerve cells, probably about 10,000 different types, (3) the large number of 
connections that a neuron receives and establishes, i.e., the cerebellar Purkinje cell 
receives aproximately 150,000 contacts, and (4) the precise patterns of connections 
between neurons and with cells from other tissues. It is considered that the different 
functions of the mature human nervous system -like perception, motor coordination, 
memory, language, affection, conciousness, thought- depend on the establishment 
and consolidation of specific patterns of neuronal connections. A first step to get 
insights into this functional network is to understand the development of the nervous 
system.
1.1. DEVELOPMENT OF THE VERTEBRATE NERVOUS 
SYSTEM
During the early development of the vertebrate embryo, the monolayered 
blastula is transformed into a three-layered structure through a process of 
morphogenetic movements termed gastrulation. These three layers are: the 
endoderm, a tube that constitutes the primitive gut, is the innermost layer; the 
ectoderm, the epithelium that covers the embryo, is the outermost layer; and the 
mesoderm, between the two, is a layer of primaiy and secondary mesenchyme cells. 
Later, during organogenesis, the various organs of the body are formed. The 
primitive gut gives rise to the epithelial components of the pharynx, esophagus, 
stomach, intestine, and the associated structures like, the salivaiy glands, liver, 
pancreas, trachea, and lungs. The primitive mesenchyme gives rise to connective 
tissues (cartilage, bone, fibrous tissue), muscles, and the vascular and urogenital
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systems. Finally, the ectoderm gives rise to the epidermis and the nervous system.
The development of the vertebrate nervous system is initiated during 
gastrulation by a process termed neural induction. The ectoderm close to the 
midline is induced to become neural ectoderm by the underlying notochord and 
mesoderm adjacent to it. During a post-gastrulation period of morphogenetic 
movements known as neurulation the induced neural tissue becomes organised into 
a hollow neural tube, the precursor of the vertebrate CNS. First, the neural 
ectoderm thickens to form the neural plate. Then, the lateral edges of the neural 
plate start to rear up in folds forming the neural folds, that gradually roll together, 
while the midline of the plate sinks deeper. Finally, the neural folds fuse to form 
the neural tube, which remains covered by a layer of ectoderm. This tube will give 
rise to the brain and the spinal cord, i.e., the central nervous system (CNS).
Along the line where the neural tube separates from the future epidermis, a 
number of ectodermal cells break loose from the epithelium to form the neural crest. 
These cells originate from the marginal zone between the neural plate and 
prospective epidermis. Neural crest cells migrate through the mesoderm to reach 
diverse regions within the vertebrate embryo where they subsequently give rise to a 
wide variety of derivatives. Neural crest cells form almost all the peripheral nervous 
system (PNS), including the autonomic sympathetic and parasympathetic ganglia, 
most of the sensory ganglia, Schwann cells and satellite cells. Moreover, they give 
rise to the chromaffin cells of the medular adrenal gland and the melanocytes of the 
skin, and in the head, many neural crest cells differentiate into connective tissues.
1.2. GANGLIA FROM THE PERIPHERAL NERVOUS SYSTEM
The peripheral nervous system is composed by ganglia from the autonomic 
and sensory systems and the peripheral nerves that lie outside the brain and spinal 
cord. The autonomic nervous system has three principal divisions: the sympathetic 
(or thoracolumbar), the parasympathetic (or craniosacral), and the enteric system.
1.2.1. Sensory ganglia
31
a) Cranial sensoi-y ganglia: are found on five of the 12 pairs of cranial nerves. 
They include:
-The trigeminal ganglion (located on the V cranial nerve): it contains neurons that 
innervate mainly mechanoreceptors, thermoreceptors and nociceptors in the face and 
both oral and nasal cavities, and give sensory innervation to the teeth.
-The geniculate ganglion (present on the VII cranial nerve): it is composed of 
neurons that innervate the specialised receptor cells of taste buds in the anterior two- 
thirds of the tongue.
-The jugular ganglion (found on the proximal X cranial nerve) and the nodose 
ganglion (found on the distal X cranial nerve): they are in charge of conveying a 
variety of visceral sensory information from the pharynx, larynx, thorax and 
abdomen.
-The petrosal ganglion (located on the distal IX cranial nerve): it is composed of 
neurons that innervate taste buds in the posterior third of the tongue.
-The vestibulo-acoustic ganglion (present on the VIII cranial nerve): it contains 
neurons that innervate the hair cells of the organs of hearing and balance.
-The trigeminal mesencephalic nucleus: located in the midbrain, it contains 
proprioceptive neurons that innervate muscle spindles and tendon organs in the 
masticatory muscles. This is the only central nervous system site in which primary 
sensory neuron cell bodies that derive from the neural crest have been found. This 
nucleus does not belong to the PNS, although it is included in this classification 
because it contains primary sensory neurons.
b) Dorsal root ganglia: are located on the dorsal roots of the spinal nerves 
immediately adjacent to the spinal cord. Neurons in the dorsal root ganglia (DRG) 
convey sensory information from the skin, muscles, and joints of the limbs and 
trunk.
1.2.2. Sympathetic ganglia
a) The paravertebral lumbar chain: includes the superior cervical ganglion (that 
innervates diverse structures in the head and neck, like the salivary, lacrimal, and 
sweat glands, vessels, and hair follicles), the middle cervical ganglion and the 
stellate ganglion (they both give innervation to the heart, lungs and bronchi), and 
the sympathetic chain ganglia (that innervate the body wall).
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b) The prevertebral ganglia: include the celiac ganglion (that innervates the 
esophagus and stomach), the aorticorenal ganglion (that innervates the kidneys), the 
superior mesenteric ganglion (that gives innervation to the small intestine), and the 
inferior mesenteric ganglion (that innervates the cecum, colon and pelvic organs). 
Finally, the adrenal medulla which contains chi'omaffin cells can be considered as a 
prevertebral ganglion as these cells ai*e developmentally and functionally related to 
postganglionic sympathetic neurons.
1.2.3. Parasympathetic ganglia
These include the ciliary ganglion (that innervates vessels in the choroid layer, 
the pupillary constrictor and ciliary muscle), the pterygopalatine ganglion (which 
gives innervation to the lacrimal glands and palatal, pharyngeal and nasal mucous 
glands), the submandibular ganglion (which innervates the submandibular and 
sublingual glands, and oral mucous glands), the otic ganglion (which innervates the 
parotids glands and oral mucous glands), the terminal ganglia of the vagus nerve 
(which innervate all the viscera of the torax and abdominal cavity), and the pelvic 
plexus (which gives innervation to the bladder, descending colon, rectum and 
genitalia).
1.2.4. Enteric ganglia
The enteric nervous system (ENS) is composed of a collection of autonomic 
ganglia, which contain sensory neurons, interneurons, motor neurons, and 
astrocyte-like glia, and are arranged in interconnected plexuses distributed in the 
wall of the gastrointestinal tract. The two major plexuses are the submucous (or 
Meissner's) and the myenteric (or Auerbach's) plexuses. The ENS ganglia 
innervate the muscles of the gut wall and the vessels and glands of the mucosa.
1.3. ORIGINS OF THE PERIPHERAL NERVOUS SYSTEM
Sensory neurons differentiate from progenitor cells that originate from two 
regions of the embryonic ectoderm, the neural crest and neurogenic placodes 
(Noden, 1978; D'Amico-Martel and Noden, 1983; Le Douarin, 1986). The 
neurogenic placodes are epithelial thickenings appearing in the cephalic ectoderm of
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the early vertebrate embiyo. In the chicken embryo, the neurons of the ventrolateral 
part of the trigeminal ganglion, and the vestibulo-acoustic, geniculate, petrosal and 
nodose ganglia are derived from neurogenic epibranchial placodes. The neuronal 
cells of the dorsomedial trigeminal ganglion, the trigeminal mesencephalic nucleus, 
the jugulai' ganglion and the dorsal root ganglia are derived from different regions of 
the neural crest (D'Amico-Martel and Noden, 1983; Vogel, 1992). The Schwann 
cells and satellite cells associated with all sensory ganglia aiise exclusively from the 
neural crest (D'Amico-Maitel and Noden, 1983; Vogel, 1992).
Trunk neural crest cells give rise to the neurons and glial cells of the 
sympathetic and parasympathetic ganglia of the body (D'Amico-Martel and Noden, 
1983; Bronner-Fraser, 1988; Le Douarin, 1980). Both neuronal and glial cells of 
the ENS are derived from the neural crest (NC). Enteric progenitors originate from 
three regions of the NC, the vagal, sacral and truncal region (Le Douarin et al. , 
1973; 1974; Bronner-Fraser, 1988; Serbedzija et al, 1991; Epstein et al, 1994).
Cell lineage studies have shown that premigratory crest cells are not generally 
commited to single fate prior to migration (Bronner-Fraser, 1988). Their 
differentiation is influenced by the microenvironment of both the migratory pathway 
and the destination site.
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2. TH E NEURO TRO PHIC TH EO R Y AND APOPTOSIS
2.1. THE NEUROTROPHIC THEORY
Neurons are generated in excess during the development of the vertebrate 
nervous system. Approximately 50% of the neurons die shortly after their axons 
reach their target fields, i.e. the tissues they innervate, during a short period called 
"phase of naturally occurring cell death" (for review, see Davies, 1994a). This loss 
may be required to match the number of neurons to the size and requirements of 
their target fields. Neuronal death occurs by apoptosis, a descriptive name given to 
a genetically regulated process of cell death (Oppenheim, 1991). According to the 
neurotrophic hypothesis, target fields regulate the size of the neuronal populations 
that innervate them by producing limiting amounts of neurotrophic factors, which 
are essential for the survival of developing neurons. Because the supply of these 
factors is though to be limiting, only a proportion of the neurons are able to obtain 
enough trophic factor to survive. Thus, the level of trophic factor production in the 
target field directly influences the size of the innervating population of neurons 
(Davies, 1994). The neurotrophic theory was initially formulated on the basis of 
work on nerve growth factor (NGF), the first neurotrophic factor to be identified 
(Levi-Montalcini, 1987), and posteriorly generalized with the discovery of other 
neurotrophic factors such as BDNF (Barde et al, 1982).
In support of the neurotrophic hypothesis, certain populations of developing 
neurons are dependent on NGF for survival in vitro and in vivo. Administration of 
anti-NGF antibodies during their phase of tai'get field innervation increases neuronal 
death, whereas exogenous NGF enhances the number of surviving neurons that 
would otherwise die (Levi-Montalcini, 1987). Recent data obtained from mutant 
mice with targeted disruption of either the NGF gene or the NGF receptor tyrosine 
kinase gene have confirmed the dependency of these neurons on NGF for survival 
during development (Crowley e ta l ,  1994; Smeyne et a l ,  1994). Furthermore, 
NGF is synthesized in the tissues innervated by these neurons coinciding with the 
beginning of target field innervation (Davies e ta l , 1987; Korsching and Thoenen,
1988). The level of NGF expression in these tissues is found to be proportional to 
their final innervation density (Haiper and Davies, 1990).
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It is currently believed that multiple neurotrophic factors may cooperate in 
regulating the survival of neurons during development and in some cases these 
factors are supplied using mechanisms apparently in contradiction with the 
neurotrophic theory. Thus, it has been shown that neurons can obtain neurotrophic 
factors via anterograde, autocrine, and paracrine routes (for reviews, see 
Oppenheim, 1991; Davies, 1996a), although the physiological relevance of these 
findings in the regulation of neuronal survival in vivo remains unclear.
2.2. APOPTOSIS
Apoptosis or programmed cell death is a genetically controlled mechanism 
used by cells to commit suicide in response to a variety of stimuli. It plays a major 
role in several tissues, including the nervous system, during development to ensure 
a proper matching between different interacting cell populations. The execution of 
this death program is often associated with characteristic morphological and 
biochemical changes that distinguishes it from necrosis; the nucleus and cytoplasm 
condense, and the dying cell fragments into membrane-bound apoptotic bodies that 
are rapidly phagocytosed by surrounding macrophages (Wyllie et al., 1980). The 
process of apoptosis is regulated through the expression of an increasingly 
discovered number of genes, conserved during evolution from nematodes and 
viruses to mammals. Some gene products are activators of apoptosis, whereas 
others are inhibitors (for review, see Davies, 1995).
A least fifteen genes encoding proteins that either inhibit or accelerate cell 
death compose the Bcl-2 family. The founder of the family, Bcl-2, is a proto­
oncogene that was originally identified at the breakpoint of translocations commonly 
occurring in human B cell follicular lymphoma (Bakhshi et ai,  1985; Tsujimoto et 
al., 1985; Cleary et al., 1986) and encodes a membrane-associated protein that 
enhances cell survival by preventing cell death (Vaux et al., 1988). The subgroup 
of vertebrate gene products that inhibit apoptosis is composed of: Bcl-2, B c 1 -x l ,  
Bcl-w, Mcl-l and Al, whereas the accelerators of cell death include: Bcl-xs, Bax, 
Bad, Bak and Nbk/Bikl (for review, see Rao and White, 1997). A striking feature 
of the Bcl-2 family members is their ability to homodimerize and heterodimerize
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through the conserved regions, BHl, BH2 and BH3 (Bcl-2 homology regions 1, 2 
and 3). The level of expression of pro-apoptotic and anti-apoptotic proteins and the 
interactions between them seem to regulate cell death (Rao and White, 1997). 
Furthermore, post-translational phosphorylation of some Bcl-2 family members is 
also involved in controlling apoptosis (for review, see Gajewski and Thompson,
1996).
Another family of proteins that regulates cell death is the interleukin-IB- 
converting enzyme (ICE) family of cysteine proteases, also termed caspases. They 
are involved in a cascade of proteolytic events and, upon activation during 
apoptosis, induce cellular disassembly as a result of cleavage of numerous cellular 
substrates (Fraser and Evan, 1996, Rao and White, 1997; Martins and Earnshaw,
1997).
Whereas the Bcl-2 family of proteins is in control of apoptosis, the ICE family 
of proteins is involved in the execution of apoptosis. It has been recently 
demonstrated that the Bcl-2 family of proteins regulate caspase activation by 
translocation of cytochrome C and a protease, AIF (apoptosis-inducing factor) from 
the mitochondria to the cytosol, functionally linking the two families (for reviews, 
see Golstein, 1997; Martins and Earnshaw, 1997).
Some signalling molecules, like neurotrophic factors, induce a survival 
response, whereas others, like the Fas ligand and TNF, promote apoptosis. A 
functional connection between the intracellular signalling pathway mediated by Fas 
or TNFR-I and the activation of the cell death machinary has been recently reported 
(Fraser and Evan, 1996). However, the intracellular events mediated by the 
neurotrophic factor receptors that lead to cell suiwival are mostly unknown.
The survival of neurons during the development of the vertebrate nervous 
system is mainly promoted by members of three groups of neurotrophic factors: the 
family of neurotrophins, the family of neuropoietic cytokines and the family of 
TGF-B-related proteins.
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3. TH E F A M IL Y  OF NEUROTROPHINS AND T H E IR
RECEPTORS
The neurotrophins are the best characterized family of neurotrophic factors. 
The family comprises six highly homologous proteins; nerve growth factor (NGF), 
brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), neurotrophin- 
4/5 (NT-4/5) and neurotrophin-6 (NT-6). These proteins regulate numerous events 
during the development of the vertebrate nervous system including neuroblast 
proliferation, neuronal survival and differentiation, axonal branching, and synaptic 
function (Davies, 1994b; Snider, 1994; Thoenen, 1995). It has been suggested that 
the NGF gene appealed more recently in evolution than BDNF and NT-3, probably 
as a result of gene duplication and diversification by mutations (Barde, 1994). 
Neurotrophins transduce their signal into the cell through binding to a receptor 
complex composed of two transmembrane proteins, a specific high-affinity receptor 
tyrosine kinase (Trk) and a common low affinity receptor (p75NTR) (for review, see 
Snider, 1994).
3.1. MEMBERS OF THE NEUROTROPHIN FAMILY
3.1.1. Nerve growth factor
Nerve growth factor (NGF) is a protein that was initially purified and 
characterized from the submandibulai' gland of the adult male mouse, where it exists 
in inexplicably large amounts, on the basis of its ability to induce fibre outgrowth 
from sensory and sympathetic ganglia both in vivo and in vitro (Cohen, 1960). The 
determination of the mouse NGF amino acid sequence (Angeletti and Bradshaw, 
1971) led to the cloning of the mouse NGF cDNA (Scott et a l ,  1983). 
Subsequently, human, bovine and chicken NGF genes have been cloned (Ullrich et 
al, 1983; Meier etal., 1986; Ebendal et al., 1986). The mouse NGF gene encodes 
a 307 amino acid precursor polypeptide that is processed to release a 118-residue 
glycosylated mature protein (Berger and Shooter, 1977; Scott etal., 1983; Edwards 
et al., 1988). Analysis of the three-dimensional structure of mature NGF has 
revealed that it contains a motif of three intrachain disulphide bridges, known as the 
"cysteine knot", and two antiparallel B strands. Non-covalent homodimerization
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through extensive hydrophobic interactions gives rise to biologically active NGF 
(McDonald e ta l,  1991).
Several in vitro and in vivo studies have provided evidence that NGF is a 
survival factor for developing sympathetic neurons, certain kinds of sensory 
neurons and basal forebrain cholinergic neurons (Chun and Patterson, 1977; 
Hamburger et a l,  1981; Davies and Lindsay, 1985; Levi-Montalcini, 1987; 
Hartikka and Hefti, 1988; for reviews, see Barde, 1989; Davies, 1994b). 
Furthermore, NGF mRNA is expressed in the target tissues of these populations of 
neurons. For example, NGF synthesis in developing mouse skin coincides with the 
onset of target field innervation by NGF-dependent trigeminal ganglion neurons 
(Davies e t a l ,  1987). NGF is also present in embryonic mouse heart and 
submandibular gland coinciding with their innervation by sympathetic neurons 
(Korsching and Thoenen, 1988). NGF mRNA is found in several regions of the 
brain including, rat hippocampus, neocortex and olfactory bulb, where it is 
expressed at high levels (Korsching et a l ,  1985; Whittemore et a l,  1986; 
Maisonpierre et al,  1990a), and chicken optic tectum and cerebellum (Ebendal et 
oA, 1986).
Mice with targeted disruption of the NGF gene have been generated to 
facilitate the study of the actions of NGF in the developing nervous system in vivo. 
Homozygous mice fail to respond to noxious mechanical stimuli due to an impaired 
nociceptive system (Crowley et a l , 1994). These mice exhibit a dramatic depletion 
in cell numbers in dorsal root, trigeminal and sympathetic ganglia. The neuronal 
loss in DRG is selective and involves small-diameter neurons that are thought to 
mediate pain and thermal receptive functions. In contrast, there is no marked deficit 
in any neuronal population within the CNS of NGF knockout mice indicating that 
NGF is not an essential survival factor in the CNS (Crowley et al,  1994).
3.1.2. Brain-derived neurotrophic factor
Brain-derived neurotrophic factor (BDNF) is a 12.3 kDa basic protein that 
was first purified from adult pig brain and identified as a survival factor for ElO 
chicken DRG neurons in culture (Barde et a l ,  1982). Data obtained from partial 
amino acid sequencing was used for cloning the pig BDNF cDNA (Leibrock et a l ,
1989). BDNF, like NGF, is synthesized as a precursor protein. Following
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cleavage and glycosylation the 252 amino acid BDNF precursor gives rise to a 119- 
residue mature polypeptide. Furthermore, BDNF has approximately 50% identity 
with NGF and contains the six cysteine residues involved in forming the "cysteine 
knot" motif found in its homologue. Biologically active BDNF exists as a tighly 
associated homodimer (Radziejewski e ta l ,  1992). BDNF has subsequently been 
cloned from other species including human (Jones and Reichardt, 1990; 
Maisonpierre et al, 1991), mouse (Hofer et al. , 1990) and rat (Maisonpierre et al. ,
1991). The gene encoding human BDNF is localized to chromosome 11, band p i3 
(Maisonpierre e ta l,  1991).
It has been demonstrated that BDNF enhances the survival and differentiation 
of several classes of CNS neurons in culture, including embryonic rat basal 
forebrain cholinergic neurons, mesencephalic dopaminergic neurons, motoneurons, 
hippocampal neurons, cerebellar granule cells, and retinal ganglion cells (Alderson 
e ta l ,  1990; Hyman et a l ,  1991; Kniisel et a l ,  1991; Oppenheim et al, 1992; for 
review, see Korsching, 1993). In the peripheral nervous system, BDNF promotes 
the survival of embryonic neural crest-derived (dorsomedial part of the trigeminal 
ganglion, trigeminal mesencephalic nucleus, jugular and dorsal root ganglion) and 
placode-derived (ventrolateral part of the trigeminal ganglion, geniculate, petrosal, 
vestibular and nodose ganglion) neurons (Davies et al, 1986a; Barde e ta l , 1987; 
Hofer and Barde, 1988),
BDNF mRNA expression is largely restricted to the CNS. In general, low 
level restricted expression of BDNF mRNA in the embryonic brain gives way to 
more widespread, higher level of expression as the CNS matures. In the adult 
CNS, BDNF mRNA is found in substantial amounts in the cortex, hippocampus, 
and cerebellum, and in lower levels in the midbrain, hindbrain, striatum, olfactory 
bulb and spinal cord (Leibrock et a l ,  1989; Hofer et a l ,  1990). In the PNS, 
BDNF mRNA is found in neurons of the dorsal root and trigeminal ganglia, where 
it is expressed by NGF-dependent neurons, and sympathetic ganglia, suggesting a 
possible autocrine and/or paracrine mechanism (Robinson et a l , 1996; Schecterson 
and Both well, 1992). Outside of the nervous system, BDNF mRNA has been 
shown to be expressed at low levels in the muscle, heart, skin and lung 
(Maisonpierre e ta l,  1990a; Schecterson and Bothwell, 1992).
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Homozygous mice with a null mutation of the BDNF gene develop symptoms 
of nervous system dysfunction, including ataxia. These mice display a substantial 
reduction in the number of neurons of the trigeminal, geniculate, vestibular and 
petrosal-nodose ganglia, whereas the CNS develops with no apparent gross 
structural abnormalities (Jones et al, 1994; Ernfors et ai, 1994a). This indicates 
that BDNF is an essential factor for the survival of several populations of cranial 
and spinal sensory neurons, whereas it does not appear to be essential for the 
development of sympathetic, dopaminergic and motoneurons (Jones et a i , 1994; 
Ernfors et ai, 1994a).
3.1.3. Neurotrophin-3
Neurotrophin-3 (NT-3) is the third member of the neurotrophin family. It 
was identified by using degenerate oligonucleotides derived from conserved regions 
between NGF and BDNF to screen a mouse cDNA library. The mature mouse NT- 
3 is a 13.6 kDa basic protein and consists of 119 amino acids that originate from a 
258-residue precursor polypeptide. Mature NT-3 is structurally related to both 
BDNF and NGF and shares about 50-60% amino acid identity with these two 
neurotrophic factors, including all six cysteine residues which in NGF and BDNF 
are involved in the formation of disulphide bridges (Hohn et a i ,  1990). 
Biologically active NT-3, like NGF and BDNF, is a homodimer (Radziejewski et 
al., 1992). The cloning of human and rat NT-3 has subsequently been reported 
(Rosenthal a/., 1990; Ernfors e ta l ,  1990; Maisonpierre etal., 1990b; 1991) and 
the gene encoding human NT-3 has been localized to chromosome 12, band p i3 
(Maisonpierre et al., 1991).
NT-3 is mainly involved in events during early development. For example, it 
stimulates sympathetic neuroblast proliferation by promoting precursor survival, 
and induces the differentiation of neural tube precursors into motoneurons (DiCicco- 
Bloom etal.,  1993; Averbuch et al., 1994). Furthermore, NT-3 transiently 
supports the survival of neural crest-derived sensory and sympathetic neurons in 
early stages of development before they switch their dependence to NGF (Buchman 
and Davies, 1993; Buj-Bello e ta l ,  1994; Birren et a l ,  1993). Moreover, NT-3 
sustains the survival of subpopulations of embryonic sympathetic, nodose, 
trigeminal and dorsal root ganglion, and mesencephalic trigeminal nucleus neurons
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in culture (Ernfors et al,  1990; Maisonpierre et a i,  1990b; Hohn e ta l ,  1990; 
Rosenthal et a i,  1990). In the CNS, NT-3 promotes the survival of embryonic 
motoneurons and noradrenergic neurons in vitro (Henderson et al,  1993; Friedman 
et at., 1993) and prevents 6-hydroxydopamine-induced degeneration of adult 
noradrenergic neurons of the locus coeruleus in vivo (Arenas and Persson, 1994). 
NT-3 also increases oligodendrocyte proliferation in the optic nerve during 
development (Barres et al,  1994).
In accordance with its role in early development, NT-3 is highly expressed in 
immature regions of the CNS, where the processes of proliferation, migration, and 
differentiation of neuronal precursors are occurring, and its expression decreases 
dramatically in these regions with maturation (Maisonpierre et a l , 1991). NT-3 
mRNA is widely expressed in the adult both in the nervous system and peripheral 
tissues. In the brain, levels of NT-3 mRNA are greatest in the cerebellum and 
hippocampus. In the periphery, areas of notable expression include heart, skin, 
gut, muscle, liver, kidney, lung and spleen (Hohn e ta l ,  1990; Rosenthal et a l ,
1990).
The physiological relevance of NT-3 during development has been revealed 
by analysis of mutant mice with targeted dismption of the NT-3 gene (Ernfors et al, 
1994b). Homozygous mice display a substantial neuronal cell loss in all sensory 
ganglia, trigeminal mesencephalic nucleus and sympathetic superior cervical 
ganglion. Importantly, the main components of the propioceptive system, namely 
the muscle spindles and Golgi tendon organs, are missing together with large- 
diameter propioceptive DRG neurons (Ernfors et al, 1994b).
3.1.4. Neurotrophiii-4/5
Taking advantage of the structural similarity between NGF, BDNF and NT-3, 
a fourth member of this protein family was identified and termed neurotrophin-4/5 
(NT-4/5). Xenopus and viper NT-4 encode a 236 amino acid precursor polypeptide 
that is processed to a 123-residue mature protein with 50%-60% amino acid identity 
to its homologues, NGF, BDNF, and NT-3, including conservation of all six 
cysteine residues common to the entire family (Hallbook et a l ,  1991). 
Homologous human and rat NT-4 clones, initially designated NT-5, were 
subsequently isolated and share about 65% amino acid identity with their Xenopus
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counterpait (Berkemeier et al., 1991; Ip et al., 1992a). It is currently believed that 
Xenopus NT-4 and mammalian NT-5 are the same molecule and are referred as NT- 
4/5.
In the PNS, human recombinant NT-4/5 supports transiently the survival in 
vitro of embryonic rodent trigeminal and jugular ganglion neurons at early stages of 
target field innervation, and mouse nodose ganglion neurons during the phase of 
naturally occurring cell death. Significantly, all of these neurons are also BDNF 
responsive during the same developmental periods. In contrast, the survival- 
promoting effect of NT-4/5 on embryonic chicken neurons is very limited (Davies et 
al, 1993a; Ibanez et a l , 1993). This difference in specificity suggests that NT-4/5 
may be a mammalian neurotrophic factor; alternatively, the structure of NT-4/5 may 
not be well conserved between mammals and birds. In the CNS, it has been shown 
that NT-4/5 sustains the in vitro survival of embryonic rat motoneurons (Henderson 
et a l,  1993), and cholinergic basal forebrain and noradrenergic locus coereulus 
neurons (Friedman e ta l,  1993).
NT-4/5 may be a target-derived neurotrophic factor for trigeminal ganglion 
neurons, since NT-4/5 mRNA has been found to be expressed in the developing rat 
whisker pad, their major peripheral target tissue, during the phase of naturally 
occurring cell death of these neurons (Ibanez et al, 1993). NT-4/5 mRNA is also 
present in several other embryonic and adult rat tissues, including brain, heart, 
muscle, lung, kidney, thymus, ovary and testis (Berkemeier et a l ,  1991; Timmusk 
e ta l ,  1993).
It has been demonstrated that mice with a targeted disruption of the NT-4 gene 
exhibit a loss of sensory neurons in the nodose-petrosal and geniculate ganglia, 
whereas sympathetic neurons of the superior cervical ganglion, facial motoneurons 
and midbrain dopaminergic neurons are unaffected. Furthermore, the phenotype of 
mice lacking both BDNF and NT-4 is similar that of BDNF or NT-4 knockouts 
alone, although there is a more severe neuronal reduction in sensory ganglia 
(Conover et al, 1995; Liu et al, 1995).
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3.1.5. Neurotrophin-6
Neurotrophin-6 (NT-6) represents the most recently isolated member of the 
neurotrophin family, and was cloned from the teleost fish Xiphophorus maculatus 
(Gbtz et a l ,  1994), In accordance with the features of all known neurotrophins, 
NT-6 is synthesized as a precursor polypeptide of 286 amino acids that upon 
proteolytic cleavage gives rise to a 143-residue mature basic protein with a 
molecular mass of 15.9 kDa that contains the six cysteines conserved in all 
neurotrophins known so far. In contrast to the other members, NT-6 has not been 
found as a soluble protein in the medium of producing cells and it is likely to be 
bound to proteoglycans of the cell surface and/or extracellular matrix (Gotz et al, 
1994).
It has been demonstrated that NT-6, like NGF, promotes the survival of 
sympathetic and a subpopulation of dorsal root ganglion neurons, whereas it has no 
effect on ciliary and nodose neurons (Gotz et al,  1994). Analysis of NT-6 mRNA 
expression in the teleost fish has revealed its presence in embryonic and adult 
cerebellum, and several other adult tissues, including gill, liver, eye, skin, spleen, 
heart and skeletal muscle (Gotz et al, 1994).
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3.2. RECEPTORS OF THE NEUROTROPHIN FAMILY
The various members of the neurotrophin family bind to two kinds of 
unrelated cell surface receptors, named p 7 5 NTR and Trk (pronounced track). 
p75NTR and Trk were first identified by cross-linking studies using radioiodinated 
NGF (Sutter et a l ,  1979) and found to interact with NGF with low and high 
affinity , respectively (for review, see Meakin and Shooter, 1992).
The low affinity receptor for neurotrophins, termed p7 5 NTR^  has been cloned 
in different species including human, rat and chicken (Chao et al,  1986; Radeke et 
a l ,  1987; Large et a l ,  1989). p75N T R  is a single 75 kDa transmembrane 
glycoprotein that contains a long extracellulai* domain with four cysteine repeats that 
are responsible for ligand recognition (Welcher et a l,  1991; Yan et a l ,  1991). 
These cysteine repeats are common to members of a family of cell surface receptors 
that includes the Fas antigen and type I and II receptors for tumor necrosis factor 
(TNFR-I and TNFR-II) (Nagata and Golstein, 1995). The shorter intracellular 
domain of p75NTR contains a small segment homologous to the death domain of Fas 
and TNFRI (Nagata and Golstein, 1995). Although it was first described as a low 
affinity receptor for NGF, it has been demonstrated that p 7 5 NTR binds with similar 
low affinity to most neurotrophins, including BDNF, NT-3 and NT-4/5 (for 
review, see Davies, 1994c).
Ligand specificity of neurotrophin receptors is determined by the high affinity 
receptor component, the receptor tyrosine kinase (Trk). Trk is a proto-oncogene 
that was first identified as a human oncogene resulting from DNA rearrangement 
between truncated tropomyosin and protein tyrosine kinase sequences (Martin- 
Zanca et al, 1986; 1989). It encodes a 140 kDa transmembrane glycoprotein that 
contains a cytoplasmic tyrosine kinase domain, and is referred to as gpl4 QtrkA or 
TrkA (Martin-Zanca et a l , 1989). Trk A is the founder of a family of homologous 
receptor tyrosine kinases that also includes TrkB and TrkC. TrkB, also named 
gpl45trkB, was cloned from a mouse brain cDNA library using a human TrkA probe 
under low stringency conditions. TrkB encodes a 145 kDa transmembrane protein 
tyrosine kinase that shares about 70% homology with TrkA (Klein et a l,  1989). 
TrkC, also designated gpl45‘ikc, was originally cloned by screening a porcine brain
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cDNA library with a human TrkA probe. TrkC encodes a 145 kDa transmembrane 
glycoprotein with tyrosine kinase activity that shares about 65% homology with 
TrkA and TrkB (Lamballe et ai, 1991). NGF, BDNF and NT-3 bind preferentially 
to TrkA, TrkB and TrkC, respectively (Kaplan et al, 1991a; 1991b; Klein et ai,  
1991a; 1991b; Soppet e ta l ,  1991; Squinto et a l ,  1991; Lamballe et a l ,  1991). 
NT-4/5 signals through TrkB (Berkemeier et a l,  1991; Klein et a l,  1992). 
Furthermore, it appears that some neurotrophins can interact with more than one 
neuroti'ophin receptor. Thus, NT-3 can also bind to TrkA and TrkB (Klein et a l , 
1991b; Soppet et a l ,  1991; Squinto et al,  1991), and NT-4/5 can activate TrkA 
(Berkemeier et a l , 1991). The receptor specificities of NT-6 have not been defined 
so far.
Interestingly, several isoforms of the receptor tyrosine kinases have been 
found, although their physiological relevance is not fully understood. The TrkA 
gene encodes two protein isoforms that differ in the presence of six amino acid 
residues located in their extracellular domain (Barker e ta l ,  1993). The TrkB gene 
generates several different transcripts that, apart from the full length gpl4 5 *rkB 
receptor, encode two truncated receptors that lack the entire intracellular catalytic 
kinase domain (Klein et al,  1990; Middlemas et a l,  1991) and several other 
isoforms that contain deletions in the leucine-rich motifs of the extracellular domain 
(Ninkina et a l,  1997). The TrkC gene encodes at least four distinct protein 
isoforms; the full length gpl45“'kc receptor, two isoforms with different insertions 
in the tyrosine kinase domain and a truncated receptor that lack the intracellular 
tyrosine kinase domain (Valenzuela et al, 1993; Tsoulfas et al, 1993).
In order to analyse the physiological relevance of the neurotrophin receptors 
during development, mutant mice lacking either the TrkA, TrkB or TrkC genes have 
been generated by homologous recombination (Klein e ta l ,  1993; 1994; Smeyne et 
a l,  1994). In general, the phenotype of mice carrying a null mutation in each 
neurotrophin receptor gene is similar to that observed for its ligand (Crowley et al, 
1994; Jones et al,  1994; Ernfors e ta l ,  1994a; 1994b). Mice lacking TrkA are 
insensitive to pain and display a substantial loss in the number of neurons of the 
trigeminal, dorsal root and sympathetic ganglia, whereas cholinergic basal forebrain 
neurons are not affected by the absence of functional T r k A /g p l4 0 ‘rkA (Smeyne et 
al,  1994). In mice homozygous for targeted disruption of the T rkB /gp l45t'kB  gene.
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there is a marked reduction in trigeminal and dorsal root ganglion neurons (Klein et 
a l,  1993). Finally, disruption of the TrkC/gpl45trkc gene eliminates la muscle 
afferent projections to spinal motor neurons and reduces the number of large 
myelinated axons in the dorsal root and posterior columns of the spinal cord, in 
addition to eliminating a subpopulation of dorsal root ganglion neurons (Klein et al, 
1994).
Although it is clear that each neurotrophin can interact independently with 
different affinity with p7 5 NTR and specific Trk receptors, the role that p7 5 NTR exerts 
in the receptor complex for neurotrophin signalling remains to be clarified. It has 
been shown that p75NTR_deficient mice do not display significant neuronal loss in 
the peripheral nervous system, but have a marked decrease in the sensory 
innervation of the skin (Lee et a l , 1992). Whereas p75NTR does not seem essential 
for neurotrophin signalling, it has been proposed that it may increase the affinity of 
receptors for neurotrophin binding during competition for limited concentrations of 
trophic factors and be involved in the discrimination between different, but 
structurally related, members of the neurotrophin family (for review, see Chao and 
Hempstead, 1995). Two models for p75NTR_Trk interaction have been proposed. 
In a conformational model, p75NTR would interact in the absence of ligand with Trk 
to change its conformation and create a high affinity binding. In the presentation 
model, the neurotrophin would bind first to p7 5 NTR and would either increase the 
local concentration of the ligand or transfer the neurotrophin to the Trk receptor 
component (Chao and Hempstead, 1995). To further complicate the understanding 
of p75NTR function, it has recently been shown that it can induce apoptosis in certain 
kind of cells such as retinal cells and oligodendrocytes. It is possible that p75NTR 
may achieve this by activating sphingomyelinase and increasing ceramide 
production, and/or activating gene transcription via nuclear factor k  B (Frade et a l , 
1996; Cassacia-Bonnefil et a l,  1996; for reviews, see Davies, 1996b; Carter and 
Lewin, 1997).
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4. THE FAMILY OF NEUROPOIETIC CYTOKINES AND 
THEIR RECEPTORS
Neuropoietic cytokines are a group of distantly related proteins with extensive 
pleiotropy in the nervous, hematopoietic and immune systems and other non­
neuronal tissues. Although they share less than 30% sequence homology at the 
amino acid level, their secondary structure adopts a similar four antiparallel helix 
bundle that resembles that determined for growth hormone (Bazan, 1991). 
Furthermore, they share a similar gene structure, suggesting that these cytokines 
evolved from a common ancestral gene (Bruce et a i,  1992), Members of this 
family bind to related multisubunit receptors that contain a common transducing 
component (Sato and Miyajima, 1994). This family of proteins is composed of 
ciliary neurotrophic factor (CNTF), the most extensively studied neuropoietic 
cytokine in the nervous system, growth-promoting activity (GPA), leukaemia 
inhibitory factor (LIF), interleukin-6 (IL-6), oncostatin M (OSM), cardiotrophin-1 
(CT-1), interleukin-11 (IL-11) and granulocyte-colony stimulating factor (G-CSF). 
Outlined below is an account of the members of this family of proteins that have 
known functions or activities in the nervous system.
4.1. MEMBERS OF THE NEUROPOIETIC FAMILY OF 
CYTOKINES 
4.1.1. Ciliary neurotrophic factor
Ciliary neurotrophic factor (CNTF) was initially identified as a neurotrophic 
activity present in eye tissues that was able to promote the in vitro survival of 
parasympathetic neurons of the chicken ciliaiy ganglion (Adler et ai, 1979). CNTF 
was purified from extracts of embiyonic chicken intraocular tissues (Barbin et ai, 
1984) and subsequently from adult rat sciatic nerve, which is a rich and easily 
accessible source for this factor (Manthorpe et al., 1986), and shown to be an acidic 
protein with an estimated molecular mass of 20-24 kD. Highly purified CNTF 
isolated from sciatic nerve was used to determine its partial amino acid sequence, 
which led to the cloning of rabbit and rat CNTF cDNAs (Lin et al., 1989; Stockli et 
al., 1989). These cDNAs encode proteins of 199 and 200 amino acids.
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respectively. In contrast to other neurotrophic factors, CNTF appears to be a 
cytosolic protein, since it lacks a signal peptide sequence for secretion and 
consensus sequences for glycosylation. In accordance with this, CNTF is not 
released into the medium from transfected HeLa or COS cells (Lin et al, 1989; 
Stockli et a i,  1989). It is unclear whether CNTF could be released from the 
cytoplasm either after a microtrauma that disrupts the integrity of the plasma 
membrane of CNTF-synthesizing cells, or by an unknown secretion mechanism.
CNTF is a trophic factor with widespread biological activity that affects 
mainly neuronal cells, but also non-neuronal cells (for review, see Sendtner et a i , 
1994). It supports the survival of several populations of PNS and CNS neurons in 
culture. For example, neurons isolated from chicken ciliary, nodose, trigeminal, 
dorsal root and sympathetic lumbar ganglia respond in vitro to CNTF (Barbin et 
ai,  1984; Manthorpe and Varon, 1985). Similarly, CNTF provides trophic support 
to spinal motoneurons (Arakawa et a i ,  1990), hippocampal neurons (Ip et a l ,
1991) and Purkinje cells in culture (Larkfors et al,  1994). Despite the survival- 
promoting effect of CNTF on multiple neuronal types, in ova administration of 
CNTF only protects chicken motoneurons from naturally occurring cell death, 
whereas sensory, sympathetic and nodose neurons are unaffected by this treatment 
(Oppenheim et a l,  1991). CNTF also prevents the axotomy-induced neuronal 
degeneration of a variety of neurons including facial (Sendtner et a l ,  1990) and 
spinal motoneurons (Li e ta l ,  1994; Vejsada et al, 1995), neurons in the anterior 
thalamic nuclei (Clatterbuck et a l ,  1993) and dopaminergic neurons of the 
substantia nigra (Hagg and Varon, 1993). Interestingly, it has been demonstrated 
that peripheral nerve axotomy enhances the retrograde axonal transport of CNTF by 
dorsal root ganglion neurons and spinal motoneurons (Curtis et al, 1993).
Apart from its survival-promoting effects on neuronal cells, CNTF also 
displays other actions on non-neuronal cells of the nervous system. For example, 
oligodendrocyte-type-2-astrocyte (0-A2) progenitor cells differentiate in vitro into 
type-2 astrocytes in the presence of CNTF (Hughes et a l ,  1988) and microglial 
cells differentiate into cells with a reactive phagocytotic phenotype (Sendtner et a l , 
1994). Furthermore, CNTF inhibits the proliferation and induces cholinergic 
differentiation of developing sympathetic neurons (Ernsberger et a l , 1989a; Saadat 
et al, 1989). CNTF acts only on limited targets outside the nervous system. It has
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been shown that it exerts myotrophic effects on denervated skeletal muscle in vivo, 
attenuating the atrophy and functional changes associated with denervation (Helgren 
etaL, 1994).
Taken together these data suggest that CNTF could play an important role in 
the nervous system, both during development and under pathological conditions, 
with limited additional roles in other tissues. Surprisingly, analysis of homozygous 
mutant mice with targeted disruption of the CNTF gene has revealed that a lack of 
CNTF has no apparent effects on the nervous system during embryonic 
development. However, CNTF appears to be essential for the maintenance of adult 
motoneurons, since they degenerate progressively during the postnatal period in its 
absence (Masu et ai, 1993). This finding is in agreement with the observation that 
CNTF mRNA expression is absent in whole rat embryos at E9 and in both brain 
and hindlimbs at E18 (Stockli et a i ,  1991). In contrast, high levels of CNTF 
mRNA are widely expressed in the adult rat nervous system, in particulai' in the 
sciatic and optic nerves, olfactoi'y bulb and spinal cord. Lower levels of expression 
are detected in the brain stem, cerebellum, septum, hippocampus, striatum, and 
midbrain (Stockli et a i ,  1991; Dobrea et a i,  1992; Ip et a i,  1993a). In these 
tissues, CNTF is mainly produced by glial cells. CNTF mRNA expression could 
not be detected in tissues outside of nervous system in adult rats (Stockli et al., 
1989; Dobrea etaL, 1992).
It has been suggested that CNTF might act as a lesion factor under 
pathological conditions. In agreement with this hypothesis, most newborn rodent 
motoneurons undergo cell death following axotomy coinciding with the period 
when CNTF is not expressed in the peripheral nerve. At the end of the first post­
natal week Schwann cells surrounding peripheral axons start to synthesize CNTF 
and motoneurons become more resistant to nerve lesions (Stockli et a i ,  1989; 
Sendtner et a i,  1990; Li et ai,  1994). CNTF very effectively prevents axotomy- 
induced cell death of newborn rat facial motoneurons (Sendtner et a i,  1990) and 
degeneration of motoneurons in mutant mice homozygous for progressive motor 
neuropathy (pmn) (Sendtner et ai, 1992b). It has been shown that CNTF synthesis 
is regulated by a neuron-Schwann cell interactive signal, since CNTF remains 
expressed in Schwann cells in the proximal segment of the sciatic nerve after 
transection, whereas its expression drops markely in the distal portion of the
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sectioned nerve, where the remaining CNTF is released at extracellular sites, until 
regeneration takes place (Sendtner et al. , 1992a). The potential role of CNTF as a 
lesion factor may also apply to the adult rat CNS, where, in contrast to the 
peripheral nervous system, the synthesis of CNTF is up-regulated by reactive 
astrocytes in the wound after injuiy (Ip et al. , 1993a). Despite all of these findings, 
the role of CNTF in vivo remains unclear and will need more efforts to be clarified.
4.1.2. Growth-promoting activity
Growth-promoting activity (GPA) activity was originally characterized in 
chicken eye extracts (Nishi and Berg, 1981). The purification of GPA from adult 
chicken sciatic nerves led to the determination of its pai tial amino acid sequence, and 
revealed it to be a protein homologous to CNTF (Eckenstein et a i ,  1990). 
Subsequently, GPA cDNA was cloned from an embryonic eye cDNA library 
(Leung et al., 1992). GPA shares 50% amino acid identity with mammalian 
CNTFs, suggesting that this protein could be the chicken homologue of CNTF. 
However, controversial data obtained from a limited number of experiments 
comparing GPA and CNTF function and expression could indicate that they are 
different molecules. GPA, like CNTF, lacks an hydrophobic amino-terminal 
sequence for secretion. However, in contrast to CNTF, GPA is released in a 
biologically active form into the medium surrounding transfected cells by an 
unkown mechanism (Leung et al, 1992), In vitro, GPA and CNTF both inhibit the 
proliferation of chicken sympathetic neuroblasts and induce a cholinergic 
phenotype, with GPA being more potent than CNTF (Heller et a l,  1993). GPA, 
like CNTF, can promote the survival of chicken E8 ciliary, ElO DRG and Ell-12 
sympathetic neurons in culture. However, in contrast to CNTF, GPA also supports 
E8 DRG neuron survival in vitro (Eckenstein et al,  1990). Moreover, GPA and 
CNTF seem to interact with similai' but not identical receptors, since GPA competes 
less efficiently than CNTF for the binding of *25i-labelled CNTF on chicken 
sympathetic neurons (Heller e ta l ,  1993). Finally, GPA mRNA, unlike CNTF, is 
expressed in the chicken embryo during development. In particular, GPA is found 
in the embryonic uveal tract, the target tissue for ciliary ganglion neurons, and in the 
embryonic sciatic nerve (Leung eta l,  1992).
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Taken together, these data suggest that GPA and CNTF might be distinct 
neurotrophic factors. Thus, it remains to be clarified whether a mammalian 
homologue to GPA exists. Alternatively, it is possible that the same protein exhibits 
different actions, in different species and at different times.
4.1.3. Leukaemia inhibitory factor
Cholinergic differentiation factor (CDF), is a pleiotropic cytokine originally 
purified from rat heart cell conditioned medium on the basis of its ability to induce 
cholinergic differentiation of rat sympathetic neurons in culture (Fukada, 1985). 
Subsequently, leukaemia inhibitory factor (LIF) was purified on the basis of its 
ability to regulate the growth and differentiation of the Ml myeloid cell line (Gearing 
etal. , 1987). It has been demonstrated that CDF and LIF correspond to the same 
protein (Yamamori et ai, 1989). LIF exhibits multiple actions in the nervous and 
hematopoietic systems (for reviews, see Hall and Rao, 1992; Patterson, 1994). The 
effects of LIF in the nervous system are in general very similar to that of CNTF. 
LIF regulates the transmitter phenotype and expression of several neuropeptides in 
cultured sympathetic and sensory neurons (Yamamori et ai,  1989; Nawa et al., 
1991; Bazan, 1991; Fan and Katz, 1993). Furthermore, LIF stimulates the 
differentiation of neural crest cells into sensory-like neurons and enhances the 
survival of several populations of embryonic and postnatal sensory neurons in 
culture (for review, see Horton e ta l ,  1996). In addition to its effects on sensory 
neurons, LIF also exerts trophic effects on cultured spinal motoneurons (Martinou 
e ta l ,  1992) and promotes the differentiation of neuronal and astrocytic precursors 
cells in the developing spinal cord (Richards et al, 1996). However, in contrast to 
the in vitro actions of LIF on several kinds of neurons, mice with targeted 
disruption of the LIF gene do not exhibit any developmental abnormality in these 
neuronal populations, but display alterations in response to injury (Stewart et al,
1992). It has been shown that LIF is transported retrogradely by DRG neurons and 
spinal motoneurons under normal conditions and its transport is increased after 
sciatic nerve injury. Interestingly, LIF mRNA expression is present in the 
peripheral nerve and up-regulated at the site of lesion and in the distal portion of the 
nerve after axotomy (Curtis et a l ,  1994; Banner et a l ,  1994). These findings
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suggest that LIF, like CNTF, may play a role in vivo in neuronal maintenance and 
axonal regeneration following injury.
4.1.4. Interleukin-6
Interleukin-6 (IL-6) is a multifunctional cytokine produced by a variety of 
cells that was originally characterized as a factor with an important role in 
inflamation and in response to infection (Hirano, 1991). In addition to its functions 
in the immune system, IL-6 is involved in physiological and pathological events that 
occur in the developing and adult nervous system. It supports the survival of 
forebrain cholinergic, m idbrain catecholam inergic, spinal cord 
acethylcholinesterase-positive, and nodose and trigeminal ganglion neurons (Hama 
etal., 1989; Kushima et al., 1992; Kushima and Hatanaka, 1992; Horton et al., 
1996). Furthermore, it induces cholinergic differentiation and expression of 
neuropeptides such as substance P in cultured sympathetic neurons (Fann and 
Patterson, 1994). Although IL-6 mRNA is not present in intact nerves, its 
expression is rapidly up-regulated in degenerating nerves after axotomy (Reichert et 
ai, 1996). IL-6 transcripts are also detected in DRG neurons after nerve transection 
(Murphy etal., 1995). These findings suggest that IL-6, like LIF and CNTF, is a 
cytokine with an important role during neuronal regeneration following axotomy.
4.1.5. Oncostatin M
Oncostatin M (GSM) is a cytokine that was initially described as a regulator of 
cell growth which could inhibit the growth of certain solid tumor cell lines and 
stimulate the proliferation of normal fibroblasts (Zarling et al., 1986). The 
determination of its paitial amino acid sequence led to the cloning of human GSM 
(Malik et al., 1989). In vitro GSM shares many common activities with LIF and IL- 
6. For example, GSM, like LIF and IL-6, induces the differentiation of leukaemia 
cells and inhibits the differentiation of embiyonic stem cells, as described for LIF. 
GSM also promotes the proliferation of Aids-related Kaposi's sarcoma cells by an 
autocrine and paracrine mechanism (Bmce et al., 1992). Apait from these actions 
on non-neuronal cells, it has been shown that GSM promotes the suiwival of 
embryonic nodose and trigeminal ganglion neurons in culture (Horton et al., 1996), 
although the function of GSM in the nervous system is in general poorly
53
understood.
4.1.6. Cardiotrophin-1
Cardiotrophin-1 (CT-1) is a novel member of the neuropoietic family of 
cytokines that was identified on the basis of its ability to induce cardiac myocyte 
hypertrophy using an expression cloning strategy. CT-1 is expressed in adult 
mouse heart, skeletal muscle, liver, lung, kidney, testis, and brain, suggesting that 
CT-1, like other cytokines, is a pleiotropic factor (Pennica et al., 1995a). It has 
been demonstrated that CT-1 has multiple functions in the hematopoietic and 
nervous system, as well as in liver and heart. CT-1, like IL-6, LIF and OSM, 
inhibits the proliferation of Ml leukaemia cells, although, in contrast to IL-6, it does 
not promote B cell expansion. CT-1 can also inhibit the differentiation of 
embryonic stem cells, in a similar way to LIF, CNTF and OSM, and shares with 
LIF a common action in promoting the survival and proliferation of myocytes in 
culture (Pennica etal., 1995b; Sheng etal. 1996). In the nervous system, CT-1 has 
been shown to support the in vitro survival of chicken ciliary, rat dopaminergic, 
and mouse sensory neurons, and induce changes in the transmitter phenotype of 
sympathetic neurons (Pennica etal., 1995b; Horton, personal communication). 
However, the effects of CT-1 in the nervous system, like those of OSM, need to be 
further analysed.
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4.2. RECEPTORS OF THE NEUROPOIETIC CYTOKINES
The functional redundancy of neuropoietic cytokines may be explained by the 
composition of their receptors. CNTF, LIF, IL-6, OSM, and CT-1 signal through 
multicomponent receptors that consist of a ligand-binding subunit (a) and one or 
more signal-transducing subunits (B). Interestingly, some of these components are 
shared between different receptor complexes (for review, see Stahl and 
Yancopoulos, 1993).
The CNTF receptor complex is composed of three subunits, named CNTFRa, 
gpl30 and LIFRB (for review, see Stahl and Yancopoulos, 1994). CNTF binds 
with low affinity to CNTF receptor alpha (CNTFRa), a specific cell surface protein 
anchored to the membrane via a glycosyl-phosphatidylinositol (GPI) linkage that is 
homologous to IL-6Ra (Davis e ta l ,  1991; for review, Davis and Yancopoulos,
1993). The complex CNTF-CNTFRa then binds to a 130 kD glycoprotein (gpl30), 
which is a B signal-transducing transmembrane receptor. This complex finally 
recmits LIF receptor B (LIFRB), a gpl30-related protein (Davis et al, 1993a). This 
heterotrimer confers high affinity binding to CNTF and signal transduction. The 
cytoplasmic domains of gpl30 and LIFRB do not apparently possess any enzymatic 
activity, however, ligand-induced heterodimerization of the two B receptor 
components activates members of the Jak/Tyk family of non-receptor tyrosine 
kinases which are constitutively associated with both gpl30 and LIFRB (Stahl et al,
1994). Tyrosine phosphorylation of Jak/tyk proteins subsequently activates 
members of the signal transducer and activator of transcription (STAT) family of 
proteins which translocate to the nucleus and participate in the transcription of 
specific genes responsive to CNTF (Bonni e ta l ,  1993; Stahl and Yancopoulos, 
1994). In contrast to the broad distribution of gpl30 and LIFRB, CNTFRa, which 
confers ligand specificity, is found restricted mainly to the nervous system. 
CNTFRa mRNA is localized in all known CNTF-responsive cells, being widely 
expressed within neurons of the adult rat PNS and CNS (Ip e ta l ,  1993b). Its 
expression in non-neuronal tissues is limited to the adrenal gland and skeletal 
muscle. Interestingly, CNTFRa mRNA is expressed during development in several 
regions of the embryo with greatest levels within the nervous system. These 
findings contrast with the absence of CNTF mRNA expression during embryonic
55
development and suggest the existence of an unknown CNTF-related factor that 
may also act via the CNTF receptor complex (Ip et a l , 1993b). In support to this 
hypothesis, mice with targeted disruption of the CNTFRa gene, in contrast to 
CNTF deficient mice, die perinatally and display a severe reduction in the number of 
motoneurons (DeChiara et a l ,  1995). Finally, it is important to indicate that 
CNTFRa can be released from the cell surface by phosphatidylinositol-specific 
phospholipase C, an enzyme that specifically cleaves GPI linkage. A released form 
of CNTFRa can act as a soluble mediator of CNTF responses and its physiological 
role has been confirmed by its presence in the cerebrospinal fluid and its release 
from muscle in response to peripheral nerve injury (Davis et al, 1993b).
The LIF receptor complex is composed of two subunits. The first 
component, LIFRB, is a transmembrane protein homologous to gpl30 that binds 
LIF with low affinity and is also involved in transducing the ligand signal (Gearing 
e ta l ,  1991). The second component of this complex is gpl30 (Gearing et a l ,
1992). The interaction between LIF and LIFRB recruits gpl30 to the complex. This 
heterodimer receptor confers high affinity ligand binding and transduces LIF signal 
into the cytoplasm (Hall and Rao, 1992; Sato and Miyajima, 1994; Stahl et al,
1994).
The IL-6 receptor complex is similar to the CNTF receptor. It contains an 
alpha binding subunit, named IL-6 receptor alpha (IL-6Ra), that is homologous to 
CNTFRa and binds IL-6 directly with low affinity. The second IL-6 receptor 
component is gpl30. Monomeric gpl30 homodimerizes following interaction with 
the IL-6/IL-6Ra complex and initiates signal transduction (Taga et a l ,  1989; 
Murakami et al, 1993; for review, see Kishimoto et al, 1992).
OSM binds directly with low affinity to gpl30. LIFRB interacts with this 
complex to create high affinity OSM binding (Gearing et al, 1992). In contrast, 
CT-1, like LIF, binds first with low affinity to LIFRB and then forms a complex 
with gpl30 that transduces the ligand signal (Pennica et al, 1995b).
As in the case of the CNTF receptor, the receptor complexes for LIF, IL-6, 
OSM, and possibly CT-1, activate the Jak/Tyk signalling pathway upon binding 
with their respective ligands (Stahl et al, 1994).
The importance of the apparent functional redundancy of some of the
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members of these family of related proteins remains a mystery, but it could be an 
effective way to avoid the deleterious effect of mutations affecting a unique gene. 
Furthermore, the presence of receptors such as CNTFRa and IL-6Ra, that confer 
ligand specificity, seems an effective way to restrict the biological effects of 
cytokines that otherwise use signalling transducers widely expressed in the body.
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5. THE FAMILY OF TGF-B-RELATED PROTEINS AND THEIR 
RECEPTORS
The transforming growth factor-B (TGF-B) superfamily of proteins is 
composed of a large number of structurally related, secreted polypeptides that 
regulate key events during development, tissue homeostasis and repair (for reviews, 
see Hoffmann, 1991; Sporn and Roberts, 1992; Rosen and Thies, 1992; Wall and 
Hogan, 1994; Kingsley, 1994). The family contains about 30 proteins with 
numerous and varied functions that act on almost every cell in the body. However, 
the effect of most TGF-B-related proteins on neuronal survival is limited, with the 
exception of two recently discovered members, glial cell line-derived neurotrophic 
factor (GDNF) and neurturin (NTN) (Lin et a l ,  1993; Kotzbauer et a l,  1996). 
Most members of the TGF-B superfamily signal through a receptor complex 
composed of two transmembrane receptor serine/threonine kinases (Massague, 
1996a), whereas GDNF and neurturin act via multicomponent receptors that contain 
a common transmembrane receptor tyrosine kinase (for review, see Mason, 1996; 
chapter 4 of this thesis).
5.1. MEMBERS OF THE TGF-B FAMILY
The various members of the TGF-B family are synthesized as biologically 
inactive precursor proteins. Cleavage of this precursor molecule and release of its 
carboxy-terminal region generates a mature biologically active protein of 110-140 
amino acids. A common feature among most members of the family is the presence 
of seven to nine cysteine residues at the same relative position within the mature 
protein. Six of these cysteine residues form a compact structure of intrachain 
disulphide bridges known as the "cysteine knot". The active signalling form of 
TGF-B family members is made up of homo- or heterodimers that aie linked by a 
single interchain disulphide bridge and hydrophobic interactions (for review, see 
Kingsley, 1994). The topology of members of the TGF-B superfamily is similar to 
that observed in members the nerve growth factor (NGF) and platelet-derived 
growth factor (PDGF). All of these factors contain the cysteine knot motif and four 
antiparallel B-sheet strands (Schlunegger and Grütter, 1992; Daopin et a l ,  1992;
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McDonald and Hendrickson, 1993). Members of the TGF-6 superfamily are 
grouped into five subfamilies; the TGF-B, the activin, the decapentaplegic and 60A 
subfamilies, the DVR group, and a group of distantly related gene products (for 
review, see Kiieglstein e ta l ,  1995a).
The TGF-B subfamily is composed of five highly homologous members, 
TGF-B 1, -B2, -B3, -B4, and -B5. TGF-B 1, the prototype of the TGF-B superfamily, 
was the first member to be isolated and together with TGF-B2 and -B3 are the 
mammalian representatives of this subfamily, TGFB-4 and TGF-B5 were cloned 
from chicken and Xenopus, respectively (Kingsley, 1994). The activin subfamily 
contains activins and inhibins that are homo- and heterodimers of two related 
subunits, inhibin-BA and inhibin-BB, and a distantly related inhibin-a chain. The 
decapentaplegic and 60A subfamily is formed by the drosophila decapentaplegic 
protein (DPP) and its mammalian homologues, bone morphogenetic proteins 2 and 
4 (BMP2 and BMP4), and the drosophila 60A protein and its mammalian 
homologues, BMP5, BMP6 or Vg-related protein 1 (Vgr-1), BMP? or osteogenic 
protein l(OP-l), and BMP8 or osteogenic protein 2 (OP-2). The DVR group 
contains the DPP and 60A subfamily, and other related proteins, including Vgl, 
BMP3, growth differentation factor l(GDFl), GDF3 or Vgr2, dorsalin and nodal. 
The Müllerian inhibiting substance (MIS), GDF-9, inhibin-a, GDNF and neurturin 
are distantly related proteins with less than 30% amino acid sequence identity to 
other members of the family (Kingsley, 1994).
TGF-Bs and related factors are involved in regulating numerous aspects of 
embryogenesis including basic body plan formation and organogenesis (Wall and 
Hogan, 1994). For example, they have been implicated in mesoderm induction, 
dorso-ventral patterning of the body axis, regression of the Müllerian duct in male 
embryos, and cartilage and bone formation. Furthermore, they can promote or 
inhibit growth depending on the cell type, modulate the immune function and 
regulate follicle-stimulating hormone (FSH) production in the pituitary gland (for 
reviews, see Massagué e t a l , 1994; Hogan, 1996). Members of the TGF-B family 
can also promote the survival of some populations of PNS and CNS neurons in 
vitro (Ki'ieglstein et al, 1995a). Embryonic rat spinal motoneurons are supported 
by TGF-B 1, when grown on a layer of astrocytes (Martinou et al, 1990), and TGF- 
B3 acts synergistically with FGF-2 to sustain purified chicken motoneurons (Gouin
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et ai,  1996). Midbrain dopaminergic neurons from rat embryos also survive in the 
presence of TGF-B 1, TGF-B2 and TGF-B3, and ai'e protected by these factors 
against methyl-phenyl-pyridine (MPP+) toxicity (Poulsen et al, 1994; Ki'ieglstein et 
a l ,  1995b). Whereas it has been shown that TGF-61 and TGF-B2 exert a 
neurotrophic effect on neonatal rat dorsal root ganglion (DRG) neurons in culture, 
and TGF-B 1 action is synergistic with NGF (Chalazonitis et al,  1992), neither 
TGF-B 1, -B2, nor -B3 promote the survival in vitro of embryonic chicken DRG 
neurons (Unsicker et a l,  1996). Furthermore, TGF-Bs can affect indirectly the 
survival of sensory neurons by regulating the expression of NGF and NT-3 in the 
target fields of NGF- and NT-3-dependent mouse sensory neurons (Buchman et al,
1994).
5.1.1. Glial cell line-derived neurotrophic factor
Glial cell line-derived neurotrophic factor (GDNF) is a basic protein that was 
initially purified from the rat B49 cell line on the basis of its ability to promote the 
survival in vitro of rat midbrain dopaminergic neurons (Lin et a l,  1993; 1994). 
Based on data obtained from partial amino acid sequencing, rat GDNF cDNA and 
human genomic GDNF were cloned and their encoded amino acid sequences were 
found to be 93% identical (Lin et a l ,  1993; 1994). Human GDNF gene was 
subsequently mapped to chromosome 5ql2-pl3.1 (Schindelhauer et al, 1995).
GDNF represents the first member of a new subfamily of proteins within the 
TGF-B superfamily. Accordingly, it is synthesized as a precursor of 211 amino 
acids that is cleaved and secreted as a polypeptide of 134 amino acids. 
Furthermore, the mature protein contains seven cysteine residues distributed in the 
same relative positions found in all members of the family. GDNF shaies less than 
20% homology with other TGFB superfamily members (Lin et a l , 1993). GDNF 
is a N-glycosylated protein with a moleculai' mass of 18 to 22 kDa. This mass is 
reduced to 15 kDa after deglycosylation. The biologically active form of GDNF is a 
disulphide-bonded homodimer with an apparent molecular mass on non-reducing 
SDS gels of 32 to 45 kDa (Lin et al, 1993; 1994).
It has been demonstrated that GDNF is a pleiotropic factor with effects on 
neurons and non-neuronal cells. GDNF was first described as a potent 
neurotrophic factor for embryonic midbrain dopaminergic neurons; it promotes the
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survival and morphological differentiation of dopaminergic neurons in vitro and 
increases their dopamine uptake (Lin e t a l , 1993). Using an in vivo system, it has 
been shown that GDNF increases the survival and neurite outgrowth of embryonic 
dopaminergic neurons from fetal ventral mesencephalic tissue grafted to the anterior 
chamber of the eye of adult rats (Stromberg et al., 1993; Johansson et ah, 1995). 
These GDNF responsive neurons originate from the substantia nigra pars compacta 
(Johansson et a l ,  1995). Thus, dopaminergic neurons respond to GDNF both in 
vitro and in vivo. GDNF mRNA is expressed in the developing and adult striatum 
(caudate/putamen), the major target tissue for this kind of neurons (Stromberg et al, 
1993; Springer et a l,  1994), and GDNF is retrogradely transported by adult 
mesencephalic dopamine neurons of the nigrostriatal pathway (Tomac et a l,  
1995a). This suggests that GDNF may act physiologically as a target-derived 
survival factor for both embryonic and adult dopaminergic neurons. However, 
mutant mice with targeted disruption of the GDNF gene do not display a loss of 
dopaminergic neurons indicating that GDNF is not essential for the development of 
these neurons (Sanchez et al, 1996; Moore et a l,  1996).
Parkinson's disease (PD) is characterized by progressive degeneration of the 
substantia nigra dopaminergic neurons. The consequent dysfunction of the 
nigrostriatal pathway produces the clinical features of the disease: resting tremor, 
rigidity, bradykinesia, and akinesia. It is believed that GDNF may be an important 
therapeutic agent in the treatment of Parkinson's disease for rescuing the neurons 
that otherwise would die. Several studies have demonstrated a protective function 
of GDNF in vivo in PD animal models. In these models the degeneration of 
dopaminergic neurons has been induced by either the administration of specific 
neurotoxic reagents or the transection of their axons within the medial forebrain 
bundle. For example, the injection of GDNF into either the substantia nigra, 
striatum or ventricles can prevent and repair the effects of the dopaminergic 
neurotoxin 1-methy 1-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice and 
monkeys, leading to a functional recovery (Tomac et al, 1995b; Gash et al, 1996). 
GDNF can also reverse the effects of the catecholamine neurotoxin 6- 
hydroxydopamine (6-OHDA) in rats (Hoffer et al, 1994; Bowenkamp et a l , 1995; 
1996; Sauer et al,  1995) and protect adult mesencephalic dopaminergic neurons 
from axotomy-induced degeneration (Beck et a l ,  1995). GDNF also affects the
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non-lesioned nigrostriatal system by increasing motor activity, dopamine levels, cell 
body size and the sprouting of dopaminergic fibers toward the injection site 
(Hudson e ta l ,  1995; Shults e ta l ,  1996). Thus, GDNF may be beneficial for the 
treatment of Parkinson's disease.
Although GDNF was initially isolated as a neurotrophic factor for midbrain 
dopaminergic neurons, the neurotrophic effect of this molecule on motoneurons has 
been extensively studied (Henderson et al,  1994; Zurn et a l,  1996; Yan et a l,  
1995; Oppenheim et a l,  1995; Li et a l,  1995; Houenou et a l ,  1996). GDNF 
promotes the in vitro survival of embiyonic rat motoneurons with a higher potency 
than other neurotrophic factors like BDNF, CNTF, and CDF-LIF (Henderson et 
a l,  1994), and induces choline acety 1-transferase (ChAT) activity and neurite 
outgrowth (Zurn et a l ,  1994). GDNF is also able to rescue in vivo developing 
chicken motoneurons from programmed cell death when administered in ovo onto 
the chorio-allantoic membrane during their period of naturally ocurring cell death 
(Oppenheim e ta l ,  1995; Houenou e ta l ,  1996). Furthermore, it has been shown 
that GDNF is retrogradely transported by lumbar spinal motoneurons ( Y an et a l ,
1995) and prevents axotomy-induced motoneuron death and atrophy following the 
transection of the facial nerve in neonatal rats (Henderson et a l , 1994; Zurn et a l , 
1996; Yan et al, 1995; Oppenheim et al,  1995). In adult rats, GDNF administered 
locally or systemically can prevent axotomy-induced decrease of ChAT in facial 
motoneurons (Yan et al, 1995). GDNF administered locally can also prevent the 
massive loss of adult spinal motoneurons after avulsion of the ventral root and 
causes hypertrophy of the surviving motoneurons (Li et al,  1995). GDNF mRNA 
is expressed in the limb bud and in primary cultures of embryonic myotubes and 
neonatal Schwann cells (Henderson et a l,  1994). In the embryonic limb bud, 
GDNF mRNA is initially transiently expressed by mesenchymal cells in a restricted 
region of the proximal limb bud where motor and sensory axon fascicles converge 
to enter the limb (Wright and Snider, 1996). Later in development, GDNF is 
expressed in the ventral root by fibroblast-like cells, in the peripheral nerve by 
Schwann cells and in a subset of muscles (Henderson et a l ,  1994; Wright and 
Snider, 1996). In the chicken , GDNF mRNA is highly expressed in the muscle at 
E6, coinciding with the beginning of the period of naturally occurring spinal
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motoneuron cell death, and drops markedly at later ages when neurons compete for 
limiting amounts of target-derived trophic support (chapter 2 of this thesis). 
Furthermore, GDNF deficient mice exhibit a reduction in the number of spinal 
motoneurons (Sanchez etal., 1996; Moore etal., 1996). This suggests that GDNF 
may act physiologically as a neurotrophic factor for motoneurons, and may be 
beneficial for the treatment of motoneuron degenerative diseases such as 
amyotrophic lateral sclerosis and spinal muscular atrophies.
A first attempt to test the therapeutic potential of GDNF on motoneuron 
diseases has been recently reported (Sagot et a i,  1996). In a mouse model of 
motoneuron degeneration (progressive motor neuropathy, pmn), GDNF, delivered 
by encapsulated GDNF-producing BHK cells (baby hamster kidney fibroblast), 
significantly reduces the loss of facial motoneurons but has no effect on myelinated 
fiber degeneration (Sagot et al, 1996). Thus, GDNF may be useful in the treatment 
of motoneuron diseases if administered in conjunction with other trophic factors 
such as IGF-1 (for review, see Lewis et a l ,  1993) that act on the nerve 
degeneration.
Other CNS neuronal populations that are supported by GDNF include 
noradrenergic neurons, cerebellar Purkinje cells, and basal forebrain cholinergic 
neurons (Arenas et a l , 1995; Mount et a l,  1995; Williams et a l,  1996). GDNF 
can prevent 6-OHDA-induced death of adult noradrenergic neurons localized in the 
locus coeruleus in vivo, and increase the level of tyrosine hydroxylase and promote 
neurite sprounting of the surviving neurons (Arenas et a l ,  1995). This 
noradrenergic nucleus is severely impaired by neurodegenerative diseases of the 
brain. Furthermore, GDNF is a potent survival and differentiation factor for 
cultured cerebellar Purkinje cells from embryonic rat, whereas granule neurons and 
cerebellar glia do not appear to be targets of GDNF action (Mount et a l,  1995). It 
has been reported that GDNF can enhance the in vitro survival of embryonic rat 
basal forebrain cholinergic neurons after NGF deprivation, as assessed by ChAT 
staining (Ha et a l,  1996). Another study has shown that GDNF can prevent the 
atrophy and sustain the phenotype of adult rat cholinergic neurons in the basal 
forebrain after transection of the fimbria/fornix in vivo (Williams et al,  1996; 
Lapchak e ta l , 1996). Neurons in the medial septum and diagonal band of Broca
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project to the ipsilateral hippocampus through the fimbria/fornix, and are of 
particular interest because they degenerate in Alzheimer's disease (Olson, 1994). 
Thus, GDNF may be of potential interest for the treatment of this disease.
GDNF mRNA is widely expressed in the CNS. Using in situ hybridization 
GDNF mRNA has been found in developing rat striatum, ventral limbic areas, and 
spinal cord (Stromberg et a l ,  1993). Using the polymerase chain reaction (RT- 
PCR), GDNF mRNA has been localized in mesencephalic substantia nigra (Schaar 
et al,  1994; Cristina et al,  1995). In a more comprehensive study using in situ 
hybridization, GDNF mRNA has been found in other numerous regions of the 
developing rat CNS, including hippocampus, cerebral cortex, cerebellum, thalamus, 
cingulate cortex, substantia innominata, brain stem (locus coeruleus, motor and 
principal sensory trigeminal nuclei), pineal gland and dorsal horn of the spinal cord 
(Nosrat et a l ,  1996). In the adult CNS, GDNF mRNA is widely expressed and 
has been detected by RT-PCR in striatum, hippocampus, cortex and spinal cord of 
both rat and human, and in the rat cerebellum (Springer et al, 1994). Finally, using 
a sensitive RNase protection assay, GDNF mRNA has also been found in the adult 
rat septum, mesencephalon, medulla oblongata, colliculi, cochlear nucleus, and 
hypothalamus (Arenas et a l,  1995). The widespread pattern of GDNF mRNA 
expression in the embryonic and adult brain suggests that GDNF could provide 
trophic support to numerous populations of CNS neurons by either an autocrine, 
paracrine and /or target-derived mechanism.
The action of GDNF is not limited to the central nervous system. Several 
populations of neurons from the peripheral nervous system also respond in vitro 
and in vivo to GDNF (as discussed in chapter 2 of this thesis). Accordingly, 
homozygous GDNF-null mutant mice show a reduction in the number of neurons in 
the petrosal-nodose ganglion (40%), superior ceiwical sympathetic ganglion (35%), 
and dorsal root ganglion (23%) (Moore e t a l ,  1996). Furthermore, GDNF 
deficient mice display profond defects in the development of the kidney and the 
enteric nervous system (ENS) (Sanchez et al,  1996; Pichel et al, 1996; Moore et 
al,  1996). Neurons from the enteric nervous system are completely absent in the 
wall of the lower oesophagus, stomach, and small and large intestine in GDNF 
knockout mice. Since GDNF mRNA expression is localized in the muscle layers of
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the gastrointestinal tract, GDNF probably provides trophic support to innervating 
enteric neurons (Trupp et a l , 1995; Nosrat et al, 1996). In GDNF knockout mice, 
enteric neurons develop and are present in the oesophagus and stomach wall at early 
stages of development, but most of them die during late embryonic ages (Sanchez et 
al,  1996). This suggests that GDNF does not affect the migration of neural crest- 
derived precursors cells but is an essential survival factor for enteric neurons.
In the rodent kidney, GDNF mRNA expression is found in the condensing 
mesenchyme surrounding the tips of the ureter bud, the area of the prospective 
tubules (Nosrat et al,  1996; Suvanto et al,  1996). The ureter bud is an évagination 
of the Wolffian duct that penetrates into the metanephric blastema and branches 
repeatedly to form the collecting tubules and ureters. This process is due to a 
reciprocal inductive interaction between the ureteric bud and the adjacent 
metanephric mesenchyme. The metanephiic mesenchyme induces the formation and 
arborization of the ureteric bud to give rise to the renal collecting system, and the 
ureteric bud induces the mesenchyme to differentiate into epithelial structures that 
form the glomeruli and proximal and distal part of the nephron (Saxen, 1987). In 
homozygous GDNF mutant mice, both kidneys and ureters are missing. In most of 
these animals the ureter buds do not develop. When they are present, they hardly 
penetrate into the metanephiic mesenchyme and do not branch (Sanchez et al, 1996; 
Pichel e ta l ,  1996; Moore et a l ,  1996). Thus, GDNF is an essential inductive 
factor for ureter bud formation and branching during renal organogenesis.
In addition to the developing kidney, GDNF mRNA is present in numerous 
other peripheral organs and tissues, including lung, heart, liver, spleen, testis, 
ovary, adrenal, thyroid, pituitary and salivary glands, thymus, skin, whisker pad, 
glomus carotidus, teeth, vibrissae, tongue, inner and outer ear, nasal cavity, eye, 
and blood (Suter-Crazzolara and Unsicker, 1994; Trupp et a l,  1995; Nosrat et a l , 
1996; chapter 2 of this thesis). The analysis of GDNF deficient mice has revealed 
that the above tissues apparently develop normally in the absence of GDNF, 
suggesting that it is not critical for their development.
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5.1.2. Neurturin
Neurturin (NTN) is a novel neurotrophic factor that has been recently isolated 
on the basis of its ability to promote the survival of superior cervical ganglion 
neurons in culture. Data obtained by partial amino acid sequencing were used to 
isolate mouse neurturin cDNA as well as mouse and human neurturin genomic 
clones (Kotzbauer et al,  1996). Neurturin is a member of the TGF-6 superfamily 
that belongs to the GDNF subfamily. It is synthesized as a precursor protein of 195 
amino acids that upon cleavage yields a 100-residue mature protein. Neurturin 
contains the seven conserved cysteine residues found in the same relative position 
across the entire TGF-6 family. Sequence comparison has revealed that mature 
neurturin shares 42% similarity with mature GDNF and less than 20% with other 
members of the superfamily. Biologically active neurturin is an homodimer with a 
molecular mass of 25 kDa on non-reducing electrophoresis gels (Kotzbauer et al, 
1996).
Neurturin mRNA is expressed in both neonatal and adult mouse brain, heart, 
ovary and blood. It has been shown that neurturin promotes the survival in vitro of 
embryonic nodose, superior cervical and dorsal root ganglion neurons, and its 
action is mediated via the MAP kinase signalling pathway (Kotzbauer et al, 1996).
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5.2. RECEPTORS OF THE TGF-B FAMILY OF PROTEINS
The various members of the TGF-6 superfamily signal through a complex of 
two distinct transmembrane receptors, termed type I and II, that constitute a unique 
serine/threonine kinase (STK) receptor family (for review, see Massagué et al,  
1994). TGF-6s bind to the type II receptor, T6R-II, which is a constitutively active 
STK that does not require ligand for activation (Lin et al, 1992; Ebner et a l , 1993; 
Attisano e ta l , 1993; Franzén et a l  1993; Wrana et al, 1994). Certain proteins act 
as modulators of the binding of TGF6 family ligands to their signalling receptor 
complexes. One such protein is betaglycan, a transmembrane proteoglycan that is 
also known as a TGF-6 type III receptor. Betaglycan binds TGF-6s and regulates 
their access to the type II receptor, either by enhancing or inhibiting the interaction 
(Wang e ta l ,  1991; Lin and Lodish, 1993). The complex TGF-6/T6R-II recmits 
T6R-I, which can only recognize the ligand when it is bound to the type II receptor, 
and the type I receptor is subsequently phosphorylated by T6R-II (Wrana et a l , 
1994). Phosphorylation of T6R-I occurs on serine and threonine residues within a 
highly conserved 30 amino acid region known as the "GS domain", a glycine/serine 
rich region located immediately upstream of the kinase domain (Wrana et al, 1994). 
Phosphorylation allows the type I subunit, the transducer of the TGF-6 receptor 
complex, to propagate the ligand signal to downstream components (Wrana et al, 
1994; Wieser et a l,  1995). Binding of TGF-6-related proteins induces serine 
phosphorylation and nuclear translocation of a novel transcription factor initially 
cloned in drosophila and termed Mother against Dpp (MAD) that has numerous 
homologues in several species, including human, indicating their involvement in the 
TGF-6 signalling cascade (Raftery et a l ,  1995; Sekelsky et a l ,  1995; Liu et a l ,
1996). Different MAD protein isoforms may tiansduce the signalling of distinct 
subsets of TGF-6 ligands and generate different biological responses by activation 
of specific genes (Graff et a l , 1996; for review, see Massagué, 1996a). Thus, the 
TGF-6 signalling cascade represents a novel mechanism of signal transduction 
distinct from that known to be employed by the members of the receptor tyrosine 
kinase family.
Apart from the T6R-I and T6R-II for the TGF-6 subfamily of ligands, the 
type I and II receptors for activin, Dpp and BMP have also been cloned and belong
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to the same family of serine/threonine kinase receptors (Mathews and Vale, 1991; 
Mathews et a l , 1992; Attisano et a l , 1992; 1993; Nellen et a l , 1994; Brummel et 
a l,  1994; Penton et a l,  1994; Xie e ta l ,  1994; Ruberte et a l ,  1995; Massagué, 
1996a). The mechanism of activation of the activin receptor complex is similar to 
that described above, but the Dpp and BMP receptor complexes both contain type I 
and II subunits that bind directly to the ligand and are required for signal 
transduction (Ruberte e ta l,  1995; Massagué, 1996a).
GDNF and neurturin signals are transduced into the cytoplasm by 
multicomponent receptors that differ from the other TGF-6 family of receptors (as 
described in chapter 4 of this thesis). It has been demonstrated that GDNF binds 
with high affinity to a glycosyl-phosphatidylinositol-linked ligand specific receptor, 
named GDNF receptor alpha (GDNFR-a) (Jing et al, 1996; Treanor et al,  1996). 
The current model for the GDNF receptor activation proposes that the complex 
GDNF/GDNFR-a associates with a signal transducer component, a transmembrane 
receptor tyrosine kinase termed RET (Takahashi et a l , 1988; 1989; Trupp et a l ,  
1996; Durbec eta l,  1996; Vega et al,  1996; Worby e ta l,  1996). This interaction 
induces an heterodimerization of the receptor components and RET is activated by 
autophosphorylation on tyrosine residues (for reviews, see Mason, 1996; 
Robertson and Mason, 1997).
The receptors for the TGF-6 superfamily of ligands described to date belong 
to the family of plasma membrane serine/threonine kinases. The significance of the 
existence of other members of the TGF-6 family that signal through receptor 
tyrosine kinases (RTK) remains to be clarified. It is possible that other TGF-6- 
related proteins also interact with either RET or other RTKs, since it has been 
shown that in certain cells, TGF-61 and TGF-62 can bind to three unidentified GPI- 
linked cell surface proteins with molecular masses of 60 kDa, 140 kDa and 180 
kDa (Massagué, 1992). Alternatively, GDNF and neurturin may belong to a new 
family of growth factors at the interface between the neuropoietic cytokine and 
TGF-6 families.
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6. A IM S OF THIS PROJECT
The aims of this project were three-fold. First, to investigate the in vitro 
responsiveness of various populations of neurons from the peripheral nervous system 
to GDNF during embryonic development and to analyse GDNF mRNA expression in 
the tissues innervated by these neurons. Second, to study the survival-promoting 
effects of neurturin on PNS neurons in culture. Third, to isolate chicken GDNFR-a 
and related cDNAs, to study the function of the cloned receptors, and to determine the 
developmental expression of the receptor mRNAs in chicken tissues.
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IX. CHAPTER 2
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EXPRESSION AND NEUROTROPHIC ACTIONS OF GDNF 
IN THE PERIPHERAL NERVOUS SYSTEM
1. INTRODUCTION
The survival of many populations of neurons in the developing vertebrate 
nervous system depends on trophic support from their innervation targets and, in 
some cases, from the afferents they receive (Oppenheim, 1991). An extensively 
studied family of trophic factors are the neurotrophins: nerve growth factor (NGF), 
brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), NT-4/5 and 
NT-6. In vitro studies have shown that each of these factors is able to support the 
survival of distinct classes of neurons (Davies, 1994a). The physiological relevance 
of many of these in vitro studies has been confirmed by analysis of the phenotypes 
of mice with targeted null mutations in neurotrophin genes (Crowley et a l,  1994; 
Ernfors et a l,  1994a, 1994b; Farinas et a l,  1994; Jones et a l ,  1994) and 
neurotrophin receptor genes (Klein 6%/., 1993, 1994; Smeyne et al,  1994). In 
general, populations of neurons in the peripheral nervous system that have been 
shown to be supported by a particular neurotrophin in culture are greatly reduced in 
number in mice with mutations in either the corresponding neurotrophin gene or the 
gene encoding its receptor tyrosine kinase (Davies, 1994c; Snider, 1994).
Several proteins that aie not structurally related to the neurotrophins are also 
able to support the survival of particular' kinds of neurons in culture. These include, 
ciliary neurotrophic factor (CNTF) (Sendtner et a l ,  1994), basic fibroblast growth 
factor (bFGF) (Eckenstein, 1994), leukaemia inhibitory factor (LIF) (Murphy et al, 
1993) and glial cell line-derived neurotrophic factor (GDNF) (Lin et al, 1993).
GDNF is a distantly related member of the transforming growth factor-beta 
family that was recently purified from the B49 glial cell line. It was initially 
described as a potent survival factor for midbrain dopaminergic neurons (Lin et al,  
1993) and motoneurons (Henderson et al, 1994; Zurn et al, 1994; Oppenheim et 
al, 1995). Furthermore, GDNF is able to protect midbrain dopaminergic neurons 
from both 6-OHDA (Hoffer et a l , 1994) and MPTP toxicity (Tomac et al, 1995b)
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and from axotomy-induced degeneration (Beck et al, 1995), and motoneurons from 
axotomy-induced cell death (Henderson et a l , 1994; Zurn et a l , 1994; Yan et a l , 
1995; Oppenheim e ta l ,  1995). GDNF mRNA has been found to be expressed in 
developing striatum (Stromberg et al, 1993; Schaar et al,  1993) and limb muscle 
(Henderson et a l ,  1994), target tissues for midbrain dopaminergic neurons and 
spinal motoneurons, respectively. Its potential effects on neurons of the peripheral 
nervous system have not, however, been extensively analyzed. Prior to the study 
presented in this chapter, it was thought that GDNF was a specific neurotrophic 
factor for midbrain dopaminergic neurons and motoneurons, raising the possibility 
of using this molecule as a therapeutic agent for the treatment of neurodegenerative 
diseases such as Parkinson's disease and amyotrophic lateral sclerosis.
The aim of this study was to analyse the neurotrophic actions of GDNF on 
avian embryonic PNS neurons throughout development and the expression of 
GDNF mRNA in the target fields of these neurons. Sensory and autonomic 
neurons of the peripheral nervous system can be easily obtained free of 
contaminating non-neuronal cells for in vitro studies (Davies, 1988a). Cranial 
sensory neurons are especially useful for ascertaining which classes of sensory 
neurons respond to a particular factor, because functionally distinct classes of 
sensory neurons are segregated into anatomically discrete groups (Davies, 1987b). 
The results show that GDNF is able to support the survival of sympathetic, 
parasympathetic, proprioceptive, enteroceptive and cutaneous sensory neurons of 
the chicken embiyo at different stages of their development.
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2. NEUROTROPHIC ACTIONS OF GDNF IN  TH E PNS
2.1. METHODS
2.1.1. Neuronal cultures
White Leghorn chicken eggs were incubated at 38°C in a forced-draft 
incubator until the required age. The trigeminal, nodose, ciliary and paravertebral 
sympathetic ganglia and the median component of the trigeminal mesencephalic 
nucleus (TMN) were dissected from chicken embryos of 6, 8, 10, 12 and 14 days 
incubation: stages 29, 34, 36, 38 and 40, respectively (Hamburger and Hamilton, 
1951) (figure 2.1). The trigeminal ganglion was further dissected into its neural 
crest-derived dorsomedial pole (dorsomedial trigeminal ganglion, DMTG) and 
placode-derived ventrolateral pole (ventrolateral trigeminal ganglion, VLTG) 
(Davies, 1988a). The dissections were performed under sterile conditions in a 
laminar flow hood using tungsten needles under a stereo microscope.
The dissected ganglia were incubated in 0.1% trypsin/calcium- and 
magnesium-free Hank's balanced salt solution (HBSS) for 10, 12, 15, 20 and 25 
minutes at 37°C for E6, E8, ElO, E12 and E14 ganglia, respectively. The 
trypsinized tissue was washed twice in Hank's F-12 medium containing 10% heat- 
inactivated horse serum (HIHS) and mechanically dissociated by gentle trituration 
using a fired-polished Pasteur pipette.
Non-neuronal cells were removed from E8 and older neurons by differential 
sedimentation (as described by Davies, 1988a). The resulting neuronal suspensions 
(> 95% pure) and the dissociated cell suspensions from E6 ganglia (at which age 
differential sedimentation is not very effective in removing non-neuronal cells) were 
plated in 35 mm plastic tissue culture dishes (Nunc, Gibco) that had been pre-coated 
with poly-DL-ornithine (0.5 mg/ml, in 0.15 M borate buffer, overnight at RT) and 
laminin (20 jig/ml, in F-14 medium, 4 hours at 37°C) at a density of 500-2,000 
neurons per dish. The cells were grown in 2 ml of Ham's F14 medium plus 10% 
HIHS, with or without different purified recombinant neurotrophic factors (GDNF, 
BDNF, NGF or CNTF), in a humidified 4% CO2 incubator at 37°C .
Six to eight hours after plating, the number of attached neurons within a 12 x 
12 mm square in the centre of each dish was counted using an inverted phase-
I
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contrast microscope (usually 100-200 neurons). The number of surviving, bright- 
phase and process-bearing neurons in this same area was subsequently counted 48 
hours after plating (by which time almost all neurons had degenerated in control 
cultures, i.e. dishes without neurotrophic factors). The number of surviving 
neurons at 48 hours is expressed as a percentage of the number of attached neurons 
at 6 to 8 hours. In each experiment, triplicate cultures were set up for all conditions.
2.2, SOLUTIONS AND MEDIA
HBSS
Hank's balanced salt solution without calcium and magnesium (GibcoBRL).
0.1% TRYPSIN
50 mg of trypsin (Worthington) was added to 5ml of Ca/Mg free PBS (GibcoBRL) 
and sterilised with an 0.22 pm filter (Nalgene).
POLY-DL-ORNITHINE
0.5 mg/ml poly-DL-ornithine (Sigma) in 0.15 M boric buffer (4.6 gr boric acid, 
BDH, in 500 ml distilled water, pH 8.4 ) was sterilised with an 0.22 pm filter 
(Gelman Sc.).
L-15
A IL unit of L-15 powder (GibcoBRL) was added to 1 L of double distilled water 
plus 100 mg streptomycin (Sigma) and 60 mg penicilin (Sigma), pH 7.3, and 
sterilised with an 0.22 pm filter (Gelman Sc.).
HAM'S F-12
A IL unit of F-12 powder (Gibco BRL) was added to 1 L of double distilled water 
plus 100 mg streptomycin (Sigma) and 60 mg penicilin (Sigma), pH 7.3, and 
sterilised with an 0.22 pm filter (Gelman Sc.).
HAM'S F-14
lOX concentrated stock solution;
A 5L unit of F-14 powder (Imperial) was added to 500 ml of double distilled water 
containing 500 mg streptomycin (Sigma) and 300 mg penicilin (Sigma). The lOx 
stock was stored in 50 ml aliquots at -40°C.
IX solution:
A 50 ml lOX aliquot was diluted into 450 ml double distilled water. 1 g of NaHCOs
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(BDH) was added and the solution was adjusted to pH 7 with dry ice and sterilised 
with an 0.22 pm filter (Gelman Sc.).
HIHS
Heat-inactivated horse serum (Gibco).
NEUROTROPHIC FACTORS
Recombinant rat NGF was a gift from John Wislow and Gene Burdon. 
Recombinant rat BDNF was a gift from John Wislow and Gene Burdon. 
Recombinant rat CNTF was a gift from David Shelton and Rae Nishi.
Recombinant rat GDNF was a gift from Arnon Rosenthal.
Neurotrophic factors were kept in F-14 plus 10% HIHS, pH 5.5, at -80°C until use.
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Figure 2.1. Location of the trigeminal and nodose ganglia, and the 
trigeminal mesencephalic nucleus in the chicken embrvo. Lateral aspect of the head 
of an ElO chicken embryo showing the locations of the trigeminal mesencephalic 
nucleus (TMN), and the trigeminal (T), geniculate (G), vestibulo-acoustic (VA), 
petrosal (P), and nodose ganglia (N). From Davies, 1988a.
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2.3. RESULTS
2.3.1. Parasympathetic neurons
The ciliaiy ganglion comprises pai'asympathetic neurons that innervate the iris, 
ciliary body and choroid and are supported by CNTF in culture (Baitin et al, 1984; 
Buj-Bello and Davies, unpublished data) but not by neurotrophins (Allsopp et ai,  
1993). To determine if GDNF is able to promote the survival of ciliary neurons, 
low-density, glial-free cultures of these neurons were established from E6, E8, ElO 
and E12 embryos (figure 2.2.A). After 48 hours incubation, virtually all neurons in 
control cultures (those not supplemented with neurotrophic factor) had died whereas 
the majority of neurons were surviving with GDNF. At each age, CNTF promoted 
the survival of similar numbers of ciliary neurons as GDNF, and there was only a 
small increase in the number of neurons surviving in the presence of both factors. 
Thus, the subsets of ciliary neurons that respond to GDNF and CNTF are largely 
overlapping.
The dose-responses of ciliary neurons to GDNF shifted to higher 
concentrations with increasing age. There was a 10-fold increase in the half- 
maximally effective concentiation (ECso) from 0.8 ng/ml in E6 cultures to 8 ng/ml in 
E12 cultures (figure 2.2.B). GDNF was less potent than CNTF; the EC so for ElO 
ciliary neurons responding to CNTF was approximately 0.05 ng/ml (data not 
shown).
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F igure 2.2. Survival responses of E6. E8. ElO and E12 ciliary neurons to 
GDNF.
2 .2 . (A ). Bar chart comparing the percent survival of ciliarv neurons in 
control cultures and cultures containing GDNF. CNTF. and GDNF plus CNTF. 
The number of surviving neurons after 48 hours incubation is expressed as a 
percentage of the number of attached neurons counted 6 hours after plating. CNTF 
was used at a saturating concentration of 10 ng/ml and GDNF was used at a 
concentration of 50 ng/ml. The mean and standard error are shown (n = 6 for E6 
and E12 cultures; n = 3 for E8 and ElO cultures).
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2 .2 .(B ). Graph of the dose-responses of ciliarv neurons to GDNF. GDNF 
was used at concentrations ranging from 0.64 pg/mi to 250 ng/ml. The mean and 
standard error of the percent survival after 48 hours incubation are shown (n = 12 
for E6 cultures; n = 3 for E8 and ElO cultures; n = 6 for E12 cultures).
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2,3.2. Sympathetic neurons
The sympathetic neurons of the embiyonic pai avertebral sympathetic chain ai'e 
supported by NGF and CNTF in culture (Chun and Patterson, 1977; Barbin et a i ,  
1984; Buj-Bello and Davies, unpublished data). To determine if these neurons also 
respond to GDNF, low-density, glial-free neuronal cultures were established from 
E8, ElO, E12 and E14 embiyos. In agreement with the previous demonstration that 
early sympathetic neurons survive for several days in the absence of neurotrophic 
factors (Ernsberger et a l , 1989b), the number of neurons surviving in E8 control 
cultures was still high after 48 hours incubation (figure 2.3.A). Despite the large 
number of neurons surviving in control cultures, GDNF and NGF both clearly 
enhanced the survival of neurons at this age. The increase in the total number of 
neurons in E8 cultures after 48 hours incubation reflects proliferation of early 
sympathetic neurons (Rohrer and Thoenen, 1987; Rothman et a l,  1978). The 
number of neurons surviving in ElO and older control cultures decreased mai’kedly. 
In these cultures, GDNF and NGF each promoted the survival of the majority of 
neurons and there was negligible additional neuronal survival in the presence of 
both factors (figure 2.3.A). Furthermore, like NGF, GDNF can promote the 
survival of sympathetic neurons at multiple embryonic ages. Thus, the subsets of 
sympathetic neurons that respond to GDNF and NGF are lai'gely overlapping.
As was observed for ciliary neurons (figure 2.2.B), there was a shift in the 
half-maximally effective concentration (ECso) of GDNF acting on sympathetic 
neurons. The ECso increased approximately two-fold from 2.6 ng/ml at ElO to 5.7 
ng/ml at E14 (figure 2.3.B). Although saturating levels of GDNF were as effective 
as NGF in promoting the survival of sympathetic neurons, GDNF was less potent 
than NGF. The ECso for E12 sympathetic neurons responding to GDNF (3.4 
ng/ml) was over two orders of magnitude greater than the EC50 for E12 sympathetic 
neurons responding to NGF (0.02 ng/ml) (data not shown).
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Figure 2.3. Survival responses of E8. ElO. E12 and E14 sympathetic 
neurons to GDNF.
2.3.(A). Bar chart comparing the percent survival of svmpathetic neurons 
after 48 hours incubation in control cultures and cultures containing GDNF. NGF. 
and GDNF plus NGF. NGF was used at a saturating concentration of 10 ng/ml and 
GDNF was used at a concentration of 50 ng/ml. The mean and standard error are 
shown (n = 12 for E8 cultures; n = 6 for ElO and E l2 cultures; n = 3 for E 14 
cultures).
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2.3.(B). Graph of the dose-responses of svmpathetic neurons to GDNF. 
GDNF was used at concentrations ranging from 16 pg/ml to 250 ng/ml. The mean 
and standard error of the percent survival after 48 hours incubation are shown (n = 
6 for ElO and E12 cultures; n = 3 for E14 cultures).
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2.3.3. Proprioceptive neurons
The median part of the trigeminal mesencephalic nucleus (TMN) of the 
chicken embryo is a circumscribed group of proprioceptive neurons that innervate 
stretch receptors in the jaw muscles and are supported by BDNF (Davies et a l ,  
1986b), CNTF (Buj-Bello and Davies, unplublished data) and NT3 (Hohn et al,  
1990) in culture. To determine if these proprioceptive neurons are responsive to 
GDNF, low-density, glial free cultures were established from E8, ElO and E12 
embryos. In control cultures, all of the neurons died by 48 hours incubation, 
whereas the majority of the neurons survived with GDNF. The GDNF survival 
response was most marked in E8 cultures where saturating levels of GDNF 
promoted the survival of over 70% of the neurons. The response of TMN neurons 
to GDNF decreased with age, falling to about 50% in E12 cultures (figure 2.4. A).
Previous work has shown that BDNF is also an effective suiwival factor for 
cultured TMN neurons (Davies et al, 1986a). However, saturating levels of BDNF 
were much less effective than GDNF in promoting the survival of E8 TMN neurons 
(30% survival with BDNF versus over 70% survival with GDNF). Similar 
numbers of TMN neurons were supported by BDNF and GDNF at ElO and E l2. 
There was no additional neuronal survival in E8 cultures containing GDNF plus 
BDNF compared with cultures containing GDNF alone and in ElO and E12 there 
was a small increase in the number of neurons surviving with both factors compared 
with either alone (figure 2.4.A). This suggests that the populations of neurons in 
the TMN that respond to GDNF and BDNF are largely overlapping.
Although saturating levels of GDNF were able to promote the survival of the 
majority of TMN neurons in culture, GDNF was not as potent as BDNF (figure
2.4.B). The ECso for ElO TMN neurons responding to GDNF (0.12 ng/ml) was an 
order of magnitude greater than the ECso for ElO TMN neurons responding to 
BDNF (0.012 ng/ml).
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Figure 2.4. Survival responses of TMN neurons to GDNF.
2.4.(A). Bar chart of the percent survival of E8. ElO and E l2 TMN 
neurons after 48 hours incubation in control cultures and cultures containing 
GDNF. BDNF. and GDNF plus BDNF. BDNF was used at a saturating 
concentration of 10 ng/ml and GDNF was used at a concentration of 10 ng/ml. The 
mean and standard error are shown (n = 3 for E8, ElO and E12 cultures).
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2.4.(B). Graph of the dose-responses of ElO TMN neurons to GDNF and 
BDNF. GDNF and BDNF were used at concentrations ranging from 3.2 pg/ml to 
50 ng/ml. The mean and standard error of the percent survival after 48 hours 
incubation are shown (n = 3).
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2.3.4. Enteroceptive neurons
The sensory neurons of the nodose ganglion innervate the thoracic and 
abdominal viscera and consist of a large subset of neurons that responds to BDNF 
(Lindsay etal., 1985; Davies e ta l,  1986a). To determine if nodose neurons also 
respond to GDNF, low-density, glial-free cultures of these neurons were 
established from E6, E8, ElO and E12 embryos. After 48 hours incubation most of 
the neurons in control cultures had died and substantial numbers were surviving 
with GDNF (figure 2.5.A). Between 40 and 60% of the neurons were supported 
by GDNF over the age range studied and similar numbers were supported by 
BDNF. Whereas there was no additive effect of GDNF plus BDNF on survival in 
E12 cultures, there was a partial additive effect of both factors at earlier ages, 
suggesting that the populations of nodose neurons that respond to GDNF and 
BDNF up to ElO are partially distinct.
In contrast to ciliary and sympathetic neurons, which become less responsive 
to GDNF with increasing age, dose response studies showed that nodose neurons 
become more sensitive to GDNF with increasing age (figure 2.5.B). There was an 
approximate 50-fold decrease in the ECso from 6.1 ng/ml at E6 to 0.12 ng/ml at 
E12.
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Figure 2.5. Survival responses of E6. E8. EIQ and E12 nodose neurons to 
GDNF.
2 .5 .(A). Bar chart comparing the percent survival of nodose neurons after 
48 hours incubation in control cultures and cultures containing GDNF. BDNF. and 
GDNF plus BDNF. BDNF was used at a saturating concentration of 10 ng/ml and 
GDNF was used at a concentration of 50 ng/ml. The mean and standard error are 
shown (n = 3 for E6, ElO and E l2; n = 6 for E8).
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2.5.(B). Graph of the dose-responses of nodose neurons to GDNF. GDNF 
was used at concentrations ranging from 3.2 pg/ml to 250 ng/ml. To facilitate 
comparison of the ECso at different ages, the E6 data were normalised to 50% 
survival at the highest GDNF concentration. This value is close to the percent 
suiwival for E8, ElO and E12 neurons at this concentration. The mean and standard 
error of the percent survival after 48 hours incubation are shown (n = 6 for E6; n = 
3 for E8, ElO and E12 cultures).
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2.3.5. Cutaneous sensory neurons
The embryonic chicken trigeminal ganglion contains of two anatomically 
segregated populations of cutaneous sensory neurons that innervate the facial 
region. Those in the dorsomedial part of the ganglion (DMTG neurons) are neural 
crest-derived and respond to NGF, whereas those in the ventrolateral part of the 
ganglion (VLTG neurons) are placode-derived and respond to BDNF (Davies et a i, 
1986a). To determine if either of these populations respond to GDNF, low-density, 
glial-free cultures of DMTG and VLTG neurons were established from E8, ElO, 
E12 and E14 embryos (figures 2.6.A and 2.6.B). After 48 hours incubation 
virtually all of the neurons in control cultures had died, whereas the majority of 
DMTG neurons were supported by NGF and the majority of VLTG neurons were 
supported by BDNF at all ages studied.
In contrast to autonomic, proprioceptive and enteroceptive neurons, no VLTG 
neurons and less than 20% of DMTG neurons survived in response to GDNF at E8. 
There was a marked increase in the number of DMTG and VLTG neurons 
responding to GDNF from ElO to E12. In E12 and E14 cultures, similar numbers 
of DMTG neurons were supported by either GDNF or NGF (figure 2.6.A) and 
similar numbers of VLTG neurons were supported by either GDNF or BDNF 
(figure 2.6.B). A limited number of experiments showed that neither DMTG nor 
VLTG neurons shown any response to GDNF at E6 (data not shown). There was 
only a small increase in survival in DMTG cultures containing GDNF plus NGF 
compaied with cultures containing the most effective neurotrophic factor alone at all 
stages studied (figure 2.6.A). In VLTG neuronal cultures, there was negligible 
additional survival in the presence of GDNF plus BDNF compared with cultures 
containing BDNF alone at all ages (figure 2.6.B). These results suggest that NGF- 
responsive DMTG neurons acquire GDNF responsiveness with increasing age and 
that BDNF-responsive VLTG neurons, likewise, acquire GDNF responsiveness as 
they mature.
89
Figure 2.6. Survival responses of E6. E8. EIQ and E12 DMTG and VLTG 
neurons to GDNF.
2 .6 .(A). Bar chart of the percent survival of DMTG neurons after 48 hours 
incubation in control cultures and cultures containing GDNF. NGF. and GDNF 
plus NGF. NGF was used at a saturating concentration of 10 ng/ml and GDNF 
was used at a concentration of 50 ng/ml.
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2.6 (B). Bar chart of the percent survival of VLTG neurons after 48 hours 
incubation in control cultures and cultures containing GDNF. BDNF. and GDNF 
plus BDNF. BDNF was used at a saturating concentration of 10 ng/ml and GDNF 
was used at a concentration of 50 ng/ml. The mean and standard error are shown (n 
= 3 for E8, ElO and E14; n = 6 for E12 cultures of both DMTG and VLTG 
neurons).
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Figure 2.7. TMN neurons cultured in the presence of GDNF and BDNF.
2 .7 .(A). Photomicrograph of E l2 TMN neurons after 48 h of incubation in 
cultures containing 10 ng/ml of GDNF.
2 .7 .(B ). Photomicrograph of E12 TMN neurons after 48 h of incubation in 
cultures containing 10 ng/ml of BDNF.
B
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3. EXPRESSION OF GDNF mRNA IN THE CHICKEN 
EMBRYO
Northern blotting was used to determine if GDNF mRNA is expressed in the 
tissues innervated by the autonomic and sensory neurons that respond to GDNF.
3.1. METHODS
3.1.1, Total RNA isolation
All steps were carried out at room temperature unless otherwise stated. All 
solutions (for composition, see Sambrook et a i ,  1989) were exclusively used for 
RNA extraction, to avoid contamination with ribonucleases.
Several tissues were dissected from white leghorn chickens and rats at 
different embryonic and posthaching or postnatal ages. Dissected tissues were 
placed in polypropylene tubes and immediately frozen at -80°C until use. Total 
RNA was extracted using guanidinium isothiocyanate (Chizgwin et a l , 1979) by a 
single-step method (Chomczynski e ta l, 1987).
Small amounts of tissue were usually homogenized by passing through a 
syringe needle in 10 jal/mg of denaturing solution (4 M guanidinium thiocyanate, 25 
mM tri-sodium citrate pH 7.0, 0.5% N-lauroylsarcosine, 0.1 M 2- 
Mercaptoethanol). 2 M sodium acetate (1:10 vol. of the denaturing solution), pH 4, 
was added to the homogenate and mixed thoroughly by inversion. Water-saturated 
acidic phenol (1:1 vol. of the denaturing solution) was added to the tube and mixed. 
Chloroform (1:10 total vol.) was then added and mixed vigorously. The tubes were 
incubated for 15 minutes in wet ice. Then, the samples were centrifuged for 10 
minutes at 15,300 rpm at 4°C. The upper aqueous phase containing total RNA was 
transferred to fresh tubes. The RNA was precipitated by adding 1:1 vol. of 100% 
isopropanol, and the tubes were placed at -20°C for periods between 30 minutes and 
overnight. The samples were centrifuged for 10 minutes at 15,300 rpm at 4°C, and 
supernatant was discarded. The pellet was washed in 70% ethanol and dried in a 
speed vacuum for 5-10 minutes. The RNA pellet was dissolved in denaturing 
solution (80 pi / 100 mg starting tissue) by vortexing. The RNA was reprecipitated 
with 1:10 vol. of 2 M sodium acetate, pH 4, and 2-2.5x total vol. of 100% ethanol.
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and samples were placed at -20°C periods ranging between 1 h and overnight. The 
tubes were centrifuged for 10 minutes at 15,300 ipm at 4°C and the supernatant was 
discarded, and the RNA pellet was washed with 70°C ethanol and dried in a speed 
vacuum for 5-10 minutes. The RNA pellet was resuspended in 15 pi of MOPS 
buffer/lOOmg of starting tissue, and 2 volumes of formamide:formaldehyde (3:1) 
were added to the samples and mixed. The tubes were placed in a water bath at 
60°C for 15-60 minutes to denature the RNA, and immediately transferred to wet 
ice. For gel electrophoresis, 4.5 pi of bromophenol/ethidium bromide (30/l)/100 
mg of starting tissue was added to the tubes, which were stored at -80C until use.
3.1.2. Gel electrophoresis and Northern blotting
Electrophoresis of RNA was carried out in a 20x20 cm 1.2% agarose/2.2 M 
formaldehyde gel, using MOPS buffer, at 100-150 mA for 4-5 h. A sample of total 
RNA from each tube was mn in an agarose/formaldehyde gel to evaluate the quality 
of the RNA and to calculate the concentration of RNA, according to ethidium 
bromide staining of ribosomal RNA and a standard RNA marker loaded on the gel. 
When required, the amount of RNA of each sample to be loaded on the same gel 
was adjusted to similar amounts.
The RNA was blotted onto Hybond-N+ filters (Amersham) overnight, and 
crosslinked to these membranes by a combination of UV irradiation (120,000 
pjoules, Stratagene Stratalinker) and baking at 80°C for 2 hours.
3.1.3. Hybridization
For hybridization, a 400 bp probe made from the coding region of rat GDNF 
cDNA (plasmid obtained from A.Rosenthal) and a 437 bp probe made from the 
coding region of chicken cDNA glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) were used. The membranes were prehybridized overnight at 36«C in 
plastic bags containing the following solution: 50% formamide, 5 x SSC, 30 mM 
sodium phosphate pH 7.0, 10 mM EDTA, 0.5% SDS, 5 x Denhardt's solution and 
250 pg/ml salmon sperm DNA. Filters were transferred to new bags and 
hybridized for 48 hours at 36®C in the above solution containing the 32P-labelled 
nick-translated cDNA probe (Sambrook et a i, 1989). Following hybridization, the 
membranes were washed three times at 60°C, for 15 minutes, in 2 x SSC with 0.2%
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SDS before exposure to Kodak Omat X-ray film.
To compare the relative levels of RNA in different lanes, the GDNF cDNA 
probe was stripped off the filters by boiling for 2x 5 minutes in O.lx SSC with
0.1% SDS and the filter was subsequently hybridized with the GAPDH cDNA 
probe. Prehybridisation and hybridization with the GAPDH cDNA probe were 
carried out in a solution of the same composition as described above. Filters were 
prehybridized in plastic bags overnight at 42°C, and hybridized for 48 hours at 42«C 
in fresh solution containing the 32p_iabelled GAPDH probe. After hybridization, 
filters were washed three times at 68oC, for 15 minutes, with 2 x SSC with 0.2% 
SDS before being exposed to X-ray film.
3.2. RESULTS
A Northern blot of total RNA from various embryonic and postnatal tissues 
dissected from chickens and rats was hybridized with a 32p_iabelled rat GDNF 
cDNA probe (figure 2.8.A). Using conditions of moderate stringency, this probe 
hybridized to the same size transcript (0.8 kb) in RNA from rat and chicken tissues, 
indicating that the probe hybridizes with the putative chicken GDNF mRNA. The 
level of GAPDH mRNA expression was used to compare the relative levels of total 
RNA between each sample. Figure 2.8.A shows the presence of similar low levels 
of GDNF mRNA in chicken embryonic brain (E8, E l2, and E l6) and postnatal 
cerebellum (PO), hemispheres (P3), and spinal cord (P4). Lower levels of chicken 
GDNF mRNA was detected in muscle at P4, whereas higher levels of expression 
were found in postnatal gizard, liver and kidney.
GDNF mRNA was detected in all of the embryonic chicken tissues that are 
innervated by the classes of neurons that respond to GDNF in vitro including, 
muscle, heart, eye (figure 2.8.B), and skin (not shown). The highest levels of 
GDNF mRNA were found in the tissues of the eye that are innervated by ciliary 
neurons (choroid, ciliary body and iris). Lower levels were detected in heart 
(innervated by nodose neurons), limb skeletal muscle (innervated by proprioceptive 
neurons). Figure 2.8.B indicates that some tissues show developmental changes in 
the levels of expression of GDNF mRNA. In muscle the level was highest at E6 
and dropped markedly at later ages. In heart the level increased from E6 to E l2. In
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eye tissues there was a gradual decrease in the level from E6 to E12 (figure 2.8.B). 
There were no obvious changes in the level of expression of GDNF mRNA in skin 
between E6 and E14 (not shown).
96
Figure 2.8.(A). Expression of GDNF mRNA in chicken and rat tissues. 
Autoradiogram of a Northern blot of total RNA extracted from different chicken and 
rat tissues hybridized with a 32p-labelled nick-translated rat GDNF probe and a-32P- 
labelled nick-translated chicken GAPDH probe.
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F igure 2.8.(B). Developmental changes in the expression of GDNF 
mRNA in tissues innervated bv GDNF-responsive neurons. Autoradiograms of a 
Northern blot of total RNA extracted from skeletal muscle, heart and eye tissues 
(choroid, ciliary body and iris) of E6, E8, ElO, E l2 and E14 chicken embryos 
hybridized sequentially with a 32P-labelled nick-translated GDNF probe and a ^zp- 
labelled nick-translated GADPH probe.
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4. DISCUSSION
The results show that GDNF promotes the in vitro survival of a wide variety 
of neurons in the peripheral nervous system of the chicken embryo. Different 
populations of neurons, however, respond at different stages in their development, 
either becoming less sensitive or more sensitive to GDNF as development proceeds. 
Both sympathetic and parasympathetic neurons are supported by GDNF from an 
early stage of their development. With increasing age, the number of sympathetic 
and parasympathetic neurons supported by GDNF decreases and the neurons 
become less sensitive to GDNF, as shown by a shift in the GDNF dose-response to 
higher concentrations. Proprioceptive TMN neurons are also supported by GDNF 
at an early stage, and the proportion supported by GDNF falls with increasing age. 
Although the majority of the enteroceptive neurons of the nodose ganglion are also 
supported by GDNF at an early stage in their development, in contrast to autonomic 
neurons, these neurons become more sensitive to GDNF as they mature. In marked 
contrast to autonomic, proprioceptive and enteroceptive neurons, cutaneous sensory 
neurons do not exhibit a survival response to GDNF at an early stage in their 
development, but acquire responsiveness to GDNF as they mature. By E l2, 
GDNF supports the suiwival of the majority of the NGF-responsive DMTG neurons 
and the majority of the BDNF-responsive VLTG neurons. These results suggest 
that GDNF plays a role in regulating the survival of various populations of PNS 
neurons at different stages of their development. Because each of these populations 
is also supported by at least one other neurotrophic factor and there is generally 
negligible additional survival in cultures containing this factor plus GDNF, it is 
likely that GDNF co-operates with various other neurotrophic factors in regulating 
neuronal survival.
Less comprehensive in vitro studies of some populations of PNS neurons of 
the mouse and rat embryos have revealed a limited response to GDNF (Henderson 
et a l, 1994; Trupp et a l,  1995). In agreement with the data presented in this 
chapter, ElO chicken nodose were found to be supported by GDNF in culture 
(Trupp et a l, 1995). Like in chicken, mouse nodose neurons show a survival 
response to GDNF. The percent survival increases from 7% survival in E l5
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cultures to 43% in E18 cultures, which is in line with the increasing sensitivity of 
developing chicken nodose neurons to GDNF with age. There is a negligible 
response of mouse trigeminal neurons to GDNF at either E15 or E18 (Henderson et 
a l, 1994). Similarly, E 16 rat trigeminal neurons are not supported by GDNF in 
vitro (Trupp et a l ,  1995). Given the late response of embryonic chicken 
dorsomedial and ventrolateral trigeminal neurons to GDNF and the more protracted 
development of rodent embryos compared with chicken embryos, it will be 
important to examine postnatal mouse trigeminal neurons to see if they too acquire 
GDNF responsiveness late in their maturation. Alternatively, GDNF may not play a 
role in the development of cutaneous sensory neurons in rodents since GDNF 
mRNA is present in E l8 rat skin, when trigeminal neurons are unresponsive to 
GDNF (Trupp et a l, 1995), and cannot be detected in neonatal rat skin (Henderson 
et a l, 1994). These results contrast with the demonstration of GDNF mRNA in 
developing chicken skin and the response of the cutaneous sensory neurons of the 
embryonic chicken trigeminal ganglion to GDNF. Furthermore, in contrast to 
embryonic chicken sympathetic neurons, embryonic rodent sympathetic neurons do 
not respond to GDNF (Henderson et a l , 1994; Trupp et a l , 1995). It is possible 
that this discrepancy in GDNF responsiveness constitutes a species difference 
between mammals and birds. CNTF, for example, promotes the survival of 
embryonic chicken sympathetic neurons but is ineffective on embryonic mouse 
sympathetic neurons (Buj-Bello and Davies, unpublished data).
In agreement with the demonstiation that GDNF promotes the in vitro survival 
of embryonic chicken sympathetic neurons, administration of GDNF to the chorio­
allantoic membrane of chicken embryos results in significantly higher numbers of 
neurons in sympathetic ganglia compared with control embryos (Oppenheim et a l ,
1995). However, no significant increases in ciliaiy, nodose or TMN neurons are 
observed in GDNF treated embryos (Oppenheim et a l, 1995). The number of 
dopaminergic neurons in the developing substantia nigra is also unaffected by 
GDNF administration in chicken embryos (Oppenheim et a l, 1995), yet GDNF is a 
potent survival factor for rat dopaminergic neurons in vitro (Lin et a l, 1993) and 
protects adult mouse midbrain dopaminergic neurons from both 6-OHDA (Hoffer et 
a l ,  1994) and MPTP toxicity in vivo (Tomac et a l,  1995b). Although 
discrepancies in the effects of GDNF on avian dopaminergic neurons in ovo and
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rodent dopaminergic neurons in vitro may be due to a difference in GDNF 
specificity in different vertebrate classes, it would be interesting to analyse the effect 
of GDNF on chicken dopaminergic neurons in vitro. However, it is unclear why 
GDNF does not rescue ciliary, nodose or TMN neurons in ovo whilst promoting 
the survival of these neurons in vitro.
The potency of rat GDNF acting on embryonic chicken PNS neurons 
observed in this current study is lower than that of rat GDNF acting on rat 
motoneurons or human GDNF acting on rat midbrain dopaminergic neurons. The 
EGso for rat GDNF acting on rat motoneurons is 0.2 pg/ml (Henderson et al., 1994) 
and the ECso for human GDNF acting on rat dopaminergic neurons is 36 pg/ml (Lin 
et al., 1993). In contrast, the lowest EC so for rat GDNF acting on chicken neurons 
was 120 pg/ml for BIO TMN neurons and E12 nodose neurons. The lower potency 
of mammalian GDNF acting on chicken PNS neurons probably reflects cross­
species differences in GDNF structure rather than lower sensitivity of PNS neurons 
to GDNF because rat GDNF acting on chicken motoneurons is three orders of 
magnitude less active than on rat motoneurons (C. Henderson, personal 
communication). It will be important to isolate chicken GDNF in order to ascertain 
its potency on various populations of chicken neurons at different stages of 
development.
A striking observation of this current study was the occurrence of 
developmental shifts in neuronal responsiveness to GDNF. Age-related shifts in 
neurotrophin dose responses have previously been observed in developing 
trigeminal ganglion neurons. For example, the sensitivity to NGF decreases by an 
order of magnitude to higher concentrations during the period of naturally occurring 
neuronal death in the embryonic mouse trigeminal ganglion (Buchman and Davies, 
1993), and the loss of responsiveness of embryonic chicken DMTG neurons to 
BDNF and NT3 is due to shifts in the dose responses to these factors by several 
orders of magnitude (Buj-Bello et al., 1994). In this study, it is not only 
demonstrated that the dose responses of some populations of neurons shift to higher 
GDNF concentrations with increasing age, but that the dose responses of other 
populations shift to lower GDNF concentrations as they mature. Because these 
changes in GDNF sensitivity would be expected to affect the quantities of GDNF
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required for survival at different stages of development, it will be important to 
determine if these changes are due to differences in the expression of GDNF 
receptors or to intracellular signal transduction pathways.
Northern blotting has shown that an 0.8 kb GDNF transcript is expressed in 
all of the tissues of the embryonic chicken that are innervated by the neurons that 
respond to GDNF. This finding strengthens the physiological relevance of the in 
vitro results. Moreover, it is observed that developmental changes in the level of 
GDNF mRNA expression in some tissues seem to mirror changes in the sensitivity 
of the innervating neurons to GDNF. For example, the level of GDNF mRNA in 
heart and the response of nodose neurons to GDNF both increase during 
development. The level of GDNF mRNA in choroid, ciliary body and iris and the 
response of ciliary neurons to GDNF both decrease during development. The level 
of GDNF mRNA in skeletal muscle and the response of proprioceptive neurons to 
GDNF also decreases during development, although the decrease in GDNF mRNA 
is far more abrupt in muscle than in ocular tissues. If changes in the sensitivity of 
neurons to GDNF aie related to levels of expression of the GDNF receptor, it will 
be important to study whether the expression of this receptor is regulated by GDNF 
itself. It is likely that GDNF synthesized in skeletal muscle also plays a role in 
supporting the survival of motoneurons which respond with increased survival to 
GDNF both in vitro (Henderson et a l, 1994) and in vivo (Oppenheim et a l, 1995). 
In skin there are no obvious changes in the level of GDNF mRNA expression over 
the same period of development as cutaneous sensory neurons acquire 
responsiveness to GDNF (not shown). It is possible that in skin GDNF may have 
additional functions before the innervating neurons start responding to GDNF. The 
synthesis of GDNF in Schwann cells (Henderson et a l , 1994) and the relationship 
of these cells to the axons of neurons that respond to GDNF raises the possibility 
that Schwann cells may be an additional important source of GDNF for these 
neurons. Type I astrocytes from the substantia nigra, basal forebrain, and cortex 
also express GDNF mRNA, indicating that glial cells may be a common source of 
GDNF for neurons (Schaar et a l, 1993). GDNF mRNA is expressed in various 
regions of the developing chicken CNS, including cerebellum, hemispheres and 
spinal cord. Similarly, using in situ hybridization, GDNF messenger has been
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found in developing rat striatum (caudate/putamen), ventral limbic areas (olfactory 
tubercle), and Clarke's column in the spinal cord (Stromberg et a i, 1993). 
Additionally, GDNF has been shown by polymerase chain reaction (RT-PCR) to be 
present in mesencephalic substantia nigra (Schaar et a i, 1994). In the adult CNS, 
GDNF mRNA is widely expressed and can be detected by RT-PCR in striatum, 
hippocampus, cortex and spinal cord of both rat and human, and in the rat 
cerebellum (Springer et a l , 1994). These data suggest the possibility that GDNF 
may be a neurotrophic factor for several neuronal populations in the central nervous 
system, including mesencephalic dopaminergic neurons, locus coemleus neurons, 
basal forebrain cholinergic neurons, cerebellar Purkinje cells and motoneurons (Lin 
et a l, 1993; Arenas et a l, 1995; Mount et a l ,  1995; Williams et a l ,  1996; 
Henderson et a l, 1994).
GDNF-null mutant mice have been generated by using homologous 
recombination in embryonic stem cells (Sanchez et a l , 1996; Pichel et a l, 1996; 
Moore et a l, 1996). In agreement with the results presented in this chapter on the 
survival-promoting effect of GDNF on PNS neurons, homozygous mice show a 
reduction in the number of neurons in the petrosal-nodose ganglion (40%), superior 
cervical sympathetic ganglion (35%), and dorsal root ganglion (23%), although no 
differences are detected in trigeminal sensory and vestibular ganglia in comparison 
to wild-type mice (Moore et a l,  1996). In addition, there is a significant loss of 
motoneurons in the lumbar spinal cord (20-30%) and trigeminal motor nucleus 
(20%) (Sanchez et a l, 1996; Moore et a l, 1996). However, no defects are 
observed in the number of midbrain dopaminergic neurons, noradrenergic neurons 
within the locus coemleus, and facial motoneurons. No other deficits were detected 
in other regions of the CNS (Sanchez et a l , 1996; Pichel et a l , 1996; Moore et a l,
1996). These observations indicate that GDNF is involved in the development of 
several populations of PNS and CNS neurons in vivo and may co-operate with 
other trophic factors in keeping them alive. Discrepancies between the survival 
effects of GDNF on certain kind of neurons in vitro, such as dopaminergic and 
noradrenergic neurons (Lin et a l, 1993; Arenas et al, 1995), and the lack of effect 
of knocking out the GDNF gene on these neurons indicate that GDNF is not an 
essential physiological survival factor for these neuronal populations during their 
development.
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In summary, it has been demonstrated that GDNF is a survival factor for 
multiple classes of sensory and autonomic neurons, and that its survival promoting 
effects are dependent on developmental age. These results have changed the notion 
that GDNF is a neurotrophic factor with a highly restricted neuronal specificity.
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X. CHAPTER 3
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NEUROTROPHIC ACTIONS OF NEURTURIN IN THE 
PERIPHERAL NERVOUS SYSTEM
1. INTRODUCTION
Neurotrophic factors aie molecules involved in the survival and differentiation 
of neurons during the development of the nervous system (Davies, 1988b). Since 
the discovery of NGF 40 years ago (for review, see Levi-Montalcini, 1987), the list 
of known neurotrophic factors is constantly increasing. Some of these factors have 
been isolated on the basis of their ability to promote the survival of embryonic 
neurons. This is the case for nerve-growth factor (NGF) (Levi-Montalcini and 
Hamburger, 1951), brain-derived neurotrophic factor (BDNF) (Barde etal., 1982; 
Leibrock et al., 1989), ciliaiy neurotrophic factor (CNTF) (Adler et at., 1979; Lin et 
at., 1989; Stockli et al., 1989), and glial cell line-derived neurotrophic factor 
(GDNF) (Lin et al., 1993; Lin et al., 1994). By the end of my Ph.D., the 
purification and cloning of a new neurotrophic factor, termed neurturin, was 
reported (Kotzbauer et al., 1996). Neurturin is a 25 kDa protein that has been 
purified from the conditioned medium of the Chinese hamster ovary cell line on the 
basis of its ability to support the survival of neonatal rat sympathetic neurons. 
Mouse and human neurturin have been cloned and sequenced, and shaie about 42% 
identity with GDNF at the amino acid level. Neurturin is, like GDNF, a distant 
member of the transforming growth factor (TGF)-B superfamily of proteins with 
less than 20% sequence similarity with other family members, but containing the 
seven conserved cysteine residues at the same relative spacing found in the entire 
family. Thus, GDNF and neurturin are homologous proteins that define a new 
subfamily of neurotrophic factors within the TGF-B family of proteins.
The TGF-B superfamily is composed of about 30 members that are divided in 
different subfamilies depending on their amino acid sequence homology; it includes 
the TGF-B, the activin, and the decapentaplegic and 60A subfamilies, the DVR 
group, and other ungrouped proteins like Müllerian inhibiting substance (MIS) (for 
review, see Kingsley, 1994). They exert a wide variety of effects on cell 
proliferation, differentiation, and organization (for review, see Roberts and Sporn,
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1990). In some cases, most members of the same subfamily, i.e. TGF-B 
subfamily, have similar functions in different systems (Massagué, 1990).
In chapter 2 of this thesis it has been shown that GDNF is a survival factor 
for multiple classes of sensory and autonomic neurons from the chicken embryo, 
and that its survival-promoting action and expression in the tissues innervated by 
these neurons aie dependent on developmental age. The physiological relevance of 
these in vitro studies has been confirmed by analysis of the phenotype of transgenic 
mice with a targeted null mutation of the GDNF gene (Moore et at., 1996). 
Survival assays have shown that neurturin and GDNF both promote the in vitro 
survival of neurons from rat superior cervical ganglion (SCG), dorsal root ganglia 
(DRG), and nodose ganglion (Kotzbauer et al., 1996). Thus, to compare further 
the similarities and differences between the activity of neurturin and GDNF in 
promoting the in vitro survival of chicken PNS neurons, a limited number of 
experiments have been performed. It has been found that neurturin, like GDNF, 
promotes the survival of developing sensory, enteroceptive, sympathetic and 
parasympathetic neurons in culture.
2. METHODS
2.1. Neuronal cultures
Nodose, ciliary and paravertebral sympathetic ganglia were dissected from 
ElO chicken embryos, and dorsomedial trigeminal ganglia were obtained from E14 
embryos. The dissected tissue was tripsinized, washed and triturated as described in 
chapter 2. The neurons were separated from non-neuronal cells by differential 
sedimentation and plated in 35 mm dishes using culture procedures that have been 
also described in chapter 2. The number of surviving neurons was counted 48 
hours after plating and expressed as a percentage of the number of attached neurons 
at 6-12 hours after plating.
Recombinant human neurturin was a gift from Arnon Rosenthal.
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3. RESULTS
3.1. Parasympathetic neurons
The parasympathetic neurons of the ciliaiy ganglion are supported by CNTF / 
GPA (Barbin et al., 1984; Eckenstein et al., 1990; Buj-Bello and Davies, 
unpublished data) and GDNF (chapter 2 of this thesis) in culture. Glial-free 
cultures of ElO ciliary neurons were set up to determine whether neurturin is able to 
promote the survival of these neurons. After 48 hours in culture all neurons grown 
without neurotrophic factors had died (not shown), whereas the majority of neurons 
survived in the presence of high concentrations of neurturin (50ng/ml). The 
number of neurons surviving was similar in cultures treated with 50 ng/ml of either 
neurturin or GDNF, and there was only a small increase of neuronal cells surviving 
in the presence of both factors (figure 3.1). This indicates that the populations of 
ciliaiy neurons that respond to neurturin and GDNF are lai'gely overlapping.
When ciliary neurons were cultured with lower amounts of either neurturin or 
GDNF, differences in the survival effect of these two factors were observed. There 
was a negligible neuronal suiwival in cultures with 1 ng/ml of GDNF, whereas with 
the same concentration of neurturin about 20% of the neurons survived. The 
survival of ciliary neurons was also higher in cultures treated with 5 ng/ml of 
neurturin than in those containing the same amount of GDNF (figure 3.1). Thus, 
although ElO ciliary neurons respond to both factors, neurturin is more potent than 
GDNF in promoting the in vitro survival of parasympathetic neurons.
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Figure 3.1. Bar chart comparing the percent survival of ElO chicken ciliary 
ganglion neurons grown with neurturin. GDNF and neurturin plus GDNF for 48h. 
The mean and standard errors are shown (n=3 for 1 ng/ml and 5 ng/ml; n=6 for 50 
ng/ml).
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3.2. Sensory cutaneous neurons
E14 chicken DMTG neurons respond in vitro to NGF and GDNF (chapter 2 
of this thesis), and to CNTF / GPA (Buj- Bello and Davies, unpublished data). 
After 48 hours of incubation, a similar number of neurons survived (about 50%) 
when grown with high concentrations of either neurturin or GDNF (50 ng/ml) 
(figure 3.2). The number of neurons alived in control dishes, i.e. without 
neurotrophic factors, was negligible (5%) (not shown). There was only a small 
increase in survival when cultures were treated with neurturin plus GDNF 
compared to cultures containing neurturin alone, indicating that neurturin and 
GDNF act on the same subpopulation of DMTG neurons. Furthermore, like 
GDNF, neurturin was unable to support the in vitro survival of E6 DMTG neurons 
(not shown).
However, differences in the survival-promoting activity of neurturin and 
GDNF were observed when E14 DMTG neurons were treated with lower amounts 
of these neurotrophic factors. At the same concentration (5 ng/ml) GDNF 
supported less neurons than neurturin (figure 3.2). Thus, like parasympathetic 
ciliary neurons, small-cutaneous sensory neurons are responsive to neurturin in 
vitro and are more sensitive to this factor than GDNF.
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F igure 3.2. Bar chart of the percent survival of E14 chicken DMTG 
neurons after 48h of incubation in cultures containing neurturin. GDNF. and 
neurturin plus GDNF. The mean and standard error are shown (n=3).
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3.3. Sympathetic neurons
The chicken paravertebral sympathetic chain contains neurons that are 
supported m vitro by NGF and GDNF (chapter 2 of this thesis), and CNTF / GPA 
(Eckenstein et al., 1990; Buj-Bello and Davies, unpublished data). To determine 
whether these neurons also respond to neurturin, low-density neuronal cultures 
were established from ElO embryos. The number of neurons surviving in absence 
of neurotrophic factors after 48h was relatively high (16%) as mentioned in chapter 
2 (not shown). After 48 hours of incubation, the majority of neurons survived in 
cultures containing neurturin at high concentrations (50 ng/ml) and there was only a 
small increase in the number of alive neurons when grown in combination with 
GDNF (figure 3.3). This indicates that the population of sympathetic neurons that 
respond to neurturin and GDNF is largely overlapping.
As observed for ciliary and DMTG neurons (figures 3.1 and 3.2), the number 
of neurons surviving in the presence of lower concentrations of neurturin (1 ng/ml) 
was less than that observed with the same amount of GDNF, although in the case of 
sympathetic neurons, the difference was smaller. These results suggest that 
neurturin is more potent than GDNF in promoting the survival of chicken 
sympathetic neurons.
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F igure 3.3. Bar chart showing the survival of ElO chicken lumbar chain 
svmpathetic neurons in culture after 48h of incubation in the presence of neurturin. 
GDNF. and neurturin plus GDNF. The mean and standard errors are shown 
(n=3).
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3.4. Enteroceptive neurons
The chicken nodose ganglion is composed of enteroceptive neurons that 
respond in vitro to BDNF (Lindsay et ai, 1985; Davies et al., 1986a), NT3 (Buj- 
Bello aL, 1994), CNTF / GPA (Buj-Bello and Davies, unpublished data), and 
GDNF (chapter 2 of this thesis). To assess if these neurons respond also to 
neurturin, ElO nodose neurons were culltured in the presence of different 
concentrations of either neurturin or GDNF alone and in combination. After 48 
hours of incubation, high concentrations of neurturin (50 ng/ml) supported the 
survival of about 50% of the neurons in culture (figure 3.4), whereas negligible 
survival was detected in control dishes, i.e. without neurotrophic factors (not 
shown). Approximately the same number of neuronal cells survived with 50 ng/ml 
of GDNF, and there was a negligible increase in the number of surviving neurons 
when neurturin was added to the culture medium. Thus, the subsets of nodose 
neurons that respond to neurturin and GDNF aie laigely overlapping.
When enteroceptive neurons were cultivated with lower concentrations of 
either neurturin or GDNF, differences in the biological activity of these factors were 
observed. The number of surviving neurons at 48 hours in the presence of 5 ng/ml 
of neurturin was three times lower (10%) than with the same amount of GDNF 
(30%), and negligible at 1 ng/ml of neurturin (figure 3.4). This indicates that, in 
contrast to ciliary, DMTG and sympathetic neurons, nodose neurons are less 
sensitive to neurturin than to GDNF.
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Figure 3.4. Bar chart of ElO chicken nodose ganglion neurons cultures 
grown for 48h with neurturin. GDNF and neurturin plus GDNF. The mean and 
standard error are shown (n=3 for 1 ng/ml and 5 ng/ml; n=6 for 50 ng/ml).
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4. DISCUSSION
The aim of this study was to determine if neurturin exerts a trophic activity on 
chicken PNS neurons that have previously been shown to respond to GDNF in 
culture (chapter 2 of this thesis). The results show that neurturin, like GDNF, 
promotes the in vitro survival of several populations of neurons from the peripheral 
nervous system. Sympathetic, parasympathetic, and small-cutaneous sensory 
neurons are more responsive to neurturin than GDNF at ElO, whereas enteroceptive 
neurons are more sensitive to GDNF than neurturin at the same age. Using high 
concentrations of neurotrophic factor, the survival of sympathetic lumbar chain, 
ciliaiy ganglion and DMTG neurons is similar in response to either neurturin or 
GDNF, whereas nodose ganglion neurons are still more responsive to GDNF. 
Furthermore, the subsets of neurons within each ganglion that are supported by 
neurturin and GDNF are overlapping, since no additive effects were observed in 
cultures that contained both factors. These results suggest that neurturin may play 
an important role in regulating neuronal survival of several populations in the PNS 
during development, and it is likely that it co-operates with other neurotrophic 
factors, such as GDNF or neurotrophins, in keeping neurons alive.
In agreement with these results in chicken embryos, E15 dorsal root, E l8 
nodose, and E21 superior cervical ganglion neurons from rat embryos have been 
shown to be supported in vitro by neurturin (Kotzbauer et al., 1996). Rat neurons 
from these ganglia were all more responsive to neurturin than GDNF in culture. In 
contrast, whereas in chicken embryos most of these neurons are also more sensitive 
to neurturin, enteroceptive neurons are less responsive to neurturin than GDNF. 
These discrepancies may be due to species différencies in neuronal responsiveness 
to these factors.
The receptors for GDNF and neurturin have been recently described. They 
are composed of a common transmembrane transducing receptor, termed RET 
(Trupp et al., 1996; Durbec et al., 1996; Vega et al., 1996; Worby et al., 1996), 
and a GPI-linked ligand specific receptor, named GDNFR-a (Jing et al., 1996; 
Treanor et al., 1996; chapter 4 of this thesis) and NTNR-oc or TrnR-2 (Klein et a l . , 
1997; chapter 4 of this thesis; Baloh et al., 1997). Similar levels of neuronal
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survival are observed when cultures are treated with high concentrations of either 
neurturin or GDNF. This may indicate that the receptors of both factors are present 
in the same subpopulations of neurons in each ganglion. Alternatively, it may be 
due to cross-reactivity of the ligands to the receptors. Different levels of receptor 
expression may explain the different potency of these neurotrophic factors. It has 
been demostrated that GDNFR-a and NTNR-a can cross-react with either neurturin 
or GDNF when the ligand is present at high concentrations (chapter 4 of this thesis; 
Klein etal., 1997). Cross-reactivity between ligands and receptors is a common 
feature for TGF-B family members (Massagué, 1996a), in contrast to the high 
specificity of neurotrophins for their tyrosine kinase receptors (Pihon et al., 1995).
The survival response of embryonic neurons from the PNS to neurotrophic 
factors is not static but changes throughout development. Although only neural 
crest-derived sensory neurons switch their response from BDNF and NT-3 to NGF 
during early stages of taiget field innervation (Buchman etal., 1993; Buj-Bello et 
al., 1994), changes in responsiveness to other trophic factors, like CNTF (Buj- 
Bello and Davies, unpublished data, Horton et al., submitted) and GDNF has been 
shown to be a common feature of all PNS neurons. In chapter 2 of these thesis, it 
has been demonstrated that GDNF is able to support a wide variety of PNS neurons 
thi'oughout development. Whereas sympathetic, parasympathetic and propioceptive 
neurons become less responsive to GDNF with age, enteroceptive and small- and 
large-cutaneous sensory neurons become more responsive to GDNF as 
development proceeds. Since neurturin exhibits a similar pattern of survival- 
promoting activity to GDNF on PNS neurons at a specific age, and E6 DMTG are 
unresponsive to both GDNF and neurturin, it will be important to analyse in detail 
the response of these neurons to neurturin during several stages of development and 
determine if the differences in potency between neurturin and GDNF are kept 
tlu'oughout development. The physiological relevance of changes in responsiveness 
to neurotrophins has been confirmed in vivo by studying the timing of neuronal 
death in the trigeminal ganglion of transgenic mouse embryos containing null 
mutations in the genes that encode the high affinity receptors for NGF, BDNF/NT- 
4/5 and NT-3 (Pihon et al., 1996). Mouse trigeminal neurons are supported by 
BDNF and NT-3 at E ll  and E l2, and then switch their responsiveness to NGF
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from E13 (Buchman and Davies, 1993). The peak of cell death in each tyrosine 
kinase receptor mutant coincides with the stage neurons aie dependent on the 
specific ligand (Pinôn et al., 1996). Thus, it will be important to analyse in vivo the 
timing of neuronal death in GDNF and neurturin null mutant mice. However, prior 
to these experiments, it will be necessaiy to complete a comprehensive study on the 
effect of GDNF and neurturin on the survival of mouse PNS neurons during 
development, since only limited data aie available about this subject at the moment. 
It was initially reported that GDNF promotes the survival of mouse E18 nodose 
ganglion neurons in culture (Henderson et al., 1994). Preliminaiy data indicate that 
GDNF and neurturin both support the in vitro survival of mouse P4 nodose 
ganglion neurons (Pihon L.G., personal communication) and both are unable to 
promote the survival of P4 superior cervical ganglion neurons in culture (chapter 4 
of this thesis). Furthermore, in GDNF null mutant mice there is a reduction in the 
number of neurons present in the nodose (40%), superior cervical (35%), and 
dorsal root ganglia (23%), indicating that GDNF is an important survival factor for 
these PNS neurons. It is to be expected that neurturin knockout mice will display a 
similar phenotype at the PNS level, although this remains to be elucidated.
In summary, it has been demonstrated that neurturin is a trophic factor with 
similar actions to GDNF in the developing avian peripheral nervous system. A 
more comprehensive survival study, including the analysis of the expression of 
neurturin mRNA in the target tissues of PNS neurons, will be necessary to 
determine the physiological relevance of this protein during neuronal development.
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XI. CHAPTER 4
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CLONING AND EXPRESSION OF CHICKEN GDNF AND 
NEURTURIN RECEPTORS ALPHA
1. INTRODUCTION
Glial cell line-derived neurotrophic factor (GDNF) is a trophic factor, initially 
purified and cloned from the rat glial cell line B49 (Lin et al, 1993), that exhibits a 
variety of biological activities. It has effects on several types of neurons from both 
the central and peripheral nervous system (for review, see Lapchak et a l ,  1996), 
and on non-neuronal cells from tissues outside the nervous system.
Mice carrying targeted disruption of the GDNF gene have been recently 
generated. Homozygous mice display bilateral renal and ureteral agenesis, complete 
loss of the enteric nervous system, and a reduction in the number of neurons from 
peripheral ganglia and spinal motoneurons (Sanchez et al, 1996; Pichel eta l,  1996; 
Moore et al, 1996). The phenotype of GDNF null mutant mice is extremely similar 
to that observed in mice homozygous for a mutation in the RET gene, which display 
renal agenesis and hypodysplasia, and absence of enteric neurons throughout the 
digestive tract (Schuchardt et al, 1994).
RET (rearranged during transfection) is a proto-oncogene that was first 
identified by transfection of NIK 3T3 cells with human T-cell lymphoma DNA; 
RET transforming potential was activated as a result of rearrangement between a 
DNA segment of RET and an unlinked DNA segment (Takahashi et a l,  1985). 
This DNA recombination gave rise to a chimeric oncogene that encoded a fusion 
protein with an amino-terminal region unrelated to any other known protein, and a 
carboxy-terminal region homologous to members of the tyrosine kinase gene family 
(Takahashi and Cooper, 1987). Full length human RET cDNA was subsequently 
cloned and sequenced, and encodes a receptor tyrosine kinase protein (RTK) 
(Takahashi et al, 1988; 1989). The homologous mouse, chicken, and zebrafish 
RET proto-oncogenes have also been cloned (Iwamoto et al,  1993; Schuchardt et 
al, 1995; Marcos-Gutierrez et al,  1997). Due to an alternative splicing in the 3' 
region of the gene, the Ret protein is expressed in two isoforms of different size, 
which differ only in their carboxy-terminal sequence (Tahira et a l ,  1990). In
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human, the long and short isoforms contain 1114 and 1072 amino acids, 
respectively. The first 1061 amino acids are identical between the two isoforms, but 
the 53 carboxy-terminal amino acids of the long isoform are absent from the short 
isoform and replaced by nine different ones (Takahashi et al,  1989; Tahira et al, 
1990). The RET protein contains a large extracellular domain with no similarity to 
any other RTK. This domain includes a cadherin-like region distal to the membrane 
and a closer cysteine-rich region. The extracellular domain is followed by a single 
transmembrane domain, and an intracellular tyrosine kinase domain that is separated 
into two by a small insertion sequence.
Mutations in the human RET gene are involved in the pathogenesis of at least 
five diseases (for reviews, see Pasini et a l ,  1996; Mak and Ponder, 1996). Three 
forms of somatic DNA rearrangement in RET have been described in papillary 
thyroid carcinomas (PTC) (Grieco et a l ,  1990; Bongarzone et al,  1993; 1994; 
Santoro, 1994). Furthermore, MEN2A (multiple endocrine neoplasia 2A), a rare 
inherited cancer syndrome that comprises medullary thyroid carcinoma, parathyroid 
hyperplasia and pheochromocytoma, and FMTC (familiar medullary thyroid 
carcinoma) are two diseases caused by germline missense mutations that affect 
conserved cysteine residues in the extracellular cysteine-rich domain (Mulligan et 
a l ,  1993; 1994). These mutations result in constitutive activation of RET by 
ligand-independent dimerization of the protein (Santoro et al, 1995). MEN2B, is 
an inherited and sporadic cancer syndrome that differs from MEN2A by the absence 
of paiathyroid hyperplasia, and the presence of ganglioneuromas in the digestive 
tract, and skeletal and ophtalmie abnormalities. MEN2B is associated with a single 
germline missense mutation (metsis > thr) in the catalytic core of the tyrosine kinase 
domain of RET (Hofstra t al., 1994; Carlson et al,  1994), which results in a gain- 
of-function by a mechanism that remains unclear. Mutations in the RET gene have 
also been implicated in human Hirschsprung's disease (or aganglionic colon), an 
common inherited and sporadic disease characterized by the loss of paiasympathetic 
neurons in the submucosal and myenteric plexi of the hindgut and the consequent 
lack of innervation of the colon (Romeo et a l,  1994; Edery et a l ,  1994). 
Numerous mutations have been described and it is currently believed that, in some 
cases, the disease results from a loss of function of RET (Carlomagno et al, 1996). 
However, RET mutations only account for 50% and 15-20% of familial and
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sporadic Hirschsprung’s disease cases, respectively. Other genes have been 
implicated in the ethiology of aganglionic megacolon such as the endothelin-B 
receptor (EDNRB) (Puffenberger et a i,  1994; Attié et a l ,  1995), and its 
physiological ligand, endothelin 3 (EDN3) (Baynash et a l,  1994; Pasini et al, 
1996). GDNF is also mutated in some sporadic cases of aganglionic megacolon 
(Ivanchuk et ai, 1996), but not in inherited cases (Salomon et a l,  1996). Thus, 
Hirschsprung's disease may represent a multigenic disease.
Interestingly, RET null mutant mice and diseases that result from RET 
mutations are characterized by lesions that affect neural crest-derived tissues, 
indicating that RET plays an important role in the development and oncogenesis of 
neural crest derivatives.
Given the striking similarity between the phenotypes of RET and GDNF 
knockout mice, it was not surprising when GDNF was found to be the ligand of 
RET (Trupp et a l , 1996; Durbec et a l , 1996a; Vega et a l,  1996; Worby et a l , 
1996). However, the fact that GDNF is a ligand for a receptor tyrosine kinase, and 
not a serine-threonine kinase like the rest of TGF-8 family members (Massagué, 
1996b), was an unexpected finding.
It is currently believed that GDNF interacts indirectly with RET via a ligand- 
specific receptor named GDNF receptor alpha (GDNFR-a) (for reviews, see 
Mason, 1996; Robertson and Mason, 1997). GDNFR-a is a 468 amino acid protein 
that has been isolated by virtue of its GDNF binding in a screen of cDNA 
expression libraries derived from enriched populations of GDNF-responsive rat 
retinal photoreceptors (Jing et al,  1996) and rat midbrain dopaminergic neurons 
(Treanor et al, 1996). Human GDNFR-a has also been cloned, and shares 93% of 
identity to its rat homologue at the amino acid level (Jing et al, 1996). GDNFR-a is 
a glycoprotein that contains 31 conserved cysteine residues and a stretch of 23 
hydrophobic amino acids at the carboxy-terminus which mediates its binding to the 
cellulai' membrane via a glycosyl-phosphatidylinositol (GPI) linkage. GDNF binds 
to GDNFR-a with high affinity, with a dissociation constant (kd) between 2.3 x 10 - 
12 M (Jing et al,  1996), and 63 x 10 -12M (Treanor et al,  1996).
Since GDNFR-a does not contain either a transmembrane or intracellular 
domain, a second transmembrane protein must transduce the GDNF signal to the 
cytoplasm. It has been demonstrated that this protein is RET. GDNF induces RET
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tyrosine phosphorylation in a dose-dependent manner, and RET mediates the 
biological activity of GDNF (Trupp et al, 1996; Jing et ai, 1996; Vega et ai, 1996; 
this chapter). However, it remains unclear whether GDNF binds directly to RET. 
Although some studies have demonstrated a physical interaction between GDNF 
and RET, by co-immunoprecipitation of iodinated GDNF with anti-RET antibodies, 
and a low affinity binding of GDNF to RET (kd of 0.2-9 x 10 -9 M) (Trupp et a l , 
1996; Vega et a l , 1996), other groups have been unable to obtain the same results 
and have shown that RET co-immunoprecipitates with GDNF only when GDNFR-a 
is present (Treanor et a l,  1996; Jing et a l ,  1996). Furthermore, direct interaction 
between RET and GDNFR-a has been demonstrated by co-immunoprecipitation of 
GDNFR-a with RET antisera after GDNF treatment (Treanor et a l ,  1996). 
Moreover, a RET extracellular domain/immunoglobulin Fc (RET/Fc) fusion protein 
can block RET activation, in a dose-dependent manner, when administered with a 
GDNF/soluble GDNFR-a preincubated mixture in a cell line that constitutively 
expresses RET (Jing et a l , 1996). These data strongly support a receptor complex 
model for GDNF signalling, that includes GDNFR-a and RET, probably as an 
heterotetradimer. According to this model GDNF binds specifically to GDNFR-a, 
and then this complex interacts with RET, which in turn dimerizes and is activated 
by tyrosine autophosphorylation.
Little is known about the intracellular signalling pathway triggered by 
activated RET. It has been shown that RET can bind and phosphorylate the SH2 
domain of adaptor proteins such as She, She, Grb2, and GrblO (Borello et a l ,  
1994, Pandey et a l ,  1995; Arighi et a l ,  1997; Lorenzo et a l ,  1997). These 
molecules have been implicated in the Ras/MAPK pathway (for review, see Segal 
and Greenberg, 1996). Accordingly, GDNF has been shown to activate both 
MAPK and the transcription factor Elk (Worby et al, 1996). Thus, it appears as if 
RET signals are transmitted to the cell nucleus by the MAPK pathway, however, 
other signalling pathways cannot be excluded.
RET is expressed in numerous embryonic tissues; it is present in the 
developing peripheral and central nervous systems, as well as in the renal system, 
including; cranial, dorsal root, sympathetic, and enteric ganglia, motoneurons, 
retina, the nephric Wolfian duct, and the ureteric bud epithelium. RET expression is 
also observed in the salivary gland, thymus, spleen, lymph nodes, and adrenal
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chromaffin cells (Pachnis et a i,  1993; Tsuzuki et a i ,  1995; Schuchardt et a i ,
1994). A similar pattern of expression is found for GDNFR-a. GDNFR-a mRNA 
is detected in dorsal root ganglia, ventral midbrain and spinal cord, retina, 
developing nephrons and digestive tract, as well as in other regions of the CNS and 
non-neuronal tissues, including, thalamus, urogenital tract and pancreactic 
primordium (Treanor et ai, 1996).
Recently, a novel neurotrophic factor termed neurturin has been cloned 
(Kotzbauer e ta l ,  1996). It is structurally related to GDNF, and in vitro exerts 
similar survival-promoting effects to GDNF on PNS neurons (Kotzbauer et a l,  
1996; chapter 3 of this thesis). Since neurturin and GDNF are homologous proteins 
that constitute a new family of neurotrophic factors, and GDNF signals through a 
ligand-specific receptor, it seems likely that the neurturin receptor is an homologous 
protein to GDNFR-a. By the end of writing up this thesis, the cloning of neurturin 
receptor alpha was reported (Klein et a l ,  1997; Baloh et a l ,  1997) and, in 
agreement with the data presented in this chapter, it is structurally related to 
GDNFR-a.
Thus, the aim of the study presented in this chapter was to clone the chicken 
homologue of GDNFR-a and putative related proteins, including the neurturin 
receptor. The screening of cDNA libraries with TrkA probes, using low stringency 
conditions, has proved to be an extremely useful tool for the cloning of its receptor 
homologues, TrkB (Klein et a l , 1989) and TrkC (Lamballe et al, 1991). A similar 
approach was undertaken, and the cloning of both chicken GDNF and neurturin 
receptors, and their expression pattern are described.
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2. CLONING OF CHICKEN GDNF AND NEURTURIN 
RECEPTORS ALPHA
2. 1. METHODS
2.1.1. Screening of a cDNA library
To isolate the chicken GDNF and NTN receptors alpha, a 1.5kb full coding 
region of the mouse GDNFR-a cDNA (gift of A. Rosenthal) was used as a probe to 
screen a once amplified ElO chicken brain cDNA library in Lambda Zap II vector 
(Stratagene) provided by V.L.Buchman. This library was chosen because when 
hybrising a Northern blot of total RNA from chicken tissues with the mouse 
GDNFR-a probe a single band of 10 kb was detected in several chicken embryonic 
tissues, including brain. This suggested that the putative chicken GDNFR-a mRNA 
or a related mRNA was expressed in embryonic brain (not shown). Before starting 
the screen, the library was titered by serial dilutions and was found to contain 
6.5x10? pfu/ml.
NOTE: all steps were carried out at room temperature unless otherwise stated. 
For the composition of the solutions used, see Sambrook et al,  1989.
2.1.1 .a) Plating and transferring the bacteriophage librarv
A culture of PKLF' Escherichia Coli bacteria was grown up to an OD600=0.8 
in YT broth containing 100 pg/ml tetracycline, 0.2% maltose and 10 mM MgS04. 
The bacterial culture was transferred to eight 6 ml tubes (0.6 ml of culture/tube) and 
mixed with 115 p.1 of 1:10 diluted recombinant phage stock solution, i.e. 
approximately 75,000 pfu/tube, and incubated for 20 minutes at 37°C for adsorption 
of phages to the bacteria. 6.5 ml of 0.7% YT top agarose contaning 0.2% maltose 
and 10 mM MgS04 , preheated at 48°C, was added to each tube, and the mixture 
was immediately transferred onto 10x10 cm LB agar plates. The dishes were 
incubated at 37°C for a period of time between 8h to 10 h until clear lytic plaques 
appeared. Following this, the dishes were placed at 4°C for l-2h before applying 
filters.
Phages were transferred to Hybon-N+ nitrocellulose filters (Amersham) (two 
replicas were made from each plaque) and denatured using the following solutions:
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0.5N NaOH for 10 minutes, IM Tris-HCl pH 7.5 for 1 minute, and 0.5M Tris-HCl 
pH 7.5 with 1.5M NaCl for 10 minutes. Phage DNA was then crosslinked to the 
membrane by a combination of UV irradiation (120,000 pjoules, Stratagene 
Stratalinker) and baking at 80°C for 2h.
2.1.2.bl Hybridization of recombinant phage DNA
The 1.5 kb insert of mouse GDNFR-a cDNA plasmid was radiolabelled by 
nick-translation (Sambrook et al, 1989) and used as a probe for hybridization.
The filters were prehybridised for 1.5 hours at 59°C in plastic bags containing 
the following solution: 4xSSC, 0.2% SDS, 5mM EDTA, 15mM sodium phosphate 
pH 7.0, 5x Denhardt's solution and 100 jig/m! of salmon sperm DNA. Filters were 
transferred to new bags and hybridized for 20 hours at 59°C in the above solution 
containing the 32p_iabelled nick-translated mouse cDNA probe. Following 
hybridization, the solution containing the labelled probe was collected and kept at - 
20°C for use in further screenings. Then, the membranes were washed at low 
stringency conditions (three times for 15 minutes at 59°C in 2x SSC containing 
0.2%SDS) before exposure to Kodak Omat X-ray film for 12 hours. 
Subsequently, filters were washed a second time at higher stringency. This entailed 
washing three times for 15 minutes at 65°C in 2x SSC with 0.2%SDS before 
exposure to Kodak Omat X-ray films for 20 hours.
Hybridization signals that were detected on duplicate autoradiographs from 
the higher stringency wash were mai'ked. The corresponding areas, that contained 
the clones of interest, were collected from the agar dishes using a Pasteur pipette 
and transferred to Eppendorf tubes containing 0.5 ml of SM buffer (Ausubel et a l ,
1995) plus 5 j L i l  of chloroform. Phages were then stored at 4°C in SM buffer until 
use.
The phage suspension collected from this first screening was titered. In an 
attempt to isolate the desired clones, a second screening of the phages obtained from 
the first screening was performed, and finally, a third screening of the phages 
collected from the secondary screening was carried out. The plating, transfer, 
dénaturation, and hybridization procedures were basically the same as described 
above, however a few changes were incorporated. The solution containing the 32p_ 
labelled nick-translated mouse cDNA probe that was made for the first screening
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was used for both the second and third screenings. Following hybridization, filters 
were washed directly using high conditions of stringency, i.e. three times for 15 
minutes at 65°C in 2x SSC with 0.2% SDS. The time of exposure of the films 
varied depending on the intensity of signals on the autoradiographs.
2.1.2. Isolation of recombinant cDNA
An in vivo excision method was used to isolate the recombinant cDNA 
(Sambrook et a l,  1989). The excision of the recombinant cDNA from the phage 
DNA and insertion into the Bluescript plasmid (pBS) was carried out by using the 
Exassist helper phage (Stratagene). For this, 200 fxl of XL 1-Blue MRF E. coli 
bacteria at OD6oo= 1 were mixed with 250 |xi of phage stock solution from the 
tertiary screening, and with 1 jal of Exassist helper phage (IxlO'o pfu/ml), and 
incubated for 15 minutes at 37°C. This step allows the adsorption of phages to the 
bacteria. Then, 3 ml of LB broth were inoculated with this mixture and placed for 
2-2h30, at 37°C, in a shaking incubator. During this time, the gene 2 protein from 
the helper phage is synthesized in the cell and nicks the (+) strand of the lambda 
bacteriophage DNA at the initiation site. As a result, the Bluescript plasmid and its 
insert DNA are replicated as a single-stranded DNA in a 5'->3' orientation. Some of 
these single-stranded molecules circularize and are packaged into phage particles, 
and secreted into the supernatant. After this period of incubation, 1 ml of the 
bacterial culture was transferred to fresh tubes and incubated for 15 minutes, at 
70°C, to kill the bacteria. Following this, the tubes were centrifuged for 15 minutes 
at 4,000 rpm, to discard the bacteria. The supernatant, that contains the phage 
particles with single-stranded plasmid (or phagemid), was transferred to fresh tubes 
and stored at 4°C until use. Subsequently, either 100 pi or 10 pi of phagemid stock 
were mixed with 200 pi of XL 1-Blue MRF' E. coli bacteria at OD6oo=l and 
incubated, for 15 minutes at 37°C, to allow adsorption of the phagemid to the 
bacteria. Finally, this mixture was plated on LB agar dishes that contained 50 pg/ml 
of ampicillin and incubated overnight at 37°C. During this time single-stranded 
plasmid DNA is converted into double-stranded DNA and replicates as a 
conventional plasmid. One single colony of bacteria was picked up from each plate 
and used to inoculated LB broth/ampicillin medium. Plasmid DNA was 
subsequently isolated from these bacterial cultures for analysis of the inserts.
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2.1.3. Minipreps and midipreps of plasmid DNA
2.1.3.a) For restriction analysis
The plasmid used for restriction analysis was isolated from either small (2-5 
ml) or medium (25-50 ml) volumes of bacterial cultures (minipreps or midipreps) by 
using a combined alkaline lysis/PEG procedure (Birnboim and Doly, 1979; 
Birnboim, 1983). Briefly, the bacterial pellet was resuspended and lysed in 100 pi 
of solution I*/ml of bacterial culture by vortexing. To denature bacterial proteins, 
chromosomal DNA and plasmid DNA, 200 pi of solution IP/ml of starting bacterial 
culture was added to the tubes and mixed. Following this, 150 pi of solution 
IIP/ml of starting bacterial culture was added to neutralize the mixture. Most of 
bacterial proteins, chromosomal DNA and other cellular debris were eliminated by 
centrifugation and the plasmid DNA was precipitated by the addition of 1:1 vol. of 
isopropanol, at -20°C. The DNA pellet was washed in 70% ethanol, dried, and 
resuspended in 15 pi of distilled water/ml of starting bacterial culture. Two 
volumes of 7.5 M ammonium acetate was added to the DNA suspension, and the 
tubes were placed for 10 minutes at -20°C before being centrifuged again for 10 
minutes at 15,300 rpm. The supernatant that contains the plasmid DNA was then 
precipitated by the addition of 1:1 vol. of isopropanol at -20°C. After 
centrifugation, the DNA pellet was washed in 70% ethanol, dried in a speed 
vacuum, and resuspended in 25 pi of distilled water/ml of starting bacterial culture. 
An equal volume of PEG-NaCl solution* was added to each tube, and after 
centrifugation for 10 minutes at 15,300 rpm, 1:1 vol. of PEG-NaCl solution was 
added again to the supernatant. The tubes were centrifuged for 10 minutes at 
15,300 rpm, and the plasmid DNA pellet was washed in 70% ethanol and dried, 
before finally being resuspended in distilled water. The concentration of the 
plasmid DNA solution was measured by a combination of a spectrophotometer and 
ethidium bromide staining in agarose gels.
* Solution I: 50 mM glucose, 25 mM Tris.Cl pH 8.0, 10 mM EDTA and 10 
mg/ml of hen egg white lysozyme. Solution II: 0.2 M NaOH and 1% SDS. 
Solution III: 5 M potassium acetate, pH 4.8. PEG-NaCl solution: 30% 
polyethylene (PEG 8000), 1.6 M NaCl.
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2.1.3.b) For sequence analysis
For sequencing, miniprep DNA prepared by the boiling method was found to 
give good results and to be very quickly obtained (Holmes and Quigley, 1981). 
The procedure was as follows. Typically, 1.5 ml of overnight bacterial culture was 
transferred to Eppendorf tubes and centrifuged for 3 minutes at 6,000 rpm. Most of 
the supernatant was removed and cells were resuspended in the remaining 100 pi of 
supernatant by vortexing. 0.3 ml of STET solution* and 30 pi of hen egg white 
lysozyme (10 mg/ml in 25 mM Tris.Cl, pH 8.0) was added to each tube and mixed 
gently. The mixture was boiled for 90 seconds and transferred immediately to wet 
ice. The tubes were centrifuged for 10 minutes at 15,300 ipm, at 4°C, to discard 
cellular debris and chromosomal DNA, and the supernatant was transferred to fresh 
tubes. Then, the plasmid DNA was precipitated by adding 1:1 vol. of isopropanol 
and centrifugating for 10 minutes, at 15,300 rpm, at 4°C. The DNA pellet was 
washed with 70% ethanol and dried in a speed vacuum. The plasmid DNA was 
finally resuspended in 50 pi of distilled water and stored at -20°C until use.
* STET: 8% sucrose, 5% Triton X-100, 50 mM EDTA, 50 mM Tris-Cl pH 8.0.
2.1.4. Restriction analysis of cloned cDNA
The presence of an insert in the purified plasmids was assessed by restriction 
analysis. Digestion with EcoRI and Xhol released insert DNA from the plasmid 
vector. For a typical reaction, Ipg of purified plasmid DNA was incubated with 
both 1 pi of EcoR I (lOu/pl, Promega) and 1 pi of Xho I (lOu/pl, Promega) in 
buffer D (lOx buffer: 60 mM Tris-Cl pH 7.9, 60 mM MgCh, 1.5 M NaCl, 10 mM 
DDT, Promega) in a final volume of 20 pi. The mixture was incubated for 2 hours 
at 37°C. Subsequently, the samples were run in a 1% agarose electrophoresis gel 
using TAE buffer (for composition see, Sambrook et al, 1989).
2.1.5. Southern blotting and hybridization of cloned cDNA
After gel electrophoresis, the DNA fragments resulting from the restriction 
reaction were blotted onto an Hybond-N+ nitrocellulose membrane (Amersham). 
Prior to blotting, the DNA from the gel was denatured by washing the gel in 0.5 M 
NaOH with 1.5 M NaCl for 40 minutes, followed by washing in 0.5 M Tris-HCl 
pH 7.2 with 3 M NaCl for another 40 minutes. Subsequently, the denatured DNA
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was transferred onto Hybond-N+ filters, and crosslinked by both UV irradiation 
(120,000 pi, Stratagene Stratalinker) and baking at 80°C.
The filters were prehybridized, as described in the section 2.1.1.b), for 30 
minutes at 60°C, and then hybridized for 12 hours at 60°C in the same solution 
containing 32p_iabelled mouse GDNFR-a cDNA that was previously used for 
hybridizing filters from the library screening. After hybridization, the filters were 
washed three times for 15 minutes, at 65°C, in 2x SSC with 0.2% SDS, before 
exposure to Kodak films overnight.
2.1.6. DNA sequencing
DNA sequencing of the cloned inserts was performed by the termination- 
chain reaction, or dideoxy method (Sanger et a l , 1977), using the version 2.0 DNA 
Sequencing Kit (USB).
2.1.6.a) Alkali dénaturation of double-stranded DNA
8 pi of plasmid DNA (2 pg), purified by the boiling method, was denatured 
by adding 2 pi of 2 M NaOH with 20 mM EDTA in a final volume of 20 pi and 
incubated for 20-30 minutes at 37°C. The mixture was then neutralized by adding 6 
pi of 7.5 M ammonium acetate. The denatured DNA was precipitated by adding 
100 pi of ethanol and placing the tube at -20°C for at least 1 hour. The tubes were 
then centrifuged for 10 minutes at 15,300 rpm, at 4°C, and the DNA pellet was 
washed with 70°C ethanol and dried under vacuum.
2.1.6.b) Annealing reaction
The denatured plasmid DNA pellet was resuspended by vortexing in 7 pi of 
distilled water, Ipl of synthesized primer (100 ng/ pi), and 2 pi of 5x sequenase 
reaction buffer (USB kit). The mixture was then incubated for 15-20 minutes at 
37°C, and immediately transferred to wet ice.
2.1.6.c) Labelling reaction
To each tube containing the annealed template-primer the following solutions 
were added: 1 pi of 0.1 M DTT, 2 pi of 1:5 Labelling Mix (USB kit), 0.5 pi of 35S- 
dATP (12.5 mCi/ml), 2 pi of 1:8 Sequenase DNA Polymerase version 2.0 (USB
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kit). During this procedure, the tube was always kept in wet ice. The mixture were 
then mixed gently and incubated at room temperature for 2 minutes. Finally, the 
tubes were centrifuged for 15 seconds to spin down the solution.
2.1.6.d) Termination reaction
For each sequencing reaction, 4 tubes were prepared by adding 2.5 pi of 
either ddATP, ddTTP, ddCTP or ddGTP Termination Mix (USB kit). These tubes 
were pre-warmed at 37°C. Subsequently, 3.5 pi of labelling reaction was 
transferred to each termination tube and mixed. The mixture was incubated for 5 
minutes at 37°C. Then, the reaction was stopped by addition of 4 pi of Stop 
Solution (USB) to each termination tube followed by mixing.
Prior to electrophoresis, the DNA for the sequencing reaction was denatured 
by heating at 85°C for 15 minutes and immediately transferring to wet ice.
2.1.6.e) Gel electrophoresis and autoradiography
Electrophoresis of radiolabelled sequencing products was carried out in a 
17x50 cm 6% denaturing polyacrylamide gel using TBE buffer (for procedure see, 
Sambrook et a l , 1989). Samples were usually run for 3-4 hours, at 50 W constant 
power, although shorter runs were also used when required. After electrophoresis, 
the gel was fixed by a combination of treatment in 10% acetic acid for 1 hour and 
baking for another hour at 80°C. Kodak BioMax X-ray films were exposed to the 
sequencing gels for aproximately 12 hours.
Note: the primers used for sequencing were made using an Applied 
Biosystems 391 DNA Synthesizer according to manufacturer's instructions. The 
oligonucleotides were usually 15 bp long, with a composition 1:1 of C/G:A/T.
131
2.2. RESULTS
2.2.1.Isolation and sequence of chicken GDNFR-a and NTNR-a
cDNAs
An ElO amplified chicken brain cDNA library was screened at low stringency 
using the full coding region of mouse GDNFR-a as a probe. From 600,000 
recombinant phages analysed, thirty one plaques which hybridized with the probe 
were detected in the first screening (1 positive/19,000 pfu). Twelve of these clones 
were further analysed. In vitro excision was carried out and cDNAs cloned into the 
plasmid Bluescript were isolated. Two sets of overlapping cDNAs were identified 
using restriction endonuclease mapping of these plasmids. The first set of clones 
contained eight overlapping cDNAs of 2.3 to 3.5 kb in which two internal EcoRI 
were present. The second set of clones contained four overlapping cDNAs of 2.5 to 
2.9 kb in which no internal EcoRI site was present. The nucleotide sequence of 
these clones was determined by the termination-chain reaction.
The first set of overlapping cDNA clones corresponded to GDNFR-a cDNA 
(as explained in next section). The two DNA strands were sequenced and the 
nucleotide sequence of the 5'->3’ strand is shown in figure 4.1. The length of this 
cDNA is 3037 bp. A C/G rich 5' region of 739 bp is followed by a single open 
reading frame (ORF) of 1410 bp that extends from nucleotide 740 to the termination 
codon TAG at nucleotide 2149. This termination codon is followed by an A/T rich 
3' untranslated region (from nucleotide 2150 to 3037) which contains a putative 
consensus poly adénylation signal (A AT A A A) 33 nucleotides upstream of the poly- 
A tail.
The second set of overlapping cDNA clones corresponded to NTNR-a cDNA 
(as explained in next section). The cloned cDNA contains 2933 bp. The two DNA 
strands were sequenced by the termination-chain reaction, and the sequence of the 
5’->3' strand is shown in figure 4.2. In this cDNA, there is a very short 5' region 
followed by a single ORF of 1398 bp that extends from nucleotide 38 to the stop 
codon TAG at nucleotide 1435. The termination codon is followed by a long A/T 
rich 3' region of 1501 bp. The sequence contains a putative consensus 
poly adénylation signal (A AT AAA) 26 nucleotides upstream of the poly-A tail.
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Figure 4.1. Nucleotide sequence of the chicken GDNFR-a cDNA 
corresponding to the 5'->3' strand. The open reading frame is indicated in bold. 
Nucleotides are numbered in the right-hand margin of the figure.
c g a g c g c g c c c c c t g a g g c a g c g g g g c t c c t c c t g a g g c g c g g g c a g c g c  50 
a c c g c c g t c t c a g t c a c c g g g c t g c g g c t a c c c g t c g g g a g c c c c c c t g c  100 
t g c g c c c g a c c t g c c c c g c c g g a g c a g c t c c c t g c a g g t g a c g g a g c t c c  150 
c t c c c a g t t t g c c c g g c t a a a c t t t c c c a g c t g c c g g c a g c a c c t g t g c g  200 
t a t c t c c c g g g c g a g c g g c a c g a c c g c c t c c g c g c g a a g a a a t a a a g t t g  250 
c g g c t t t g a g g a g g g g a c g a a t c c c t t c c t g c a g g g c t c g g g c a c t c g c g  300 
g g g a g c c c c g t a g g t g c g t g c g g g g c g t c a g c g c t c t t c c c c c c a c c c c t  350 
c c c c g t g a g c g c t c g g t c c c t c c c c g g g c a c a g g c t g c t g c c a c c c a a g g  400 
a g g c g c c c g g c t g c t g c c c c g c t g c c g c c g c t c c g t g c a c a c a c a c a g a c  450 
a c a c a a a t a c g g t g c g t t g c g c c t c c g g g a g t c a g c g c c t c c g c c t t c a g  500 
g t t g c t c a g a c c t g a a a t c t a c g g g g a a t c t c a g c g t t c t t g t c g c c g c t  550 
c c t g c c g g t g g a a g c g g t g a a g a g g a g a g a t t t t g a t c a t t a t c a t t a t t  600 
a t t g t t a t t t c c c c c t t c t t a t a t c a a t g g a t c g g a a c t t g g a g t c t t t g  650 
c a c c t c g g c g g t t t t g g a a t a t c t a c a t g c t g a g c c t c t t t g t t g t g g c a  700 
c a t c g g c t c a g t t c g g g g g a a c c a t c c g g a g a c g g c a c g a t g t t c c t c g c  750 
g c t c c t c t a c t t g g c t c t g c c c t t a g c g g a c g t a c t t c t g t c g g c a g a a g  8 00 
t c a g c g g g c t g c c c g g a g g g g a c c g c c t c g a c t g c g t g a a a g c c a g c g a t  8 50 
c a g t g t c t c a a g g a g c a g a g c t g t a g t a c t a a g t a c a g g a c a c t g a g g c a  9 00 
g t g t g t a g c c g g c a a a g a g a g c a a c t t c a g c c g g g c g a c g g g c c t g g a g g  950 
c g a a g g a t g a a t g c a a a a g c g c c a t g g a g g c t c t c a a g c a g a a a t c t c t g  1 0 0 0  
t a c a a c t g c c g c t g c a a g a g g g g c a t g a a g a a g g a g a a a a a c t g c c t g c g  105  0 
c a t t t a c t g g a g c a t g t a c c a g a g c t t a c a g g g a a a t g a c t t g c t t g a g g  1 1 0 0  
a t t c t c c c t a t g a a c c a g t t a a c a g c a g g c t a t c a g a c a t a t t c a g g c t a  1 1 5 0  
g c a c c g a t t g t a t c a g t g g a g c c a g t a c t a t c a a a g g g g a a c a a c t g c t t  1 2 0 0  
g g a t g c a g c a a a a g c t t g t a a c c t a a a t g a t a c c t g c a a g a g g t t c a g a t  1 2 5 0  
c t g c t t a c a t a a c c c c c t g c a c c a g c a g c a c g t c t a a t g a a a t c t g t a a c  13 00 
a a g c g g a a g t g t c a t a a g g c c c t c c g g c t a t t t t t t g a c a a a g t t c c c c c  13 5 0 
a a a g c a c a g c t a c g g g a t g c t c t t c t g c t c c t g t c g a g a c g t a g c c t g t a  1 4 0 0  
c a g a a a g g a g g c g g c a g a c t a t t g t t c c t g t g t g t t c a t a t g a g g a c a g g  145  0 
g a g a a a c c a a a c t g c c t g a a t t t a c a a g a a t c c t g c a a g a a g a a t t a c a t  1 5 0 0  
c t g c a g a t c t c g c c t t g c a g a t t t t t t c a c a a a c t g c c a g c c t g a g t c a c  155  0 
g c t c t g t t a g t a g c t g t c t g a a g g a g a a c t a c g c t g a c t g c c t c c t c g c t  160 0 
t a c t c g g g g c t c a t t g g c a c a g t g a t g a c a c c g a a c t a c a t a g a c t c a a g  165 0  
t a g t c t c a g c g t t g c c c c a t g g t g t g a c t g c a g c a a c a g t g g t a a t g a c a  17 00 
t a g a t g a a t g c c g g a a a t t t c t g a a t t t c t t c c a g g a c a a c a c a t g c c t t  17 5 0 
a a a a a t g c a a t t c a g g c t t t c g g c a a t g g t a c t g a t g t g a a t g t g t g g c a  180  0 
g c c a a t a t t a c c g g t a c a g a c c a c t a c a g c c a c a a c t a c a a c a g c t t c c a  185  0 
g a c t t a a a a a c a c a g g t t c a g a g a c c a c c a a c a a t g a a a t a c c c a c c c a c  1 9 0 0  
a a t g a t t c a c c a g c a t g t g c g a a c c t g c a g g c a c a g a a g a a g c g g a a a t c  1 9 5 0  
c a a t g a a t c t g t a g a t a c a g a a c t c t g t c t t a a t g a g a a t g c t a t t g g g a  2 000  
a a g a c a a c a c a c c a g g a g t c t c c a c c a g c c a c a t a t c c t c g g a g a a t t c t  205  0 
t t t g c c c t t c c t a c a a g c t t c t a t c c a a g c a c a c c a c t c a t t c t g a t g a c  210  0 
a a t t g c a c t c t c a c t c t t t t t g t t c c t a a g c t c a t c a g t c g t c t t g t a g c  2 1 5  0 
t g c a t t g c a a a a g g a c a t g t a a a a a a a t c t g t t t c c t g t c c t c t g t t g t t  2200  
t a t c t g g a a t t c c a g g t c t g g g g g c t a a g c t g a g g c a c t t c t g c t a g a a c  2250  
a g t t t g t c a g c t g g a a a a a t t t t t t c t c t c t a a a a a a g c t t c t t g t g a t a  23 00 
t t t a g a g g c t t t g t g a a t a c t t g g t g c a g t g c t a c a t t c c a a a c c c a a g a  2350  
g g c t t t t g g g c a t g c a g t g t t t t g a a g a g a c a g t g t a t a a a t t t g c c t g t  2400  
a a a g a g a t c t g g t t g g a t t a t t t t a a t a a t t a t a t t a a t t c t g g c c t t t a  2450  
c c t g a g a a g g a g g a t g g c a g t t t t c t t a a g a t c c t a t t t a t c t e a t t g g a  2500  
t g g t t t t g g t t t t c a a a t t g a t c a a a c t c c a g a t t a t c a a g g a t g t c a g g  2550  
c t t t t g t c t a a t g g t g a a t g t t c t c c c a g a g a g t g g a c t t t a t g a a a c t t  2 600
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c t t c a t t t g a t a a a t t g c t a c t g a t g t t a a a c t c t t t c a g t g t a t t a g c a  2650  
t t t t c c t c t t t a a a t g t t t a c g t a c t g t a a g t g a t t c t g c g t t c c c t g c t  2700  
g a g a a g c c a t t c t a a t t c a c a t a c a g g t g t a a c g t a t g t c t t t c a g t t a a  2750  
a t t c t t a t a g a g t g t g g c a t a g a a c t t t c t a a c a a a a c a t t t a t c t t t t a  2800  
a t t a t a a t c a t c t a g c c t t a a c g a g g g t g a a g a t t c t t t a a a t t a a c a a g  2 850 
a a g c a g c c a t t g t g a a a g c t c c g t a a a c g t a c a t t t c a t a a a c t t t g a g g  2900  
a t g a a c a g t a g a a a a a a a t t t t g c t g c a g g g t t t c a g c t g t a c a g t c a c c  2950  
g g t c t t c t g t g c t t c c a t t g t g a c a a t a t a g t c c a a t t a t t a t a c t g t t c  3000 
a t t c a a t a a a a a a g a t a t g c a t t t t a c t t g c t c t a c t  3037
134
Figure 4.2. Nucleotide sequence of the chicken NTNR-a cDNA 
corresponding to the 5'->3' strand. The open reading frame is indicated in bold. 
Nucleotides are numbered in the right-hand margin of the figure.
c c t a a a c g c a c g t g g a g g a a c t c g t g g a t g t a c t a a c a t g a t t t t g g c c a  50
a c g c c t t c t g c a t c g t c c t c t t t g t a g a t g a g a c c c t c c g c t c g c t g g c c  100 
g c c c c c c c g t c c c c c c c c g g g c a g g a c c t g c a g g g c t g g c g g g t g c c g g t  15 0
g g a c t g c a t a c g t g c c a a c a a g c t g t g t g c a g c c g a g g g c a g c t g c a g c t  2 00
c c c g g t a c c g c a c c c t g c g g c a g t g c c t g g c g g g a c g c g a c c g c a a c a c c  2 50
a t g c t g g c c a a c a a g g a g t g c c a g g c g g c c c t g g a g g t g c t g c a g g a g a g  3 00
c c c g c t g t a c g a c t g c c g t t g c a a g a g g g g c a t g a g a a a g g a g a t t c a g t  3 50
g c c t t c a g g t c t a c t g g a g t a t a c a c c t c g g g c t g g c c g a a g g a g a a g a g  40 0
t t t t a c g a a g c t t c c c c c t a c g a g c c g a t c a c c t c t c g t c t c t c t g a t a t  45 0
a t t c a g a c t c g c t t c a a t t t t c t c a g g a a t g g a c c c t g c c a c c a a t t c c a  500  
a a a g c a a c c a c t g c c t c g a c g c g g c c a a a g c g t g c a a c c t g a a c g a c a a c  550 
t g c a a g c g c c t g c g c t c g g g c t a c a t c t c c a c c t g c a g c a a g g a g a t c t c  6 00
g g c c a c c g a g c a c t g c a g c a g g a g g a a a t g c c a c a a a g c c c t g c g c c a g t  65 0
t c t t c g a c a a c g t g c c c a g c g a g t a c a c c t a c c g c c t c c t c t t c t g c t c c  700  
t g c a a g g a c c a g g c g t g c g c c g a g c c g c g g c g g c a a a c c a t c g t c c c c t t  75 0 
c t g c t c c t a c g a g g a c a a g g a g a a a c c c a a c t g c t t g g a t c t g c g c a a c g  800 
t g t g c c g c g c c g a c c a c c t g t g c c g g t c c c g g c t g g c t g a t t t c c a c g c c  85 0 
a a t t g c c a g g c c t c c t t c c a g t c a c t g a c c a g c t g c c c t g g g g a c a a c t a  900  
t c a g g c g t g c c t g g g c t c c t a c a c a g g g c t c a t t g g t t t t g a t a t g a c g c  950 
c c a a c t a c g t g g a t g c c a g c a c c a c c a g c a t c a c t a t c t c g c c c t g g t g c  100 0  
t c c t g c a a a g g c a g c g g c a a c t t g g a g g a g g a g t g t g a g a a g t t c c t g c g  1 0 5 0  
g g a c t t c a c t g a g a a c c c c t g t c t c c g a a a t g c t a t c c a a g c c t t c g g c a  110 0  
a t g g c a c c g a t g t c a a c c t c t c c c c c a a g a a c c c c t c a c c t c c c a t c a c a  115 0  
a t g c t g c c c a a g g t g g a g a a a a g t c c t g c c t t g c c t g a t g a c a t c a a c g a  12 00 
c a g c a a c a c c a t g t a c g a c a c g a g c a t c a t c a c c a c c t g c a c c t c c a t c c  12 50 
a g g a g c a c g g a c a g a a g c t a a a c a a g t c c a a a g a g c a g a g c c t g t g c t a c  13 0 0 
t c a g a g a c c c a g c t c a c c a c g g a c a c g a t g c c a g a c c a g a a g a c c t t t g t  135  0 
g g a t c a g a a g g c a g c c g g c a g c c g g c a c c g g g c a g c c c g g a t c c t t c c a g  14 0 0 
c t g t g c c c a t t g t g c t g c t g a a g c t g c t g c t a t a g g g g a c a a t t g c c g c a  1 4 5 0  
t c t c a g c t c c g g a g t g c t g g g c t c a t c t c g g g c t c c a g a c t g c a a g c g g a  1500 
a c a c c a g c g a t g c c c a a g g c c a g a a g g a c c c t c a c a g t g a t g g g a a a c t t  1550 
c a g t g g t t t t c t t t t t t t t t t t t t c c t t t t c c t t c t t t t t t t t t g g c c t t  1600 
t t t g t t c g t t t g a t g g t g c g t t g g g t t t c t a c t g c t g g a g c a c g a g c c c g  1650 
g c a c a a c c c a c c c a g g c a a c c a c a a a g g g g a a c c a a t g c a a t c a a c g g c a  1700 
c c g g g g a g g g g a g a a a g g c a g c g a g c a g a g c t g t g g g a t g a g g g c t g t c t  1750 
g c a g g g c t a c c a a c c c a g c g t g c t g a g g g a c c c g t t g g g g a c g t g g g a c g  1800 
t t t g c g c a t c g c c g c g g c a c a g c g g t g c c a t t g g g g c t c c t t t g g g c a c a  1850 
g a c t c t c c g c t g c c c c a c g t c g t c c c c g g g a c t g t t t t c t t t t c c t t t c c  1900 
c g t g g t t g g t g a g a g t t t t c a a a t c a g a a a a g a a a c c a a t a t t c a a a c g g  1950 
t g t g a g g c t g t c c t g a t g t t t t c t a t c t g t c a c t c g g a g g g g g a g g t t t t  2000 
c c t t t t t a t t a t t t a c c c t t t c t t t t t c a t t a t g c c t t t c t t t c c c a t c t  2050 
t c a t t c c a t c g g a t t t g g g t t g g g a t g g g a t c c g a c c c c a g c g g c g g t t g  2100  
g a g t c c t c t g t a t g t t a c t c a g t t t t c t t t t a t a t a t a c a t a t a t a g t g t  2150  
a t g t a t a t a g c g c t c a c c t a t a c c t a c a g c t a t g t a t g t a t a g a c g t a a c  2200  
c a t a g a g a t c t a c c g g c g t g g c t c t c t a a g g t t t c c t t t c a a a a a a g g a g  2250  
g g c t g c a a a a t g t a t g a t t g t a a a g t t t a t t t t t t t t a a a c g a t g t c t a t  23 00 
a a t g g a a a t a a t a a t a a t a a t t a a t a a t a a t a a t a a t a a t a a a a g g a g a a  2350  
g a a a g a a c c a a g a g g a g a a c a a a g c a c c a c c t g a g g g g a g g a a g g g g g g g  2400  
g t c c g a c g t c c c a t a g a g c a t c c c a a g c c c t g g c t g c a t g c t g g g g g a t g  2450  
c t c a g c t a t a g a g a g g c a c a g a t t t g g g t c a a c c c c a c a c g t c t t g c a g t  2500  
g c t g c a g g a c g c c t c g c c t g g c t g t t t g g c t c t g g g a g a c g t g c a a a c a a  2550  
g c a a a c a t t t c a a a g g a g c t g a c a g g t t g c t c g c g t g g c a g a g c t c t t t t  2 600
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t t c t t t a a a g c a c c t c a t c c t c c g t g c t g c t t c t t t t t c c c c a c c c c c c a  2650 
g t g c t t a a a a c c c a a a c g a a g g t t g a a a t t t g g g t c a c g c a a a a c c t c g t  2700  
g t t c c t c c t c c t c c c c c c t t c c c c a g t c a g a a g t c c t t t t c c c a c c t t c t  2750  
g c t c g c a c c g t g c a g c a g c a g c a g c a c c g a c c c g c a g g c a g c t c t g c g c a  2800  
g t g g g g c t c c a a g g c t g c c g a g a c c c c a t t g c a a a a g g a g g g g c a a a t c t  2850  
t c c c c t t t g c a a a g c a g g g a g c g a a a a c a c g t t t g a t g t g c a a g t t g g c a  2900  
c g g g g a a a a t a a a c a t g t c a c g t c t c t c g c c g g  2933
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2.2.2. Protein sequence of chicken GDNFR-a and NTNR-a
Chicken GDNFR-a cDNA encodes a predicted protein of 459 amino acids 
(Software, DNA Strider). Sequence comparison with the published rat GDNFR-a 
(Treanor et al,  1996; Jing et a l , 1996) indicates that the chicken protein has 80 % 
identity with its rodent homologue, including conservation of all 30 cysteines 
(figure 4.3). This indicates that they are structurally homologous proteins. 
Whereas the carboxy-terminal region of chicken GDNFR-a shares only 45% 
identity with rat, the rest of the protein is highly conserved between birds and 
mammals (87% identity within the first 375 amino acids).
Another cDNA clone, different from GDNFR-a, was obtained from screening 
the same library with the same probe as described above. This cDNA encodes a 
protein of 465 amino acids, named for reasons given below NTNR-a. This protein 
has 49% identity with chicken GDNFR-a, including all 30 cysteines localised at the 
same relative positions (figure 4.4). Search in the database have shown that this is a 
novel protein.
Chicken GDNFR-a and NTNR-a both possess an hydrophobic amino- 
terminal domain of 13 amino acids, that corresponds to a putative signal peptide for 
secretion, followed by a cysteine rich domain (figure 4.4). The carboxy-terminal 
region of both GDNFR-a and NTNR-a shows the characteristic features of 
glycosyl-phosphadidylinositol (GPI)-linked proteins: a carboxy-terminal 
hydrophobic domain (23 and 14 amino acids, for GDNFR-a and NTNR-a, 
respectively) separated by an hydrophilic linker region from a cleavage/binding 
consensus sequence for GPI linkage (Ser42s Thi'429 Ser43o for GDNFR-a, and Ala443 
Gly444 Ser445 for NTNR-a) (Gerber et a l , 1992). These features suggest that both 
GDNFR-a and NTNR-a are secreted proteins attached to the extracellular surface of 
the plasma membrane by a GPI-linkage. Moreover, these data indicate that 
GDNFR-a and NTNR-a form a novel family of homologous proteins.
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Figure 4.3. Aligned protein sequences of rat and chicken GDNFR-a.
Identical amino acids are marked with asterisks and the conserved cysteines are enclosed in vertical boxes. The amino-terminal, hydrophobic, putative signal peptides are underlined. Rat GDNFR-a sequence was obtained from Treanor et ai, 1996.
rat GDNFR-a 
ch. GDNFR-a
M FLATLYFALPLLDLLM SAEVS • * * * * * * * * * * * * * * * * * -GGDRL* * * * * *EC
M FLALLYLALPLADVLLSAEVSGLPGGDRLEC
7KASDC
t  *  *  *  *  *
7KASDC
LK EQ 9 
* * * * *
LKEQS
STKYR 47 
* * * * *
STKYR 50
r a t  GDNFR-a TLRQ 
* * * *
ch. GDNFR-a TLRQ
/A G K ETNFSLTSGLEAKDE
t * * * *  *  *  * * * * * * * *
7AGKESNFSRATGLEAKDE
RSAMEALKQKSLYK
* * * * * * * * * * * * *
KSAMEALKQKSLYK
KRGMKKEK
* * * * * * * *
KRGMKKEK
97
100
rat GDNFR-a
ch. GDNFR-a N 2
RIYWSMYQSLQGNDLLEDS P Y E P V N S R L S D IF R A V P F IS D V F Q Q V E H  147
t * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  *  *  *  *
iR IY W SM Y Q SLQ G N D LLED SPY EPV N SR LSD IFR LA PIV S- -VEP 145
rat GDNFR-a - ISK G N M
* * * * *
c h . GDNFR-a VLSKGNN
LDAAKAl
• : * * * * *
jDAAKAC
STLDDTl
k *  *  *
STLNDI
IKKYRSAYIT 
* * * * * * * *
PC
K R F R S A Y IT P C rS S T S N E I
PTSMSNEV 
* * * * *
tSTRRK 
* * *
CKfKRB
CHKAL 
* * *
CHKAL
196
195
rat GDNFR-a 
ch. GDNFR-a
RQFFDKVPAKHSYGMLF * * * * * * *  * * * * * * * *
RLFFDKVPPKHSYGM LF
D
\k k
R D IA  * *
RDVAIC
PERRRQTIVPV
I f * * * * * * * * * *
rE R R R Q T IV PV
SYEERERPE
k *  *  * * * *
SYEDREKPIS
C L S L
k  *
246
CLNL 245
rat GDNFR-a QDS * *
ch. GDNFR-a QES
KTNYI
k * * *
KKNYI
RSRLADFFTMl
k * * * * * * * * *
ilSRLADFFTN
2 P E S R S V S
k * * * * * * *
IKC
QPESRSVSSIC
LKENYAEf
»r * * * * *  *
LKENYAEl
L L A Y SG L IG T V  29 6
< f * * * * * * * * * *
L L A Y SG L IG T V  295
rat GDNFR-a 
ch. GDNFR-a
MTPNYVDSSSLSVAPWS DC
* * * * *  * * * * * * * * * *  t i t
M T PN Y ID SSSLSV A PW S
SNSGNDLEI 
* * * * *
E C LjKFLNFFKDNT  * * * * * *  * * *
dNSG N D ID EÜ R K FLN FFQ D N I
ClLKNAIQAFG 346
i t * * * * * * * *
gL K N A IQ A F G  345
r a t  GDNFR-a NG SD VTM W QPAPPVQTTTATTTTAFRVKNKPLGPAGSENEIPTHVLPP- 
* * * * * * * * * * * * * * * * * * *  * * * * * * * * *  *
ch. GDNFR-a N G T D V N V W Q P IL P V Q T T T A T T T T A S R L K N T G S E T T N --N E IP T H N D S P ^
C 395 
*
393
rat GDNFR-a A N LQ A Q K -L K SN V SG ST H IC  
* * * * * * *  * * * * * * *
ch. GDNFR-a ANLQAQKKRKSNESVDTEI
LSDSDFGKDGLAGAS- S H IT T K -S M A A P P S  
*■ *  *  *  *  *  *  *  *  *  *  *  *
442
L N E N A IG K D N T PG V ST SH IS  S E N S F A L P T S  443
rat GDNFR-a C SLSSL PV L M L T A L A A L L SV SL A E T S 
* * * * * * *
ch. GDNFR-a F Y P S T P L I L M T I A L S L F L F L S S S W L
458
459
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Figure 4.4. Aligned protein sequences of chicken GDNFR-a and NTNR-a.
Identical amino acids are marked with an asterisks, and the conserved cysteines are enclosed in vertical boxes. The amino-terminal, hydrophobic, putative signal peptides are underlined. The carboxy-terminal hydrophobic domain is double-underlined and the putative binding/ cleavage consensus sequences for GPI linkage are enclosed in horizontal boxes. Gene Bank accession numbers: chicken GDNFR-a, U90541; NTNR-a, U90542.
GDNFR-a M FLALLYLALPL ADVLL -  S - * * * * * * -AEVSGLPGGDRL- * * * * * * ■D2
NTNR-a M IL A N A F C IV L F V D E T L R SL A A PPg-PPG O D -L O G W R V PV D C
VKASDÇ 
*
QCL
IRANKLCA
40
48
GDNFR-a KEQS 2 STKYRTLRQ 7A G K ESN FSRA TG LEA -K D E KSAMEALKQKS-LY 88* * k * * * * * * * k * * * * * * * * k * * * * * * *
NTNR-a AEGS SSRYRTLRQ 2 LAGRDRN-------- T M L -A N K -E z 2 A A L E V L -Q E S P L Y 91
GDNFR-a N ? R z
* k *•k
NTNR-a D z R z
KRGMKKEt * * * * *
KRGMRKEIQ
LRIYW SMYQSL-QGNDLLEDS P Y E P V N S R L S D IF R L  137 * * * * * * ***** *********
L Q V Y W S IH L G L A E G E E F Y E A S P Y E P IT S R L S D IF R L  141
GDNFR-a A P IV S V -E P V L -S K G N N  
*  *  *  *  *  *  *
NTNR-a ASIFSG M D PA TN SK SN H
AAKAOM
*
LD. 
* * * * * *
LDAAKA
LNDIf 
* * * *
jC K R FR SA Y IT  
*  *  *  *  *  *
C MLNDN C K R L R S G Y IS T :
PËI
k
T S S T S - N E  
*  *
S K E IS A T E
184
191
GDNFR-a I 
NTNR-a H
NKRK 
* *
3RRK
TKALRLFFDKVPPKHSYGMLF
t  *  *  *  *  *  *  *  *  *  *  *  *
TKALRQFFDNVPSEYTYRLLF
SO r :
*
DVAI 
*  *
3CKDQA
rE R R R Q T IV P V p
*  * * * * * * *  k
A EPRRQ TIV PEia
SY
k *
SY
234
241
GDNFR-a
NTNR-a
EDREK P
* * * * * * *
N :
k
E D K E K P N :
LNLQES 
*• *
LDLRNVt
KKNYI
RADH
*
LSI
C r s r l a d f f t : 
* * * * * * *  *
'N : t
RSRLADFHAN2
2 P E S R S V S S
k *  *
2 A S F Q S L T S
LKENYAEia 
*  *
PGDNYQA
284
291
GDNFR-a L L A Y S G L IG T V M T PN Y ID SS S L S V -  -  APW :
*  * * * * *  * * * * * * *  *  *  t
NTNR-a L G S Y T G L IG F D M T P N Y V D A S T T S IT IS P W 3
S N SG N D ID E# 
*  *  *  *
KGSGNLEEEC
RKFLNFFQ 332 
*  *  *  *
E K FL R D FT  341
GDNFR-a DNT 
*
NTNR-a ENP
LjKNAIQAFGNGTDVNVW— Q PIL P V Q T T T A T T T T A S R L K N T G S E T T  380
t * * * * * * * * * * * * *  * * * *
^ R N A IQ A F G N G T D V N L S P K N P S P P I-T M L P K V E K -S P A L P D D IN D S  389
GDNFR-a N N E IP T H N D S P A  
*  *
NTNR-a NTM YDTSI -  I T T
ANLQAQKKRKSNESVDTEL
*  *  *  *  *
rSIQ-EHGQKLNKSKEQSL
LNENAIGKDNTPG# T ^  430 
*  *  *  *
5ifSETQLTTDTMPDQKTF 437
GDNFR-a H I  S S E N S F A L P T S - F Y P S T P L I L M T I A L S L F L F L S S S W L
*  *  *  *
NTNR-a VDQKA|ÂGSt^HRAAR I  L P A V P IV L L K L L L
139
469
465
3. FUNCTIONAL ANALYSIS OF CHICKEN GDNF AND
NEURTURIN RECEPTORS ALPHA
Comparative analysis of chicken GDNFR-a and rat GDNFR-a protein 
sequences has shown that they are homologous proteins with 80% identity (this 
chapter). Rat GDNFR-a is a GPI-linked ligand-specific receptor that binds with 
high affinity to GDNF and associates with the transmembrane protein tyrosine 
kinase RET to form a receptor complex that transduces GDNF signal to the 
cytoplasm of the cell (Trupp et al,  1996; Durbec et a l,  1996a; Jing et a l ,  1996; 
Treanor et al, 1996; Vega et a l ,  1996; Worby et a l ,  1996). Thus, it is likely that 
cloned chicken GDNFR-a binds to the same ligand as its rodent homologue.
A novel neurotrophic factor named neurturin (NTN) has been recently 
purified and cloned. Neurturin contains 42% identical amino acids to GDNF 
(Kotzbauer et al, 1996). The aim of this study is to ascertain whether GDNF and 
neurturin are the ligands of cloned chicken GDNFR-a and the GDNFR-a homologue 
termed, for reasons given below, NTNR-a.
3.1. EFFECT OF PHOSPHOLIPASE C ON CULTURED PNS 
NEURONS
Proteins bound to the membrane by a glycosyl-phophatidylinositol (GPI) 
anchor can be readily distinguished from other membrane-associated proteins by the 
use of the enzyme phosphatidylinositol-specific phospholipase C (PIPLC) which 
specifically cuts these proteins free from their anchors and thereby releases them 
from the membrane. This approach was used to determine whether GDNF and 
neurturin are both neurotrophic factors that mediate their biological action via a GPI- 
linked receptor. Part of the data presented in this section was incorporated into the 
publication by Treanor et al, 1996.
3.1.1. Methods
E6 nodose and E14 sympathetic lumbar chain ganglia were dissected from 
chicken white leghorn embryos. The neurons of the latter ganglia were separated 
from non-neuronal cells by differential sedimentation (Davies, 1988a). Cells were
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grown in the 10 mm diameter wells of 4-well 35 mm plastic tissue culture dishes 
(Nunc, Gibco) (as described in chapter 2).
4 |xg/ml of PIPLC (a gift from A. Rosenthal) was added to the culture 
medium of some of the dishes 1.5 hours before and 12 and 24 hours after addition 
of neurotrophic factors (either BDNF, NGF, GDNF or NTN). The number of 
surviving neurons was determined 36 hours after plating and expressed as a 
percentage of the number plated (as described in chapter 2).
3.1.2. Results
BDNF, GDNF and neurturin responsive E6 chicken nodose ganglion neurons 
were cultured in the presence or absence of PIPLC (4 pg/ml) for 36 hours. The 
number of neurons surviving with GDNF at either 50 ng/ml or 1 pg/ml was cleaily 
reduced when neurons were grown in the presence of PIPLC (figure 4.5). 
Similarly, PIPLC treatment reduced the number of neurons surviving with either 
low concentrations of neurturin (5 ng/ml), from over 70% to less than 10% (figure 
4.6), or high concentrations of neurturin (1 pg/ml), from about 70% to 45 %. This 
reduction in neuronal survival was not due to a neurotoxic effect of PIPLC, because 
the survival response of nodose neurons to BDNF, which signals via a 
transmembrane TrkB receptor tyrosine kinase (Klein et ai,  1989), was unaffected 
by PIPLC (figures 4.5 and 4.6).
To ascertain whether PIPLC exerts a similar action on other types of neurons 
than the BDNF responsive nodose ganglion neurons, E14 sympathetic lumbar chain 
neurons were grown in the presence of PIPLC. The number of surviving neurons 
with high concentrations of GDNF (1 pg/ml) was greatly reduced, from about 70% 
to 25%, in the presence of PIPLC (figure 4.7). However, PIPLC treatment did not 
affect the number of neurons that survived with NGF, which, like BDNF, signals 
via a transmembrane receptor, the TrkA receptor (Martin-Zanca et al., 1989).
These results suggest that the survival-promoting effects of GDNF and 
neurturin on PNS neurons is mediated by GPI-linked receptors.
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F igure 4.5. Effect of PIPLC treatment on E6 chicken nodose ganglion 
neurons cultured in the presence of either GDNF or BDNF. Bar chart of the 
percent survival of E6 chicken nodose ganglion neurons grown with either BDNF 
(10 ng/ml) or GDNF (GDNF 1: 50 ng/ml or GDNF 2: 1 pg/ml) for 36 hours in the 
presence or absence of PIPLC. The means and standard errors are shown (n=4).
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Figure 4.6. Effect of PIPLC treatment on E6 chicken nodose ganglion 
neurons cultured in the presence of either neurturin or BDNF. Bar chart of the 
percent survival of E6 chicken nodose ganglion neurons grown with either 
neurturin (5ng/ml) or BDNF (5ng/ml)) for 36 hours. Half of the cultures were 
treated with PIPLC. The means and standard errors are shown (n=4).
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Figure 4.7. Effect of PIPLC treatment on E14 chicken sympathetic lumbar 
chain neurons cultured in the presence of either GDNF or NGF. Bar chart of the 
percent of survival of E14 chicken sympathetic lumbar chain neurons grown with 
either NGF (10 ng/ml) or GDNF (1 pg/ml). The means and standard errors are 
shown (n=4)
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3.2. ECTOPIC EXPRESSION OF CHICKEN GDNFR-a AND
NTNR-a ON SCG NEURONS
To ascertain the involvement of GDNFR-a and NTNR-a in the survival 
responses of developing neurons to their putative ligands, GDNF and neurturin, 
cultured neurons that do not respond to either GDNF or neurturin were 
microinjected to introduce expression plasmids encoding GDNFR-a and NTNR-a. 
Since GDNFR-a and NTNR-a are ligand binding receptors and do not tranduce the 
signal intracellularly, an expression vector encoding RET, the ligand transducing 
component of both GDNF and NTN receptor complexes, was also used for 
microinjection. From a survey of several different populations of neurons, 
sympathetic neurons of the superior cervical ganglion (SCG) of postnatal day 4 (P4) 
mice were found to not be supported by either GDNF or neurturin in culture. 
Reverse transcription/polymerase chain reaction (RT/PCR) analysis revealed that 
these neurons do not express endogenous mRNAs encoding GDNFR-a, NTNR-a 
or RET, whereas P4 mouse nodose neurons, which survive in response to GDNF 
and neurturin, express these mRNAs (Buj-Bello et a l,  1997). Furthermore, 
because postnatal mouse SCG neurons die rapidly in defined medium lacking 
neurotrophic factors, they are ideal for examining the involvement of ectopically 
expressed receptors in mediating neurotrophic factor responses.
3.2.1. Methods
3.2.1.a) Construction of expression vectors
GDNFR-a and NTNR-a cDNAs were subcloned into the pMEX vector. A 
2.7 kb BamHI/SnaBI GDNFR-a cDNA fragment containing the full coding region 
was subcloned into a BamHI/Smal linearized pMEX vector of 3.7 kb. The ligation 
was carried in a total volume of 11 pi, containing: 1 pi of lOx ligation buffer, 6 pi 
of cDNA fragment (40 ng), 1 pi of linearized pMEX (10 ng), 2 pi of distilled water 
and 1 pi of T4 DNA ligase (Biolabs). The mixture was incubated overnight at 4°C. 
The orientation of the insert was checked by restriction map analysis. A 1.8 kb 
NTNR-a DNA fragment containing the full coding region was subcloned into the 
linearized pMEX vector using the cloning sites Sphl/Smal. The 1.8 kb DNA
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fragment was composed of a 110 bp PCR amplified Sphl/Smal DNA fragment 
(Vent DNA polymerase was used for amplification, Biolabs) and a 1758 bp 
Smal/Smal cDNA fragment. Ligations were carried out using similar conditions as 
those described above and insert orientations were determined by restriction map 
analysis. Given the fact that PCR amplification of DNA can result in mutations, the 
5' end of the insert was sequenced using the termination chain reaction method 
(section 2.1.6). Long form RET cDNA inserted into pRc/CMV vector (a gift from 
A. Rosenthal) was used for microinjection.
Competent XL 1-Blue E.coli cells were transformed with either the ligation 
products or RET plasmid, and grown in culture medium. Plasmid DNA was 
purified using the Qiagen mini- and midiprep kits, according to manufacturer's 
instructions. For microinjection, each construct was diluted at a concentration of 
100 pg/ml in phosphate-buffered saline (PBS).
3.2.l.b) Neuronal culture and microinjection
Superior cervical ganglia were dissected from CDl mice at P4. The ganglia 
were dissociated and the neurons were separated from non-neuronal cells by 
differential sedimentation (chapter 2). The resulting neuronal suspension was plated 
in 60 mm plastic tissue culture dishes pre-coated with poIy-DL-ornithine and 
laminin (chapter 2). Cells were grown for 12 hours in a defined medium consisting 
of Ham's FI4 supplemented with glutamine and 10% of SATO (containing 
pathocyte-4-BSA, putrescine, progesterone, L-thyroxine, sodium selenite, tri-iodo- 
thyronine), and 2 ng/ml of NGF. After this time, the cultures were washed 
extensively with neurotrophin-free medium, and neurons were pressure-injected 
into the nucleus (Ailsopp et aL, 1993) with the expression plasmids (either 
pMEX/GDNFR-a, pMEX/NTNR-a, pRc-CMV/RET or a combination of these 
constructs). The cultures were supplemented with either GDNF or neurturin 
immediately after injection, and the number of surviving neurons was counted 48 
hours later and expressed as a percentage of the number of injected neurons.
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3.3.2. Results
P4 mouse SCG neurons in culture were microinjected with expression 
plasmids encoding GDNFR-a, NTNR-a or RET. Ectopic expression of either 
GDNFR-a or NTNR-a alone in SCG neurons had a negligible effect on the number 
of neurons surviving with either GDNF or neurturin (less than 5% survived in 
medium containing these factors following injection with either GDNFR-a or 
NTNR-a expression plasmids) (figure 4.8.B). A similar low level of survival was 
observed in cultures of these injected neurons growing in medium without added 
factors (figure 4.8.A). This suggests that neither GDNFR-a nor NTNR-a alone are 
capable of mediating survival responses to GDNF and neurturin.
Because RET is an essential component of the GDNF receptor complex 
(Trupp et a i, 1996; Durbec et a l, 1996a; Jing et a i, 1996; Treanor et a l, 1996), 
neurons were co-injected with expression plasmids for RET and either GDNFR-a or 
NTNR-a to see if neurons expressing both of these receptors components would 
exhibit specific survival responses to GDNF and neurturin. Ectopic expression of 
RET alone promoted the survival of approximately 10% of SCG in the absence of 
added factors (figure 4.8.A). However, neither GDNF nor neurturin significantly 
increased the survival of RET-expressing neurons (p > 0.05, t-test, n=6) suggesting 
that RET alone is not capable of mediating survival responses to GDNF and 
neurturin. In contrast, neurons co-expressing NTNR-a plus RET had a 
substantially enhanced survival response to neurturin that was statistically greater 
than that of neurons expressing RET alone (p = 0.003, t-test, n=6). Likewise, 
neurons co-expressing GDNFR-a plus RET had substantially enhanced survival 
response to GDNF that was significantly greater than that of neurons expressing 
RET alone (p = 0.0002, t-test, n = 8) (figure 4.8.B). In contrast, neurons co­
expressing GDNFR-a plus RET showed no enhanced survival response to neurturin 
and there were no more RET/GDNFR-a expressing neurons surviving with 
neurturin than RET-expressing neurons. Likewise, the number of RET/NTNR-a 
expressing neurons surviving with GDNF was not significantly different from the 
number of RET-expressing neurons surviving with this factor (p > 0.2, t-test, n = 8) 
(figure 4.8.B). These results imply that GDNFR-a and NTNR-a are receptors for 
GDNF and neurturin, respectively, and that RET is required for signalling and the
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survival response to both factors. Although GDNFR-a and NTNR-a in the 
presence of RET conferred specific survival responses to GDNF and neurturin at 
concentrations of 5 ng/ml, at 10-fold higher concentrations of these factors some 
cross-talk in responsiveness was observed, with GDNF being a more promiscous 
neurotrophic factor than neurturin (figure 4.9).
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Figure 4.8. Bar chart of the percent survival of P4 mouse SCG neurons 48 
hours after microinjection with expression plasmids for GDNFR-a. NTNR-a and 
RET both singularlv and in combination. The injected neurons were incubated in 
medium containing either neurturin or GDNF. The means and standard errors of 
the combined results of 8 separate experiments are shown (n > 4 for each 
experimental condition).
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Figure 4.9. Bar chart of the percent survival of P4 mouse SCG neurons 48 
hours after microiniection with expression plasmids for GDNFR-a. NTNR-a and 
RET both singularlv and in combination, in the presence of 50 ng/ml of either 
neurturin or GDNF. The means and standard errors of the combined results of 6 
separate experiments are shown (n > 4 for each experimental condition).
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4. EXPRESSION ANALYSIS OF CHICKEN GDNF AND
NEURTURIN RECEPTORS ALPHA
4.1. EXPRESSION ANALYSIS BY NORTHERN BLOTTING
Since there is sequence homology between GDNFR-a and NTNR-a, the use 
of a probe from the 3' region avoids the possibility of cross-hybridization of the 
GDNFR-a probe with NTNR-a mRNA and vice versa.
4.1.1. Methods
4.1. La) Preparation of the probes by polvmerase chain reaction amplification
Since there is sequence homology between GDNFR-a and NTNR-a, DNA
probes were obtained by polymerase chain reaction (PCR) amplification of non- 
homologous fragments of the GDNFR-a and NTNR-a cDNA, to avoid cross- 
hydridisation of the GDNFR-a probe with the NTNR-a mRNA transcripts and vice- 
versa. The primers used for PCR amplification of chicken GDNFR-a and NTNR-a 
were: 5 -GCCACATATCCTCGGAGAATTC-3' and
5 -TAGAATGGCTTCTCAGCAGG-3' for GDNFR-a, and
5 -CCAGAAGACCTTTGTGGATCAG-3' and
5 -GACAGCCTCACACCGTTTGAAT-3' for NTNR-a.
The PCR reaction was carried out in 0.5 ml Eppendorf tubes. 36 p.1 of a 
master mixture containing 19 |Xl of distilled water, 2 (xl of a ICO mM dNTPs, 10 p.1 
of 25 mM MgCh and 5 p,l of lOx PCR reaction buffer (Promega) was added to 10 
p.1 of primers (5 p.1 of each primer at 15 pmol/p.1) and 1 p.1 of plasmid pBs/GDNFR- 
a or pBs/NTNR-a (1 ng/p.1). After mixing, 1 p.1 of Taq DNA polymerase (Promega) 
was added to the tube, and after further mixing, 50 p.1 of mineral oil was added to 
avoid evaporation of the sample during PCR amplification. The PCR conditions for 
each of the 20 cycles were: dénaturation of the double-stranded DNA for 1 minute at 
95°C followed by annealing of the primers to the DNA at 60°C for 1.5 minutes and 
extension or DNA synthesis for 2 minutes at 72°C.
After amplification, the single PCR product was separated from the plasmid 
DNA and primers by electrophoresis in a 1% low-melting-temperature (LMP)
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agarose gel. The amplified DNA band was cut from the gel and the DNA was 
purified from the agarose by STE/phenol/chloroform extraction (Sambrook et a l , 
1989). The GDNFR-a and NTNR-a DNA fragments were then labelled by nick- 
translation (Sambrook et a l, 1989).
4.1.1.b) Northern blotting and hybridization
Several tissues were dissected from white leghorn chicken embryos at 
different stages of development. Total RNA was isolated, electrophoresed and 
blotted to Hybon-N+ membranes as previously described in chapter 2. 
Hybridization was also carried out according to the same procedure described in that 
chapter. A specific 686 bp PCR-amplified chicken GDNFR-a DNA probe, and a 
specific 626 bp PCR-amplified chicken NTNR-a DNA probe were used for 
hybridization with GDNFR-a and NTNR-a mRNAs, respectively. The probes were 
32P-labelled by nick-translation. Hybridization was carried out for 48 hours at 42°C 
in the solution described in chapter 2 and containing the radiolabelled probe. 
Following hybridization, the filters were washed at 65°C in 2X SSC with 0.2%SDS 
before exposure to Kodak Omat X-ray film. Filters were first hybridized with the 
32P-labelled nick-translated GDNFR-a probe. Subsequently, the DNA probe was 
stripped off the filters by boiling, and rehybridised with the 32p-]abelled nick- 
translated NTNR-a probe.
4.1.2. Results
Northern blotting was used to study the expression of GDNFR-a and NTNR- 
a transcripts in chicken embryos at different developmental stages. A single 
GDNFR-a transcript of approximately 10 kb and two NTNR-a transcripts of 
approximately 3.5 and 2.8 kb were present in the nervous system and several other 
tissues. However, in some tissues only one NTNR-a transcript of 3.5 kb was 
detected.
Whereas similar levels of NTNR-a transcripts (2.8 and 3.5 kb) were present 
in the spinal cord, medulla oblongata, pons, cerebellum, midbrain (including the 
tectal vesicles), and forebrain at ElO, the expression of GDNFR-a was far higher in 
the spinal cord than other CNS regions at this stage (figure 4.10). Among non­
neuronal tissues. Northern blotting at ElO revealed very high levels of NTNR-a
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mRNA in the liver compared to other tissues such as muscle, skin, kidney, and 
intestine. The expression of NTNR-a mRNA was barely detectable in lung and 
heart at this stage of development. In non-neuronal tissues, GDNFR-a mRNA was 
present at moderate levels in kidney and intestine, and at low levels in liver and 
skin. This transcript was hardly detectable by Northern blotting in muscle, lung, 
and heart (figure 4,10).
Northern blotting of tissues dissected from chicken embryos at E18 revealed 
that both GDNFR-a and NTNR-a mRNAs were expressed at variable levels in both 
neuronal and non-neuronal tissues (figure 4.11). In the CNS, GDNFR-a and 
NTNR-a transcripts were expressed at high, moderate, and low levels in the 
midbrain, forebrain, and spinal cord, respectively. Among non-neuronal tissues, 
very high levels of NTNR-a transcripts were present in liver, whereas only very 
low levels of GDNFR-a mRNA were expressed in this organ. Northern blotting 
also revealed moderate levels of expression of NTNR-a mRNAs in the small and 
large intestines, and kidney, and low levels in lung, muscle, and skin. GDNFR-a 
transcript was present at moderate levels in lung and kidney, and at low levels in the 
small and large intestines, whereas it was not detected by Northern blotting in 
muscle and skin (figure 4.11).
Developmental changes in the expression of these transcripts were clearly 
observed in some tissues (figure 4.12). In the spinal cord, GDNFR-a and NTNR-a 
mRNA levels decreased markedly between ElO and E12 and remained at low levels 
at later embryonic stages. In the skin, there was a gradual decrease in the 
expression of GDNFR-a and NTNR-a mRNAs with age. In contrast, the 
expression of GDNFR-a and NTNR-a transcripts increased slightly in the midbrain 
and forebrain between ElO and E14.
Thus, GDNFR-a and NTNR-a mRNAs are widely distributed in neuronal and 
non-neuronal tissues, and the level of expression of these transcripts changes in 
some of tissues during the development of the chicken embiyo.
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F igure 4.10. Expression of GDNFR-a and NTNR-a mRNAs in the 
chicken embrvo at ElO. Northern blot of total RNA from various tissues. Filters 
were hybridized sequentially with GDNFR-a and NTNR-a probes. Bands 
corresponding to the 10 kb GDNFR-a and 3.5 and 2.8 kb NTNR-a transcripts are 
indicated. Ethidium bromide picture of the 28S ribosomal RNA on filters is shown 
to compare the relative levels of total RNA present in each sample.
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Figure 4.11. Expression of GDNFR-a and NTNR-a mRNAs in the chicken 
embrvo at E l8. Northern blot of total RNA from various tissues of chicken 
embryos at E l8. Filters were hybridized sequentially with GDNFR-a and NTNR-a 
probes. Bands corresponding to the 10 kb GDNFR-a and 3.5 and 2.8 kb NTNR-a 
transcripts are indicated. Ethidium bromide staining of the 28S ribosomal RNA on 
filters is shown to compare the relative levels of total RNA present in each sample.
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Figure 4.12. Developmental changes in the expression of GDNFR-a and 
NTNR-a mRNAs in the chicken embrvo. Northern blot of total RNA from chicken 
midbrain, forebrain, spinal cord, and skin at different ages. Filters were hybridized 
sequentially with GDNFR-a and NTNR-a probes. Bands corresponding to 
GDNFR-a and NTNR-a transcripts are shown. In the photograph of the ethidium 
bromide stained gel (midbrain, forebrain and spinal cord) and filter (skin), 28S 
ribosomal RNA is shown to compare the relative levels of total RNA present in each 
sample.
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4.2. EXPRESSION ANALYSIS BY IN  SITU  HYBRIDIZATION
4.2.1. Methods
4.2. La) Cryosectioning of chicken embryos
Chicken brain and trunk from embryonic days 10 and 18 were dissected, 
embedded in OCT component (Tissue Tek), and immediately frozen in liquid 
nitrogen. Serial sections between 15 jam and 30 p,m were cut using a cryostat and 
mounted on poly-L-lysine-coated slides. Sections were kept at -80°C until use.
4.2. Lb) Synthesis of digoxigenin-labelled riboprobes
The synthesis of digoxigenin (DIG)-labelled riboprobes involves several
steps.
4.2.1.b)l. Subcloning of DNA fragments into a vector
The 686 and 626 bp PCR-amplified DNA fragments of GDNFR-a and 
NTNR-a used as probes for hybridization of Northern blots (this chapter) were 
subcloned into the vector pGEM-T (Promega). For the ligation reaction, 12 ng and 
6 ng of vector DNA was mixed with 50 ng and 25 ng of 686 and 626 bp DNA 
fragments, respectively, in Eppendorf tubes. 1 p.1 of lOx ligation buffer (Promega) 
was added to each tube and the final volume was made up to 10 pi with distilled 
water. 1 pi of T4 DNA ligase (3 units/pl, Promega) was added and the mixture was 
incubated for 4 hours at 4°C for the ligation reaction to proceed. XLl Blue 
competent E.coli bacteria were transformed with the product of the ligation reaction. 
Following transformation, restriction analysis of miniprep DNA was used to select 
bacterial colonies containing plasmid vectors carrying the correct insert DNA and to 
determine the orientation of the insert. Correctly identified colonies were then 
grown up to amplify and isolate plasmid DNA (for procedures, see Sambrook et ai, 
1989; this chapter).
4.2.1.b)2. Linearization of plasmids
The plasmid pGEM-686bp insert was linearized by digestion with the 
endonucleases Sac II and Pst I, whereas the plasmid pGEM-626bp insert was
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linearized by digestion with the restriction enzymes Sal I and Sph I, for reasons 
given below. Fully digested plasmids were purified by phenol/chloroform 
extraction (Sambrook et a l, 1989).
4.2.1.b)3. Synthesis of sense and antisense DIG-labelled RNA
The following solutions were added and mixed in an Eppendorf tube: 4 pi of 
5x transcription buffer (DIG RNA labelling kit, Boehringer), 2 pi of 0.1 M DTT, 2 
pi of lOx DIG RNA labelling mix (Boehringer), 1 pi (38 units) of ribonuclease 
inhibitor (RNA Guard, Pharmacia), 10 pi (150 ng) of linearized plasmid, 1 pi of 
either T7 RNA polymerase (50 units, Gibco) or SP6 RNA polymerase (20 units, 
Promega). The mixture was incubated for 1.5 hours at 37°C. After one hour of 
incubation the RNA synthesis was monitored by loading a sample of the reaction in 
an agarose gel. For synthesizing GDNFR-a sense and antisense RNA, the plasmid 
pGEM-686bp insert was linearized with Sac II and Pst I, respectively, and the 
transcription enzyme used was SP6 and T7 RNA polymerase, respectively. In the 
case of NTNR-a sense and antisense RNA synthesis, the Sal I linearized pGEM- 
626bp plasmid and the SphI linearized pGEM-626bp plasmid were incubated with 
T7 and SP6 RNA polymerase, respectively.
The transcription reaction was stopped by addition of 130 pi of STE and 5 pi 
of 10% SDS. Sephadex G-50 column (Nick Column, Pharmacia Biotech) was 
used according to manufacturer's instructions to separate the DIG-labelled riboprobe 
from the unincoiporated nucleotides. Prior to use, the Sephadex G-50 column was 
washed with STE containing 0.1% SDS. Following this, 50 pi of tRNA (10 
mg/ml) was added to the column to avoid non-specific binding of the synthesized 
RNA to the Sephadex. Finally, the column was washed again with STE containing 
0.1% SDS. The RNA was precipitated by the addition of 1:20 vol. of 3 M sodium 
acetate and 2-2.5 vol. ethanol followed by overnight incubation at -20°C. 
Subsequently, the RNA pellet was washed in 70% ethanol and resuspended in 50 pi 
of distilled water. Approximately 1 pg of RNA was synthesized and recovered 
from each transcription reaction using this procedure.
The synthesized RNA (1 pg) was finally diluted in 1 ml of in situ 
hybridization buffer. 50 ml of this buffer contained the following reagents: 25 ml of 
formamide, 12.5 ml of 20x SSC, 0.5 ml of 10% Triton X-100, 2.5 ml of CHAPS,
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5 ml of yeast RNA (10 mg/ml), 0.25 mi of 1 M EDTA pH 8.0, 1 ml of distilled 
water, 2.5 ml of Heparin (1 mg/ml), 0.75 ml of lOOx Denhardt’s solution, and 1 gr 
of Blocking reagent (Nucleic Acid Detection Kit, Boehringer).
4.2.1.C) In situ hybridization
4.2.1.c)l. Pre-treatment of sections for hybridization
The slides containing the sections were kept in boxes at -80°C before use. 
Prior to hybridization, the slides were placed in racks and immersed for 5 minutes in 
chilled 4% paraformaldehyde/PBS, pH 7.5. Following this, the sections were 
rinsed twice in PBS, pH 7.5, before being immersed for 10 minutes in 0.1 M 
triethanolamine pH 8.0/ PBS + (v/v) acetic anhydride 0.25%. Next, the slides were 
immersed twice, for 2 minutes each time, in PBS pH 7.5 followed by 2 minutes in 
each of 70% ethanol, 96% ethanol and 100% ethanol. After a 5 minutes soak in 
chloroform and 2 minutes in 100% ethanol, followed by 2 minutes in 96% ethanol, 
the sections were finally air dried in a laminar flow hood.
4.2.1.c)2. Hybridization
A few drops of either sense or antisense RNA (1 pg/ml in hybridization 
buffer) were distributed on the surface of each section. The sections were then 
covered by a piece of parafilm to avoid evaporation of the solution, and placed into a 
humified box. Hybridization was carried out in a water bath, for 24 hours, at 55°C.
4.2.1.c)3. Post-hvbridization washes
After hybridization, the sections were washed sequentially for 5-10 minutes, 
at 55°C, in the following solutions: solution I (50% formamide, 5x SSC, 0.1% 
Triton X-100, 0.5% CHAPS); 75% solution I/2x SSC; 50% solution I/2xSSC; 
25% solution I/2x SSC; twice in 2x SSC/0.1% CHAPS; 0.2x SSC/0.1% CHAPS. 
Then, the sections were washed twice for 5-10 minutes at room temperature in 
TBT (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% Triton X-100). This was 
followed by a 30 minutes room temperature wash in 1% Blocking agent/TBT with 
2% sheep serum and two 5 minutes washes in TBT.
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4.2.1.c)4. Incubation with anti-digoxigenin antibodies
100-150 jil of 1:150 dilution of anti-digoxigenin-AP, Fab fragment 
(Boehringer) in TBT/2% sheep serum was distributed on the surface of the sections, 
and incubated overnight at 4°C.
4.2.1.c)5. Post-antibodv washes
After incubation with antibodies, the sections were washed three times at 
room temperature, for 10 minutes, in TBT, followed by three washes for 5 minutes 
in NTM (100 mM NaCl, 100 mM Tris-Cl pH 9.5, 50 mM MgCh, 0.1% Tween- 
20). Finally, the sections were incubated at 4°C in 4.5 p.1 of NBT solution 
(Boehringer) + 3.5 p.1 of bovine calf intestine phosphatase (Cip)/ml of NTM, and 
left in a dark place for few hours until the colorimetric reaction had finished. The 
extend of the colorimetric reaction was monitored using a microscope. The slides 
were then mounted with AFl, a glycerol/PBS mounting solution (Citifluor), and 
kept at 4°C until examination under the microscope.
4.2.2. Results
In situ hybridization was used to analyse the expression at the cellular level of 
both GDNFR-a and NTNR-a mRNAs in neural tissues. This technique is 
especially useful for detecting the presence or absence of these transcripts in the 
ganglia of the peripheral nervous system, bearing in mind that neurons from most 
ganglia respond in vitro to both GDNF and neurturin.
In accordance with Northern blot analysis, in situ hybridization revealed 
prominent expression of GDNFR-a and NTNR-a in spinal motoneurons at ElO and 
low levels of both transcripts in these neurons at E18 (figure 4.13). In the 
peripheral nervous system, GDNFR-a and NTNR-a were prominently expressed in 
the ganglia of the sympathetic lumbar chain and dorsal root ganglia (figure 4.13). 
In situ hybridization also revealed marked expression of GDNFR-a mRNA in 
cerebellar granule cells (GC), Purkinje cells (PC), and neurons in the deep 
cerebellar nuclei (DN) (figure 4.14). The same pattern of expression was observed 
for NTNR-a mRNA in cerebellum (not shown). When using DIG-labelled sense 
riboprobes as a negative control for hybridization, the probes did not hybridize with 
any staicture, and only a general low background was detected (not shown).
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F igure 4.13. Transverse sections of the lumbar region of ElO and E l8 
chicken embrvos hvbridized with DIG-labelled GDNFR-a and NTNR-a antisense 
riboprobes. Localisation of a dorsal root (DRG) and sympathetic chain ganglion 
(SC) is shown. Motoneurons in the ventral spinal cord are indicated with an arrow. 
Scale bar = 200 pm.
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Figure 4.14. Sagital section of the cerebellum of E l8 chicken embrvo 
hybridised with DIG-labelled GDNFR-a antisense riboprobe. Localisation of 
Purkinje cells (PC), granule cells (GC), and neurons from the deep nuclei (DN) is 
shown.
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4.3. EXPRESSION ANALYSIS BY RT-PCR
The aim of this study was to analyse the expression of GDNFR-a and 
NTNR-a mRNAs in embryonic chicken PNS neurons that respond to both GDNF 
and neurturin in vitro. Since the number of neurons obtained from each dissection 
is too small for Northern blot analysis, specific mRNAs were detected by PCR 
amplifying reverse transcribed total RNA (RT-PCR). A semiquantitative RT-PCR 
assay was used to compare the relative levels of GDNFR-a and NTNR-a transcripts 
in certains populations of PNS neurons at ElO and E14.
4.3.1. Methods
4.3.1.a) Dissection and purification of neurons
ElO ciliary, nodose, and sympathetic lumbar chain ganglia, and E14 
dorsomedial trigeminal ganglion (DMTG) were dissected from White Leghorn 
chicken embryos. Neurons were separated from non-neuronal cells by differential 
sedimentation (Davies, 1988a). Purified neurons were immediately frozen and kept 
at -80°C until further use.
4.3.1.b) RNA extraction for PCR
Total RNA was extracted from neurons that were purified from 30 to 50 
ganglia. Cells were lysed in 0.5 ml of solution D (for composition, see chapter 2) 
by passing the neuronal suspension through a 25 gauge needle fitted to a 1 ml 
syringe. Eppendorf tubes containing the cell lysates were placed on ice, and the 
following solutions were added sequentially: 2 jil of E.coli tRNA (5 mg/ml), 50 |il 
of 2 M sodium acetate pH 4.4, 0.5 ml of water saturated acidic phenol, and 150 jxl 
of 25:1 chlorofomi:isoamyl alcohol. The mixture was shaken vigorously, incubated 
on ice for 15 minutes, and centrifuged at 13,000 rpm for 30 minutes. The upper 
aqueous phase was transferred to fresh tubes, and RNA was precipitated by the 
addition of two volumes of ethanol followed by incubation at -20°C overnight. 
Tubes were then centrifuged at 13,000 rpm for 30 minutes. The RNA pellet was 
washed in 70% ethanol and air dried on the bench. The RNA was resuspended in 
50 jxl of 10 mM Tris pH 7.5, 6 mM MgCh, 20 mM VRC's (vanadyl-ribonucleoside
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complex, Sigma), 2.5 units of RNase-free DNase I (Pharmacia). The mixture was 
incubated at 37°C for 1 hour. The RNA was further purified using an RNaid kit 
(BIO 101). In brief, three volumes (150 |il) of NaClOs and 30 jil of RNA binding 
matrix were added to the RNA followed by incubation for 5-10 minutes at room 
temperature to allow RNA to bind to the matrix. The matrix was sedimented by 
brief centrifugation and washed twice in 0.7 ml of RNaid wash solution. The 
remaining RNAid wash solution was completely removed, with a fine pipette tip, 
and RNA was eluted from the matrix by resuspension in 100 p,l of distilled water 
and incubation at 60°C for 3 minutes. Following centrifugation, at 13,000 rpm for 
1 minute, the supernatant containing the RNA was tranferred to fresh tubes and 
stored at -80°C until use.
4.3.1 .c) Reverse transcription
For each reaction, 2 p.1 of resuspended RNA was reverse transcribed in a 40 
p,l final volume reaction containing: 8 p.1 of 5x RT Superscript buffer, 4 p.1 of 5 mM 
dNTPs, 4 p,l of 100 p.M random hexanucleotides (RH), 4 pi of 0.1 M DTT. For 
negative controls, RNA was replaced by distilled water. The sample was heated for 
3 minutes at 90°C, and then 1 p.1 of Superscript reverse transcriptase (Gibco) was 
added to the mixture. Another negative control with no reverse transcriptase was 
performed. The reaction was allowed to proceed for 1 hour at 37°C, after which 
time it was stopped by heating the sample for 6 minutes at 95°C.
4.3.l.d) Polvmerase chain reaction
Chicken GDNFR-a, NTNR-a and GAPDH cDNAs were amplifified by PCR 
from cDNA that had been synthesized from RNA extracted from ElO ciliary, 
sympathetic lumbar chain, and nodose ganglion neurons, and E14 DMTG neurons. 
For each PCR reaction, 35 p.1 of a master mix solution was added to an 0.5 ml 
Eppendorf tube. The composition of the master mix (n, number of PCR) was: (nx) 
5 p.1 of lOx PCR buffer (Promega), (nx) 10 pi of MgCh, (nx) 2 pi of 100 mM 
dNTPs, and (nx) 18 pi of distilled water. The following solutions were added to 
each tube containing 35 pi of master mix: 5 pi of each primer, 5 pi of cDNA, 1 pi 
of Taq DNA polymerase (Promega). After mixing, each reaction was overlayed 
with 50 pi of mineral oil. The amounts of cDNA in samples were normalised by
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amplification of a fragment of GAPDH cDNA.
The primers used were:
Chicken GAPDH: 5'-TGGTGTCTTCACCACCAT-3' and 
5-GCATGGACAGTGGTCATA-3'
Chicken GDNFR-a: 5 -GCCACATATCCTCGGAGAATTC-3' and 
5-TAGAATGGCTTCTCAGCAGG-3'
Chicken NTNR-a: 5'-CCAGAAGACCTTTGTGGATCAG-3' and 
5-GACAGCCTCACACCGTTTGAAT-3'
The tubes were transferred to the heating block of a PCR machine and 
amplification was carried out for 35 cycles using the following parameters: 
dénaturation at 95°C for 1 minute, annealing at 60°C for 1.5 minutes, and DNA 
synthesis at 72°C for 2 minutes.
The PCR products of each reaction were then electrophoresed in a 1 % agai'ose 
gel. Bands of 686, 626, and 242 bp were present corresponding to amplified 
GDNFR-a, NTNR-a, and GAPDH DNA fragments, respectively.
4.3.2. Results
Chicken ElO sympathetic, nodose and ciliary ganglion neurons, and E14 
DMTG neurons are supported by GDNF and neurturin in culture (chapters 2 and 3 
of this thesis). Furthermore, the chicken GDNFR-a and NTNR-a have been cloned 
and demonstrated to be the ligand-specific components of the receptor complex that 
mediates GDNF and neurturin signalling in neurons, respectively (this chapter). By 
using RT-PCR of total RNA isolated from these neurons, it was demonstrated that 
both GDNFR-a and NTNR-a mRNAs are expressed by these cell types (figure 
4.15). The level of expression of GDNFR-a mRNA was similar in ElO 
sympathetic and parasympathetic neurons, but higher in both ElO enteroceptive and 
E14 small-cutaneous sensoiy neurons. In contrast, NTNR-a mRNA was present at 
similai' levels in all of these neuronal types, although a moderately higher level was 
observed in nodose ganglion neurons (figure 4.15).
When comparing the level of expression of both GDNFR-a and NTNR-a 
transcripts in each population of neurons, it was observed that in some kinds of 
neurons, like ciliary ganglion and sympathetic chain neurons, NTNR-a mRNA was
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more highly expressed than GDNFR-a mRNA. In contrast, some other populations 
of neurons, like nodose ganglion and DMTG neurons, expressed more GDNFR-a 
than NTNR-a mRNAs (figure 4.15).
These findings demonstrate that GDNF and neurturin responsive PNS 
neurons express in vivo GDNFR-a and NTNR-a mRNAs.
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Figure 4.15. RT-PCR detection of endogenous GDNFR-a and NTNR-a 
transcripts in chicken ciliary, nodose, dorsomedial trigeminal ganglion, and 
sympathetic lumbar chain neurons. The presence of similar amounts of total RNA 
in samples is demonstrated by amplification of a 242 bp fragment of GAPDH 
mRNA.
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V. DISCUSSION
The results presented in this chapter report the cloning and characterization of 
the chicken receptors for GDNF and neurturin. The chicken receptor for GDNF is 
homologous to the recently discovered rat GDNFR-a (Jing et a i, 1996; Treanor et 
a i, 1996). The chicken receptor for neurturin, termed NTNR-a, is a novel protein 
that is structurally related to GDNFR-a. The cloning of rat, mouse and human 
homologues of NTNR-a has also been reported recently (Klein et a i , 1997; Baloh 
et a i, 1997). It is shown that both chicken GDNFR-a and NTNR-a are GPI-linked 
cell-surface proteins that lack a cytoplasmic domain capable of transducing the 
extracellulai' signal to the intiacellular compartment. Furthermore, it is demonstrated 
by microinjection that GDNFR-a and NTNR-a play a key role in ligand 
discrimination in the physiological responses of neurons to GDNF and neurturin, 
and that RET receptor tyrosine kinase is a common transmembrane component of 
the active GDNF and neurturin receptor complexes that transduces the ligand signal 
into the cytoplasm. The physiological relevance of GDNFR-a and NTNR-a during 
embryonic development is shown by analysis of their expression pattern. The 
transcripts for these receptors are widely distributed in the nervous system and in 
non-neuronal tissues. Significantly, these transcripts are expressed in GDNF- and 
neurturin-responsive neurons from the peripheral nervous system.
In agreement with the protein structure of both chicken GDNFR-a and 
NTNR-a described in this chapter, human and rodent GDNFR-a and NTNR-a 
protein sequences have also been reported and display similar characteristics to their 
chicken homologue. Thus, both avian and mammalian receptors are small proteins 
that contain an amino-terminal hydrophobic putative signal sequence for secretion, a 
short carboxy-terminal hydrophobic region, a cleavage/binding consensus sequence 
for GPI-linkage and 30 conserved cysteine residues (Jing et a i, 1996; Treanor et 
ai, 1996; Klein et al. , 1997; Baloh et al. , 1997). Furthermore, chicken GDNFR-a 
is 80% identical to rat GDNFR-a at the amino acid level, and the sequence identity 
between GDNFR-a and NTNR-a, which is 49% in the chicken, is 48% in human 
(Klein et al. , 1997; Baloh et al. , 1997). Thus, GDNFR-a and NTNR-a constitute a 
novel family of stmcturally related receptors. It is likely that other members of the
169
family exist and their identification forms the basis of future research.
Several isoforms of TrkA, TrkB and TrkC containing truncations in either 
their intracellular or extracellular domains have previously been identified (Klein et 
a i, 1990; Middlemas et a i ,  1991; Barker et a i, 1993; Valenzuela et al., 1993; 
Tsoulfas et al., 1993; Ninkina et al., 1997). It would be interesting to analyse 
whether truncated variants of GDNFR-a and NTNR-a also exist, because this could 
affect either the binding to their ligands or their interaction with RET. In fact, a 
truncated isoform of NTNR-a with a deletion of 133 amino acids near the amino 
tenninal region has already been identified, however, it has not been shown whether 
the physical interaction of this variant with other proteins is altered by the deletion 
(Baloh et al., 1997).
The results in this chapter show that chicken neurons that respond to GDNF 
and neurturin loose responsiveness to these factors, but not to neurotrophins, when 
cultured in the presence of PIPLC, an enzyme that specifically hydrolyses GPI 
moieties. Similarly, the number of cultured rat spinal motoneurons surviving with 
either GDNF or neurturin is greatly reduced following PIPLC treatment (Treanor et 
al., 1996; Klein et a i, 1997). This indicates that GDNF and neurturin survival 
responses in neurons are mediated via a GPI-linked receptor. Most convincingly, 
the survival response of these PIPLC-treated neurons to either GDNF or neurturin 
can be restored by administration of a soluble form of GDNFR-a and NTNR-a, 
respectively (Treanor et al. , 1996; Klein et al., 1997). Furthermore, the neurturin- 
induced survival of P4 SCG neurons that ectopically co-express NTNR-a and RET 
is markedly reduced by PIPLC tieatment (Buj-Bello et al., 1997). In agreement 
with the results obtained from primary neuronal cultures, GDNF administered with 
soluble GDNFR-a induces RET autophosphorylation in Neuro-2A cells, a 
neuroblastoma cell line that expresses intrinsically high levels of RET, and PIPLC 
treatment of these tumoral cells expressing ectopically GDNFR-a decreases the 
binding of GDNF to the cell surface (Jing et a l, 1996). Thus, it seems that both 
GDNFR-a and NTNR-a are receptors bound to the membrane via a GPI linkage. 
GDNF and NTN appear to be members of an emerging class of neurotrophic factors 
that signal through a receptor complex that includes a GPI-linked component, with 
CNTF being the founder of this class. The CNTF receptor is a tripartite receptor
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that also contains an alpha component (Davis et a i, 1991). CNTFRa is suficient to 
confer CNTF responsiveness upon transfection in cells that respond to LIF and 
express both gpl30 and LIFRB, the other two components of the CNTF receptor 
(Ip et a l, 1993c). Furthermore, cell lines not normally responsive to CNTF 
respond to treatment with a combination of CNTF and soluble form of CNTFRa 
(Davis et a l, 1993b). Although funcionally similar, CNTFRa is not structurally 
related to either GDNFR-a or NTNR-a.
The current model for GDNF and neurturin receptors implies GDNFR-a and 
NTNR-a as the ligand-binding GPI-linked proteins in multicomponent receptors that 
contain RET protein tyrosine kinase as a common transmembrane signalling 
component. Results in this chapter support this model, since ectopic expression of 
either GDNFR-a or NTNR-a alone in mouse P4 SCG neurons do not confer 
responsiveness to GDNF and neurturin, respectively. Similarly, neither GDNF nor 
neurturin promotes the survival of neurons that ectopically express RET alone. In 
contrast, co-expression of either GDNFR-a plus RET or NTNR-a plus RET induces 
survival responsiveness to GDNF and neurturin, respectively, of intrinsically non- 
responsive neurons. Thus, microinjection has proven to be a powerful tool for 
studying the function and binding abilities of receptors into a physiological context. 
In agreement with this model, GDNFR-a was the only receptor isolated by 
expression cloning strategies searching for GDNF binding proteins (Jing et a l, 
1996; Treanor et a l, 1996), and both GDNF and neurturin can induce RET tyrosine 
phosphorylation (Trupp et a l, 1996; Durbec et a l, 1996a; Jing et a l, 1996; Treanor 
et a l, 1996; Vega et a l, 1996; Worby et a l, 1996; Klein et a l, 1997; Baloh et a l, 
1997).
There is still controversy as to whether GDNF and neurturin bind directly to 
RET or whether they interact first with GDNFR-a and NTNR-a, respectively, and 
then this complex associates with RET. Transfection studies on cell lines have 
demonstrated that GDNF can stimulate tyrosine phosphorylation of RET when 
GDNFR-a is present, but not when RET is expressed alone, and that RET is co- 
immunoprecipitated with GDNF antibodies in cells that also express GDNFR-a 
(Jing et a l , 1996; Treanor et a l, 1996). Similaiiy, neurturin is able to induce RET 
phosphorylation only when NTNR-a is present (Baloh et a l , 1997), and NTNR-a
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co-immunoprecipitates with RET after neurturin exposure in cells ectopically 
expressing both RET and NTNR-a (Klein et ai,  1997). However, in apparent 
contrast to these data, RET has been immunoprecipitated with anti-GDNF 
antibodies and induced to autophosphorylate after GDNF treatment in MN1 cells, a 
motoneuron hybrid cell line that responds to GDNF and expresses RET (Trupp et 
al., 1996). Furthermore, iodinated GDNF can be co-immunoprecipitated with anti- 
RET antibodies in RET transfected, but not in untransfected, 3T3 fibroblasts, and in 
LA-N-5 cells that express high endogenous levels of RET mRNA. Moreover, a 
low affinity binding of GDNF to RET expressing cells has been detected (Trupp et 
al,  1996; Vega et a l , 1996). Although it is not clear whether RET binds directly to 
GDNF, it has been demonstrated that RET is an essential component of the receptor 
complex. Accordingly, GDNF-induced neuronal outgrowth of neuroblasts is 
severely impaired in RET deficient mice (Durbec et a l ,  1996a). Nevertheless, it 
will be important to determine whether GDNFR-a mRNA (or related proteins, like 
NTNR-a) is expressed in the cell lines used for these controversial experiments. 
Alternatively, the generation of mice models lacking the GDNFR-a and/or the 
NTNR-a genes will clarify if these receptors are physiologically necessary for 
GDNF and neurturin signal. It would be also interesting to see if PNS neurons 
from RET deficient mice respond to either GDNF or neurturin in culture, and 
compare these results with those obtained from either GDNFR-a or NTNR-a 
knockout mice and wild type mice. Furthermore, this could indicate if RET is the 
only transmembrane receptor involved in transducing GDNF and neurturin 
signalling.
The results presented in this chapter show that RET is a signal transducing 
component shared between GDNF and neurturin, and that the ligand specificity is 
conferred by the alpha component of their receptor complexes. However, it is also 
demonstrated that GDNF and neurturin, at high concentrations, can interact with 
NTNR-a and GDNFR-a, respectively. Accordingly, P4 SCG neurons co­
expressing either NTNR-a and RET or GDNFR-a and RET can survive in the 
presence of GDNF and neurturin, respectively. These results are in agreement with 
data reported recently that suggest a low-affinity interaction between neurturin and 
GDNFR-a and between GDNF and NTNR-a with, in both cases, a Kd > liiM (Klein
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é t a l ,  1997). Furthermore, in NTNR-a (also named TrnR2, TGF-B related 
neurotrophic factor receptor 2) and RET co-expressing fibroblasts, neurturin and 
GDNF both stimulate RET phosphorylation in a dose-dependent manner, although 
with neurturin being 30 times more potent than GDNF (Baloh et a l , 1997). Thus, 
it appears as if GDNF and neurturin would interact at high affinity with GDNFR-a 
and NTNR-a, respectively, and some cross-reactivity is observed when the 
receptors are exposed to high concentrations of the heterologous ligands. 
Surprisingly, RET phosphorylation in fibroblasts that ectopically co-express 
GDNFR-a (or TrnRl) and RET is induced by neurturin and GDNF with the same 
potency, suggesting that GDNFR-a interacts with the same affinity with GDNF and 
neurturin (Baloh et a l ,  1997). Taken together, these data generate a new 
controversy about the specificity of GDNFR-a and NTNR-a for their ligands that 
remains to be clarified. If cross-reactivity exists physiologically, then the terms 
GDNFR-a and NTNR-a will have to be changed to TrnRl and TrnR2, respectively, 
as already proposed by Baloh et ai  Null GDNFR-a and NTNR-a mutant mice may 
be useful for analysing the existence of cross-reactivity. For example, it would be 
interesting to study the in vitro response of PNS neurons from NTNR-a and 
GDNFR-a knockout mice to GDNF and neurturin, respectively.
Northern blotting of total RNA from several chicken tissues has revealed that 
GDNFR-a and NTNR-a mRNAs are often co-expressed and both are widely 
distributed in neuronal and non-neuronal tissues. Chicken GDNFR-a is expressed 
as a single 10 kb transcript, whereas two NTNR-a mRNAs of 3.5 kb and 2.8 kb are 
found in most tissues. Similarly, two NTNR-a messages of approximately 4 kb 
have been detected in adult mouse brain (Baloh et al,  1997). In the chicken central 
nervous system, GDNFR-a and NTNR-a mRNAs are found in all regions analysed, 
including midbrain, forebrain and spinal cord at both ElO and E l8, and cerebellum 
and pons-medulla at ElO. Interestingly, the level of expression of these transcripts 
in spinal cord at ElO is relatively high compared to other regions of the CNS, but it 
is relatively low at E l8. Accordingly, GDNFR-a and NTNR-a expression in the 
chicken spinal cord drops markedly from ElO to E l2, and remains low at later ages. 
In situ hybridization has revealed that these transcripts are localised in the 
ventrolateral cell columns of the chicken spinal cord, and supports the observation
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that expression is higher at ElO than at E l8. Similarly, the level of expression of 
GDNFR-a in the ventrolateral horn of the rat spinal cord decreases from embryonic 
to adult ages and NTNR-a mRNA is also found in the ventrolateral cell column at 
embryonic ages. However, in contrast to the results obtained in chicken, NTNR-a 
transcripts appear to be located in the dorsal horn of the rat spinal cord in the adult 
(Klein et a l , 1997). These differences in the localisation of NTNR-a expression 
with development may be due to species differences. GDNFR-a and NTNR-a 
expressing cells in the embryonic chicken and rat spinal cord are likely to be 
motoneurons, which also express RET mRNA and are known to respond to both 
GDNF and NTN in vitro (Henderson et al,  1994; Treanor et al, 1996; Klein et al,  
1997). The loss of motoneurons during the phase of naturally occurring cell death 
may account for the reduction in the level of expression of these transcripts in the 
spinal cord with age. In agreement with the results obtained in chicken, GDNFR-a 
and NTNR-a mRNAs are widely expressed in other regions of the embryonic 
rodent CNS (Treanor etal ,  1996; Klein etal ,  1997; Baloh e ta l ,  1997). Thus, 
GDNFR-a mRNA can be detected by in situ hybridization in the developing rat 
ventral midbrain, pons and medulla oblongata, thalamus, cerebellar primordium, 
hippocampus, cortex and retina (Treanor et a l ,  1996), and NTNR-a mRNA 
expression is localised in the embryonic rodent ventral midbrain (Klein et al, 1997; 
Baloh e tal  1997).
GDNFR-a and NTNR-a transcripts are present in the midbrain where GDNF 
responsive dopaminergic neurons are located (Treanor et al ,  1996; Klein et al, 
1997), and in spinal cord where GDNF and neurturin motoneurons are present 
(Treanor et al ,  1996; Klein et al,  1997). It would be interesting to see if the 
survival of mesencephalic dopaminergic neurons is also promoted by neurturin.
In the peripheral nervous system, GDNFR-a and NTNR-a are also expressed 
by GDNF and neurturin responsive neurons. Thus, they have been found, using 
RT/PCR, in purified neurons from embryonic chicken ciliary, nodose, dorsomedial 
trigeminal and sympathetic ganglia, all of which survive in the presence of either 
GDNF or neurturin in vitro (Trupp et al,  1995; chapters 2 and 3 of this thesis). In 
agreement with these findings, the expression of both GDNFR-a and NTNR-a 
mRNAs has been found in embryonic rat dorsal root ganglion, and NTNR-a 
transcripts are expressed in E l5 rat sympathetic ganglia (Treanor etal,  1996; Klein
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e ta l ,  1997). Neurons from E15 rat DRG and E21 SCG are supported by both 
GDNF and neurturin in culture (Kotzbauer et al,  1996).
In non-neuronal tissues of the chicken embryo, GDNFR-a and NTNR-a 
mRNAs can be detected by Northern blotting at relatively moderate levels in the ElO 
intestine, kidney, skin, muscle and liver, whereas these transcripts are barely 
detectable in lung and heart at the same age. GDNFR-a and NTNR-a transcripts are 
also present in all tissues analysed at E l8, although GDNFR-a mRNA was barely 
detectable by Northern blotting in skin, heart and muscle. In agreement with the 
results obtained in chicken, GDNFR-a and NTNR-a mRNAs are also widely 
expressed in non-neuronal tissues of the rat embryo (Treanor eta l,  1996; Klein et 
al,  1997). GDNFR-a can be detected by in situ hybridization in several developing 
tissues, including kidney, intestine, whisker pad and urogenital tract, amongst other 
regions (Treanor e t a l , 1996). Moreover, it has been recently shown that NTNR-a 
transcripts are found in the embryonic gut, bladder, cardiac conduction system and 
diaphragm (Klein eta l,  1997). In rat embryos, GDNFR-a and NTNR-a mRNAs 
seem to be often co-expressed in the same tissues, occasionally in adjacent 
structures, suggesting complementary biological roles for GDNF and neurturin 
(Klein et a l ,  1997). For example, in the limb GDNFR-a is expressed mainly in 
muscle cells, whereas NTNR-a is found in the brachial plexus, and in the gut 
NTNR-a is expressed in the mucosal epithelium and smooth muscle, whereas 
GDNFR-a is located mainly in the smooth muscle layer (Klein et al,  1997).
RET, the signal tranducing component of the GDNF and neurturin receptor 
complexes (Trupp et al,  1996; Durbec et al,  1996a; Jing et a l ,  1996; Treanor et 
al,  1996; Vega et al,  1996; Worby et a l ,  1996; Klein et al,  1997; Baloh et al,  
1997; this chapter), is co-expressed with GDNFR-a and NTNR-a in most tissues. 
The analysis of RET expression during embryogenesis has revealed the presence of 
RET transcripts in several regions of the central nervous system, including pons, 
medulla, hypothalamus, thalamus, cerebellum, retina, ventral hindbrain and spinal 
cord (Pachnis etal ,  1993; Schuchardt etal ,  1995; Tsuzuki etal,  1995; Iwamoto et 
al,  1993; Trupp e ta l ,  1996). In the peripheral nervous system of chicken and 
rodent embryos, RET mRNA is expresssed in all cranial ganglia as well in the 
dorsal root, sympathetic and enteric ganglia (Pachnis et al,  1993; Schuchardt et al.
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1995; Tsuzuki et ai,  1995). In non-neuronal tissues, RET transcripts have been 
found in the developing kidney, in particular in the Wolfian duct, ureteric bud 
epithelium and growing tips of the collecting ducts (Pachnis etal,  1993; Schuchardt 
etal., 1995; Tsuzuki et al,  1995). Furthermore, RET mRNA is expressed in liver, 
lung, spleen, thymus, ovary, testis, salivary glands, lymph nodes and chromaffin 
cells of the adrenal gland (Pachnis etal,  1993; Tsuzuki et al,  1995). In contrast to 
rodents, RET mRNA is also present in the ventral roots of chicken embryos 
(Schuchardt et a l ,  1995). Although embryonic rodent glial cells do not express 
RET mRNA, they express GDNFR-a and NTNR-a transcripts (Treanor et a l ,  
1996; Baloh et al,  1997). Thus, it would be interesting to elucidate the role that 
GDNF and neurturin play in these cells.
In agreement with expression studies, mice with targeted disruption of the 
RET gene display renal agenesis or severe disgenesis, complete neuronal loss of the 
enteric nervous system in the intestine, whereas the esophagus and stomach are 
partially affected, and absence of the superior cervical ganglion (Schuchardt et a l , 
1994; Durbec et a l , 1996b). The phenotype of GDNF null mutant mice is very 
similar to that of RET knockout mice, however, only 35% of neurons are lost in the 
SCG (Moore et a l ,  1996). This suggests that other neurotrophic factors, like 
neurturin, may act physiologically on promoting the survival of this kind of 
neurons. A detailed analysis of RET deficient mice may clarify whether other 
neuronal populations of the peripheral nervous system are also affected by this 
mutation, since 40% and 23% of neurons from the petrosal-nodose and dorsal root 
ganglia, respectively, are lacking in GDNF knockout mice.
A comprehensive study on the co-expression of GDNFR-a, NTNR-a and 
RET in several tissues of the chicken during embiyogenesis, using Northern blot 
and in situ hybridization, will be necessary to further understand the function of 
these receptors. Moreover, it would be interesting to analyse whether the level of 
expression of GDNFR-a, NTNR-a and RET mRNAs in PNS neurons, as 
determined by quantitative RT/PCR, correlates with the responsiveness of these 
neurons to GDNF and neurturin throughout development. Preliminary results in 
this chapter suggest this, since the level of expression of NTNR-a mRNA was 
higher than GDNFR-a mRNA in ciliary and sympathetic ganglion neurons and these
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neurons are more responsive to neurturin than GDNF in culture (chapter 3). In 
contrast, the level of expression of GDNFR-a mRNA was higher than NTNR-a 
mRNA in nodose ganglion neurons, which are more responsive to GDNF than 
neurturin in vitro (chapter 3).
In summary, the cloning of both chicken GDNFR-a and NTNR-a has been 
reported. These homologous proteins are cell-surface receptors that bind 
preferentially to GDNF and neurturin, respectively, and are bound to the membrane 
via a glycosyl-phosphatidylinositol linkage. Expression analysis of GDNFR-a and 
NTNR-a transcripts has revealed that they are widely present in both the nervous 
system and non-neuronal tissues and are co-expressed by neuronal populations that 
respond in vitro to GDNF and neurturin. The signal transducing component of both 
GDNF and neurturin receptor complexes is RET, a shared transmembrane tyrosine 
kinase. This system of sharing receptor components would seem to be an 
economical way of transducing signals from several growth factors and is also 
employed by the cytokines (Davis and Yancopoulos, 1993) and members of the 
TGF-B protein family (Massagué, 1996a).
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Table 1. Expression of GDNFR-a and NTNR-a mRNAs by Northern
blotting in several chicken tissues at both ElO and E18.
+ : detected 
- ; not detected
nd. : not determined
GDNFR-a NTNR-a
Total brain nd. - nd. 4*
Forebrain + + + 4-
Midbrain + 4- + 4-
Pons & Medulla + nd. + nd.
Cerebellum + nd. + nd.
Spinal cord + + + 4-
Muscle - - + +
Skin + - + +
Kidney + + + +
Total intestine + nd. 4- nd.
Small intestine nd. + nd. 4-
Large intestine nd. + nd. 4-
Heart - - - -
Liver 4* 4" 4-
Lung - + - 4-
ElO E18 ElO E18
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Table 2. Expression of GDNFR-a and NTNR-a mRNAs by Northern
blotting in chicken midbrain, forebrain, spinal cord and skin between E6 and E l6.
+ : detected 
- : not detected 
nd. : not determined
GDNFR-a NTNR-a
Midbrain nd. nd. + + + nd. nd. nd. + + + nd.
Forebrain nd. nd. + + + nd. nd. nd. -h + + nd.
Spinal Cord nd. nd. + - - nd. nd. nd. + - - nd.
Skin + + + + + + + + + + + 4-
E6 E8 ElO E12 E14 E16 E6 E8 ElO E12 E14 E16
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Table 3. Expression of GDNFR-a and NTNR-a mRNAs bv either in situ 
hybridization or PCR in several kinds of chicken neurons between E6 and E l6.
+ : detected 
- : not detected 
nd. : not determined
GDNFR-a NTNR-a
Dorsomedial trigeminal g. neurons nd. + nd. nd. + nd.
Sympathetic lumbar chain neurons + nd. nd. + nd. nd.
Nodose ganglion neurons + nd. nd. + nd. nd.
Ciliary ganglion neurons + nd. nd. + nd. nd.
Spinal motoneurons + nd. + + nd. +
Dorsal root ganglion + nd. nd. -t- nd. nd.
Cerebellar Purkinje cells nd. nd. + nd. nd. +
Cerebellar deep nuclei neurons nd. nd. + nd. nd. +
ElO E14 E18 ElO E14 E18
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